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Research into the neural circuits that underlie the amplification of motivation has 
been focused on the traditional “reward pathway.” Recent work, however, has implicated 
another striatal level structure, the central nucleus of the amygdala, in the amplification 
of motivation. Here, I extend these findings and demonstrate mu opioid receptor 
activation of the central nucleus of the amygdala enhances the motivational power of 
cues associated with reward. Recent findings in from human imaging studies have hinted 
that another striatal level structure, the neostriatum, may also participate in the 
amplification of motivation. Here, I demonstrate that mu opioid receptor activation in 
neostriatum enhances motivation for learned cues and primary rewards. Mu opioid 
receptor activation in dorsolateral neostriatum potently enhanced the attractiveness of 
cues in a manner similar to amygdala activation and did so in a manner not consistent 
with a habit hypothesis. However, consumption of primary rewards was not enhanced.  
Here, I demonstrated for the first time that enkephalin in dorsomedial neostriatum surges 
when rats consume a sweet, fatty food. Further, this consumption can be stimulated by 
microinjection of a mu opioid receptor activating drug. Although, dorsomedial neostriatal 
activation participated in motivation for primary rewards, activation did not have an 
effect on motivation for learned cues. Finally, in ventrolateral neostriatum, mu opioid 
receptor activation enhanced the attractiveness of a contiguous cue and motivation to 
consume primary rewards. These findings extend the neural substrates of motivation 
beyond traditional reward structures and have implications for the description and 







For an animal to survive in a complex environment, prediction is essential. A system 
for learning what cues predict the presence of nutrient dense food, receptive sexual 
partners, and injurious stimuli is necessary for survival. An understanding of these 
systems was initially described by Pavlov. He demonstrated that animals could use an 
auditory stimulus to anticipate the receipt of food (Pavlov and Anrep 1927). Since this 
description, many models of Pavlovian learning have been advanced, each focusing on 
how a cue gains predictive value. A popular form of such models are temporal difference 
models such as the Rescorla-Wagner model and it’s many updates and modifications 
(Rescorla and Wagner 1972; Wagner and Rescorla 1972).  
A hallmark of these models is that the learned association remains stable once 
established and requires stepwise updating to change associative strength between two 
stimuli. However, actual behavior of an animal is more dynamic. For example, a 
previously learned food cue will elicit different responses in a hungry or sated individual 
(Dickinson and Balleine 1990; Corbit and Balleine 2003; Kessler 2009) and a previously 
disgusting salt stimulus can become palatable and desirable when a salt-deficiency is 
induced (Berridge and Schulkin 1989; Tindell, Smith et al. 2006; Robinson and Berridge 
2013). This means that although the predictive value of a cue can remain stable the 
incentive value of the cue can fluctuate dramatically on a moment to moment basis. Cues 
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that have attained more than predictive value are said to have gained incentive salience 
(Bindra 1978; Robinson and Berridge 1993). Incentive salience is dynamically computed 
at each cue encounter, incorporating associative strength between a reward and it’s 
predictive cue and neurobiological state of mesocorticolimbic circuits at the moment of 
cue re-encounter, influenced by drug states, appetite/satiety states, stress states, etc. 
(Zhang, Berridge et al. 2009). An individual’s mesocorticolimbic state combines 
synergistically with learned conditioned stimulus (CS)- unconditioned stimulus (UCS) 
associations to generate incentive salience (‘wanting1’) on the fly, and the result of the 
combination can raise, lower, or even completely reverse the previously learned 
motivational value (Berridge, Flynn et al. 1984; Pecina and Berridge 2008; Tindell, 
Smith et al. 2009; Zhang, Berridge et al. 2009; Robinson and Berridge 2013).  
Zhang and colleagues’ (Zhang, Berridge et al. 2009) formal conceptualization of this 
idea is the depicted mathematical model (Figure 1.1). In this model, incentive motivation 
is conceptualized with the equation V= (rt*Κ); where V is incentive salience, rt is the 
learned associations between a cue (Pavlovian CS) and its reward (UCS), and K is 
physiological state such as appetite or brain activation (Zhang, Berridge et al. 2009). This 
model relates to a prediction error model of learning (Rescorla and Wagner 1972; 
Wagner and Rescorla 1972), in that it uses this model’s V (associative strength) as part of 
the rt (learned associations of the cue). What an incentive motivation model allows is a 
dynamic motivational transformation of that learned association: multiplying rt by K, the 
motivational state of the individual at the time of the cue encounter. A stimulus-response 
                                                 
1 Here I will use ‘wanting’ in quotation marks to signify attribution of incentive salience to rewards and 
reward paired cue (Robinson and Berridge 1993). This refers to a motivational state of enhanced attraction, 
consumption and invigoration of/by rewards and reward cues. This ‘wanting’ is implicit and does require 
conscious processing, differentiating it from wanting without quotation marks.  
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(S-R) or habitual model of responding only allows the cue to elicit the same response no 
matter the motivational state (K) of the individual. This model describes the 
transformation of learned CSs into motivational, ‘wanted’ CSs. It does not, however, 
posit a process or neurobiological mechanism for this transformation. The aim of this 
dissertation is to probe the neurobiological mechanisms underlying the dynamic 
amplification of incentive salience. 
 
Pavlovian conditioned approach as a method to test the generation and targeting 
of incentive salience 
To test the underlying neurobiological mechanisms of incentive salience an 
appropriate behavioral measure of incentive salience attribution, intensity, and target is 
necessary. How can we measure the strength of incentive salience of different cues in 
animal models? Individual differences in the target of incentive salience have been found 
in autoshaping or “sign-tracking” experiments in rats (Flagel, Akil et al. 2009; Saunders 
and Robinson 2010; Yager and Robinson 2013), which model the ‘motivational magnet’ 
feature of ‘wanted’ Pavlovian cues, in that they elicit rapid approach and draw behavior 
to them like a magnet. In one version of autoshaping, phasic presentation of a lever CS 
(CS+ lever; sometimes called the sign) always predicts a reward UCS: a sucrose pellet 
delivered to a dish (CSdish; sometimes called the goal). After learning the Pavlovian CS-
UCS association, many individual rodents, fish, pigeons, dogs, and people come to 
approach and bite (in the case of animals) the discrete CS+ sign and are known as “sign-
trackers” (Zener 1937; Breland and Breland 1961; Jenkins and Moore 1973; Boakes, Poli 
et al. 1978; Flagel, Watson et al. 2007; Nilsson, Kristiansen et al. 2008; Kessler 2009; 
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Tomie, Lincks et al. 2012). By contrast, other individuals come to approach the goal 
location where reward is delivered (CSdish) during the CS+ sign presentation and are 
known as “goal-trackers” (Jenkins and Moore 1973). Goal-tracking vs. sign-tracking 
differences emerge in the first few days of Pavlovian training in rats, and remains stable 
(Lolordo and Rescorla 1964; Mansour, Fox et al. 1994; Mahler and Berridge 2009). 
Using sign- and goal-tracking as a behavioral measure of incentive salience, I can then 
manipulate candidate brain areas to test the underlying substrates of incentive salience 
amplification.  
Traditional amplifiers of incentive motivation  
The mesolimbic dopamine system has been mentioned as one system involved in 
the amplification of incentive motivation. One part of this circuit, the nucleus accumbens, 
has long been identified as a limbic motor interface, a region capable of translating 
motivational value into behavior (Mogenson, Jones et al. 1980). For example, 
microinjections of amphetamine or mu opioid receptor activating DAMGO into nucleus 
accumbens shell or core produces robust increases in cue-triggered instrumental 
responding for sugary rewards as measured in Pavlovian to instrumental transfer (PIT) or 
in neuronal incentive salience signals (Wyvell and Berridge 2000; Pecina and Berridge 
2008). Similarly, microinjections of DAMGO or amphetamine raise conditioned 
reinforcement value or breakpoint values in instrumental tests that might reflect incentive 




Is the accumbens special in this ability to multiply the motivational value of a 
learned association or is this a function shared by all striatal structures? We have found 
that DAMGO microinjections in other striatal-type structures such as the central 
amygdala (CeA) also increase cue-triggered “wanting” in PIT and likewise increase the 
motivational magnet strength of an individual’s favorite reward cue in a sign-tracking 
versus goal-tracking test (Mahler and Berridge 2009, 2011). This means that there is at 
least one other area capable of amplifying “wanting” for learned cues. This dissertation 
will further explore the CeA as an area capable of generating motivation and test the 
neostriatum as another structure that may generate motivation.  
Moving outside the nucleus accumbens: central nucleus of the amygdala  
CeA has distinct inputs and outputs that distinguish it from other nuclei in 
amygdala (Killcross, Robbins et al. 1997; Swanson and Petrovich 1998). Anatomically, 
the CeA can be viewed as a serial output nucleus for the basolateral amygdala (BLA) (de 
Borchgrave, Rawlins et al. 2002), and as a serial starting point for the extended amygdala 
complex (Heimer, Van Hosen et al. 2008; McGinty, Hayden et al. 2011). Importantly, the 
CeA can be viewed as a striatal-level structure within macrocircuits that organize cortico-
striatal-pallidal networks to generate motivated behavior (Swanson 2005; Phillips and 
Hitchcott 2009). The aim of this dissertation is to probe the function of striatal level 
structures and this allows us to conceive of the CeA as a striatal structure that generate 
incentive motivation. 
 Functionally, CeA is a site where mu opioid stimulation via DAMGO 
microinjection can markedly increase motivation to seek and consume palatable food 
6 
 
rewards, and CeA interacts with nucleus accumbens in opioid enhancements of food 
intake (Gosnell 1988; Eblen and Graybiel 1995; Dickinson, Campos et al. 1996; Phillips, 
Vacca et al. 2008; Cox, Benkelfat et al. 2009). CeA also plays special roles in translating 
learned Pavlovian information into active motivation (Berridge, Flynn et al. 1984; 
Hollerman and Schultz 1998; Everitt, Parkinson et al. 1999; Hall, Parkinson et al. 2001; 
Holland and Gallagher 2003; Corbit and Balleine 2005). For example, stimulation of mu 
opioid receptors in the central nucleus of the amygdala (CeA) magnifies the ability of 
cues to trigger incentive motivation toward sucrose or sex incentives and to act as CS 
motivational magnets (Mahler and Berridge 2009, 2011).  Here, I will more stringently 
test the role of the CeA in focusing and targeting incentive salience on a preferred cue.  
Moving outside the nucleus accumbens: neostriatum  
 Dorsal neostriatum, especially dorsolateral neostriatum, traditionally has been 
viewed in terms of motor functions of movement and  habits in responding to reward 
cues (Schultz and Dickinson 2000b; Packard and Knowlton 2002a; Yin, Knowlton et al. 
2004; Balleine and Ostlund 2007; Wise 2009).  However, dorsal striatum recently has 
become implicated in motivation-related functions (Volkow, Wang, Fowler, Logan, 
Jayne, Franceschi et al. 2002; Volkow, Wang et al. 2006; Palmiter 2008b; Stice, Spoor et 
al. 2008; DiFeliceantonio, Mabrouk et al. 2012; Nummenmaa, Hirvonen et al. 2012).  
Furthermore, dorsolateral striatal function is needed for motivational cues to excite 
reward seeking behavior (Corbit and Janak 2007). Given the building evidence that 
dorsolateral striatum may have some motivational function, and that many studies 
probing the dorsolateral striatum have not included specific tests for motivation, 
increasingly attention has been focused on the putative role of the dorsolateral 
7 
 
neostriatum in generating motivation to reward-cues (Parkinson, Cardinal et al. 2000; Ito, 
Dalley et al. 2002; Vanderschuren, Di Ciano et al. 2005; Vanderschuren and Everitt 
2005). 
As described above, reward-cues can trigger intense motivational states, 
increasing attraction to the cue and urge for the associated reward (Robinson and 
Berridge 1993). But the intensity of a cue’s attractiveness still fluctuates, depending on 
the brain state of the individual at the moment of encounter.  A recovering addict may 
successfully resist drug cues on many encounters, yet on another occasion find the same 
cues irresistible, triggering relapse, and spiraling back into the pattern of addiction. 
Therefore, cue-evoked activations of dorsolateral neostriatum might represent a novel 
mechanism for the generation of incentive motivation that makes the cue tempting and 
attractive. Alternatively, dorsolateral neostriatum activations might reflect non-
motivational functions such as mediation of learned predictions of reward to follow, 
learned stimulus-response habits, or incipient movements evoked by reward cues, as is 
previously suggested. The experiments in this dissertation will explicitly test these two 
hypotheses and attempt to demonstrate that dorsolateral neostriatum participates in 
generation of motivation in addition to its role in habit expression and motor learning. 
In contrast to the dorsolateral neostriatum, which has most commonly been tested 
in terms of habit expression and formation, the dorsomedial neostriatum has been 
demonstrated to be important for the formation of action-outcome associations. For 
example, disruptions of dorsomedial neostriatal activity decreases rats’ sensitivity to 
reinforcer devaluation, meaning they work continue to work for a diminished reward 
(Yin, Knowlton et al. 2005). This finding led to the hypothesis that dorsomedial 
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neostriatum stores information about the value of instrumental outcomes, and begs the 
question: Can dorsomedial neostriatum also generate motivation for sensory reward? 
There is some evidence dorsomedial striatum tracks the receipts of sensory 
reward. In dorsomedial neostriatum, preproenkephalin mRNA levels track short term 
satiety state and not long term deprivation state (Will, Vanderheyden et al. 2007). The 
decrease in preproenkephalin mRNA after feeding is likely due to a release of enkephalin 
during eating that may drive the motivation to eat (Kelley, Baldo, Pratt et al. 2005), 
although there is no direct evidence for this claim. Here I test this hypothesis using 
advances in microdialysis collection and analysis techniques that allow for the in vivo 
detection of endogenous peptides in freely moving and eating rats.  
The hypothesis that opioid circuitry in dorsomedial neostriatum participates in 
generating motivation to consume, or even over-consume, a palatable food reward is  
concordant with its anatomical wiring from limbic prefrontal cortical inputs (Ragsdale 
and Graybiel 1988; Gerfen 1989; Ragsdale and Graybiel 1990; Eblen and Graybiel 1995; 
Kincaid and Wilson 1996; Levesque and Parent 1998). These inputs in dorsal neostriatum 
are confined to “patch” or striosome compartments (Pert, Kuhar et al. 1976; Herkenham 
and Pert 1980; Gerfen, Herkenham et al. 1987), which may also project directly to 
dopamine containing neurons in the substantia nigra (Fujiyama, Sohn et al. 2011). These 
patches are mu opioid receptor rich, the receptor for the ligand enkephalin in the dorsal 
striatum, therefore manipulation of these patches by endogenous enkephalin levels or 
exogenous drug, may increase incentive motivation (Pert, Kuhar et al. 1976; Akil, 
Watson et al. 1984). This dissertation will explicitly test this hypothesis. 
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Opioid manipulation of more ventral areas of neostriatum has been demonstrated 
to produce intense eating (Bakshi and Kelley 1993b, a). This portion of striatum receives 
projections from forelimb and oromotor areas of sensory motor cortex and dopaminergic 
manipulation of this area often results in oromotor stereotypy (Kelley, Lang et al. 1988; 
Kelley, Gauthier et al. 1989b; Delfs and Kelley 1990; Dickson, Lang et al. 1994). Often, 
manipulations that generate motivation for primary rewards also increase motivation for 
learned cues, but this is not always the case (Bakshi and Kelley 1993b, a; Pecina and 
Berridge 2000; Zhang and Kelley 2000; Jackson 2009). So it is unknown if mu opioid 
receptor activation will enhance motivation for learned cues as it does for primary food 
rewards.  
Summary of current studies 
The goal of this dissertation is to determine if areas outside the traditional “reward” 
pathway are capable of generating intense motivation. Specifically, I manipulated mu 
opioid receptor activation in the central nucleus of the amygdala, dorsolateral neostriatum, 
dorsomedial neostriatum, and ventrolateral neostriatum; and I manipulated dopamine in 
the dorsolateral neostriatum. I found that these areas do participate in the generation of 
intense motivational states, but differ in the target (UCS or CS, predictive CS or 
contiguous CS) of that intense state.  
Chapter 2: Opioid Stimulation of Central Nucleus of the Amygdala Enhances 
Incentive Salience of a Preferred Cue 
 In these experiments I will further examine the effect of mu opioid receptor 
stimulation of the central nucleus of the amygdala on the motivational magnet properties 
of a preferred cue. These experiments build off of those previously performed in our lab, 
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but focus intensely on goal-tracking animals. Previous work suggested that both sign- and 
goal-trackers showed enhanced motivation for their preferred cue. The current 
experiment used new cameras angled directly into the food magazine to demonstrate that 
goal-trackers showed a similar enhancement of incentive motivation for the preferred cue 
after mu opioid receptor stimulation.  
Chapter 3: Effects of Mu Opioid and Dopamine Receptor Stimulation in Dorsolateral 
Neostriatum on Incentive Salience of a Preferred Cue  
Having established that mu opioid receptor stimulation of CeA enhances the 
motivational magnet properties of learned cues, I sought to test another area with the 
potential to generate incentive motivation, dorsolateral neostriatum. Mu opioid receptor 
activation enhanced sign- and goal-tracking in a pattern similar to that seen after mu 
opioid receptor activation in CeA. Because this portion of neostriatum is well established 
to be involved in habit expression, I experimentally tested a habitual or a motivational 
interpretation. Specifically, I tested the ability of mu opioid receptor activation to 
maintain a motor ritual in the face of environmental and reinforcer outcome change. We 
found results consistent with a motivational hypothesis, that behavior remained flexible 
and not habitual. Finally, I tested whether mu opioid receptor activation could enhance 
the value of a conditioned reinforcer for an entirely new instrumental task, it did. These 
results suggest that dorsolateral neostriatum is involved in the generation of intense 
motivation as well as it established roles in habit expression.  
To explore the neurochemical specificity of this enhancement of incentive 
salience attributed to the preferred target cue, I microinjected a low dose of amphetamine 
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into the DLS during autoshaping. After amphetamine microinjection, purely sign- and 
goal-tracking rats did not demonstrate an increase in responding. Those rats that were 
mainly sign-trackers, but showed some goal-tracking greatly increased the amount of 
goal-tracking they performed following amphetamine microinjection.  
Chapter 4: Enkephalin in Dorsomedial Neostriatum Says “Eat More Now!” 
Dorsomedial neostriatum has been implicated in encoding the value of outcomes for 
instrumental outcomes. In this set of experiments I tested whether dorsomedial 
neostriatum can generate intense motivation for a tasty outcome (M&M candy). First, we 
used advancements in microdialysis to determine that enkephalin levels surge after 
animals consume M&M candies. Then I microinjected a mu opioid receptor agonist into 
the dorsomedial neostriatum and observed a huge increase in consumption only when the 
microinjections where in the dorsal anteromedial quadrant of neostriatum. Delta receptor 
activation did not produce the same effect. Finally, I determined the enhancement was 
solely in motivation for the food and not in its hedonic impact with the affective taste 
reactivity test.  
Chapter 5: Disruption of sign-tracking and enhancement of goal-tracking after mu 
opioid receptor activation in ventrolateral neostriatum 
Opioid manipulation of more ventral areas of neostriatum has been demonstrated 
to produce intense eating (Bakshi and Kelley 1993b, a). It is unknown however, if mu 
opioid receptor activation in this same area produces enhanced motivation for learned 
cues in an autoshaping paradigm. Often, manipulations that generate motivation for 
primary rewards also increase motivation for learned cues, but this is not always the case 
(Bakshi and Kelley 1993b, a; Pecina and Berridge 2000; Zhang and Kelley 2000; Jackson 
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2009). Here I report that activation of mu opioid receptors does not enhance motivation 
for the CSdish in goal-tracking animals, but disrupts sign-tracking and enhances goal-























Figure 1.1. Model of incentive salience generation and a mathematical model of 
incentive salience generation. “Liking” and “wanting” are fractured into separable 
systems. Physiological signals (K) are capable of altering the incentive salience or 












Opioid Stimulation of Central Nucleus of the Amygdala Enhances Incentive Salience 
of a Preferred Cue 
Introduction 
Reward cues (Pavlovian CSs) can carry incentive salience: eliciting craving for 
the reward, and making the cues themselves ‘wanted’, approached and even the target of 
consummatory acts such as ingestive licks, nibbles, and bites that normally belong to an 
associated food reward (UCS). Thus food cues can tempt a binge-eater to overindulge or 
drug cues can trigger relapse in a drug addict (Akil, Watson et al. 1984; Robinson and 
Berridge 1993; Berthoud and Morrison 2008; Kessler 2009), and such cues can attract 
appetitive-consummatory behaviors acting as ‘motivational magnets’(Jenkins and Moore 
1973; Rosse, Fay-McCarthy et al. 1993; Cetinkaya and Domjan 2006; Flagel, Watson et 
al. 2008). 
However, reward cues are not always attractive, but rather vary across time in 
motivation potency. A cue’s power to trigger temptation fluctuates especially when 
encountered in different physiological-brain states (e.g., drug intoxication, stress, hunger, 
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satiety) (Mansour, Fox et al. 1994; Zhang, Berridge et al. 2009; Smith, Berridge et al. 
2011). Particular activations in mesocorticolimbic brain states, we will suggest, are why 
particular cue encounters may make addicts relapse into excessive consumption even 
after the same cue has been successfully resisted many times before(Wyvell and Berridge 
2000; Tindell, Smith et al. 2009; Zhang, Berridge et al. 2009; Smith, Berridge et al. 2011). 
Some brain activations may also focus “wanting” more narrowly onto a single target, as 
well as elevating intensity [19].  
Useful individual differences in the target of incentive salience have been found 
in autoshaping or “sign-tracking” experiments in rats (Flagel, Akil et al. 2009; Saunders 
and Robinson 2010), which model the ‘motivational magnet’ feature of incentive salience 
for Pavlovian cues. In one version of autoshaping, phasic presentation of a lever CS (CS+ 
Lever; sometimes called the sign) always predicts a reward UCS: a sucrose pellet 
delivered to a dish (CSdish; sometimes called the goal). After learning the Pavlovian CS-
UCS association, many individual rodents, fish, pigeons, dogs, and people come to 
approach and bite the discrete CS+ sign and are known as “sign-trackers”(Breland and 
Breland 1961; Boakes, Poli et al. 1978; Kessler 2009). By contrast, other individuals 
come to approach the goal location where reward is delivered (CSdish) during the CS+ 
sign presentation and are known as “goal-trackers” (Jenkins and Moore 1973; Boakes, 
Poli et al. 1978). Goal-tracking vs. sign-tracking differences emerge in the first few days 
of Pavlovian training in rats, and remains stable (Mahler and Berridge 2009; Meyer, 
Lovic et al. 2012).  
This difference in individual phenotype is related to underlying mesolimbic brain 
traits, but can also be experientially biased by environmental situations such as 
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encountering uncertainty in CS-UCS contingencies, receiving reward UCS directly 
without needing to approach a goal, receiving amphetamine or related drugs, or having 
been previously sensitized by drugs administered weeks earlier (Peterson, Frommer et al. 
1972; Boakes, Poli et al. 1978; Timberlake, Wahl et al. 1982; Simon, Mendez et al. 2009; 
Anselme 2010; Holden and Peoples 2010; Robinson and Berridge 2010; Doremus-
Fitzwater and Spear 2011). Some similarity in underlying mechanisms might be recruited 
in both sign-trackers and goal-trackers to attribute incentive salience to individualized 
targets, at least when mesocorticolimbic brain systems are in a stimulated state. 
Stimulation of mu opioid circuits in the central nucleus of the amygdala (CeA) was 
indicated to achieve that mesocorticolimbic state by an earlier study in our laboratory: 
producing elevation of incentive salience in both sign trackers and goal trackers, and 
simultaneously focusing that intense incentive salience onto a single Pavlovian target 
(Mahler and Berridge 2009).  
Here, I explore further the idea that in autoshaping the two Pavlovian CSs (sign 
and goal) have potentially distinct roles: acting as 1) the trigger to elicit a phasic pulse of 
intense incentive salience, versus as 2) the target of focused incentive salience attribution 
(that becomes the most ‘wanted’ Pavlovian object of desire). That is, CeA opioid 
stimulation may make sign-trackers ‘want’ the CS+ Lever more, and similarly make 
goal-trackers ‘want’ the CSdish more, each in a phasic pulse when triggered by CS+ 
encounter (Mahler and Berridge 2009). I hypothesize that the CS+ acts as the trigger in 
both sign-trackers and goal-trackers to evoke a temporary surge in the intensity of CeA-
amplified incentive salience, which lasts seconds. However, the target CS that is 
attributed with focused incentive salience differs between sign-trackers and goal-trackers 
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during a state of CeA opioid stimulation. For sign-trackers, the target is the same trigger 
or CS+ Lever that predicts sucrose. By contrast, for goal-trackers the target is the CSdish 
object/location where the UCS is delivered. Finally, I hypothesize that the breadth of 
focus for incentive salience attribution on the individualized target is also narrowed by 
CeA stimulation in a winner-take-all fashion. That is, individualized Pavlovian 
information-to-motivation links are amplified to make the most ‘wanted’ target even 
more intensely attractive after CeA opioid stimulation, while alternative targets may even 
decline in relative attractiveness.  
However, a potential problem for our hypothesis is that goal-trackers may 
essentially lack incentive salience, as only sign-trackers appear to show high cue-
triggered “wanting” (Lundy 2001; Flagel, Watson et al. 2007). Sign-trackers have been 
suggested to model addiction-like features of incentive salience much more than goal-
trackers (Flagel, Watson et al. 2008; Flagel, Akil et al. 2009; Saunders and Robinson 
2010, 2011), whereas goal-trackers might approach their dish using non-”wanting” 
mechanisms, such as cognitive expectancy mechanisms or via simpler S-R habit 
(Saunders and Robinson 2011). A potential reconciliation between such evidence and our 
hypothesis might be achieved if it could be shown that specific mesocorticolimbic states 
(e.g., CeA opioid stimulation) produce the higher intensities and sharper focus of 
incentive salience in goal-trackers. Specifically, our hypothesis is that CeA stimulated 
states cause goal-trackers to show pulses of high incentive salience that are equal in 
intensity to sign-trackers, though focused on a different target: the dish.  
 To test this hypothesis, it is necessary that goal-trackers in a state of 
mesocorticolimbic activation show the full cue-triggered sequence of motivated 
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appetitive-consummatory behaviors that characterizes a ‘motivational magnet.’ For a 
sucrose pellet UCS, these are sequences of approach, nibble, sniff, grasps and bite 
behaviors directed to the metal object (CSdish or CS+ Lever). That sequence was not 
completely confirmed for goal-trackers in the earlier Mahler and Berridge study because 
the opaque metal wall of the goal dish precluded a clear camera view of actions inside, so 
that it was not possible to observe a goal-tracker’s mouth performing nibble, sniff and 
bite behaviors in the dish (Mahler and Berridge 2009).  
Here I aimed to more stringently test whether CeA stimulation enhances incentive 
salience using an additional close-up camera focused on the inside surface of the dish. 
This measured the full appetitive-consummatory sequences of approach, nibbles, sniffs, 
grasps and bites of the CSdish in goal-trackers. We also aimed to more closely examine the 
winner-take-all aspect of narrower focusing on a single target induced by CeA DAMGO, 
in individuals that show nearly balanced mixtures of goal-tracking vs. sign-tracking, as 
well as in the more extreme phenotypes. Our results here confirm that CeA stimulation 
does make goal-trackers approach and ‘consume’ their metal CSdish more, and in more 
focused fashion. The intensity and focus of the enhancement in goal-trackers’ behavior is 
comparable to sign-trackers’ enhanced behavior toward CS+ lever, consistent with the 
trigger vs. target hypothesis for Pavlovian incentive salience.  
Materials and Methods 
 Subjects 
 Sprague Dawley rats (n=19; female) weighing 280-340 grams at the start of the 
experiment were pair housed on a reverse light/dark cycle. Water was provided ad 
19 
 
libitum; food was provided ad libitum except during weeks containing autoshaping 
training or test sessions, when rats were restricted to 90% free feeding weight and fed 
about 12gs of standard laboratory chow daily after each training session. All experiments 
were conducted in accordance with protocols approved by the University of Michigan 
Committee on Use and Care of Animals (UCUCA). 
Surgery 
Rats were anesthetized with ketamine (80mg/kg), xylazine (7mg/kg), and atropine 
(0.04mg/kg). The central nucleus of the amygdala was targeted by placing bilateral 
cannulae aimed at (CeA) AP ≈ -2, ML≈ 4, DV ≈ -5.8. Placement coordinates for cranial 
cannulae were calculated based on Paxinos and Watson (Paxinos and Watson 2007), and 
lowered into place with a stereotaxic apparatus (Kopf Instruments). Each rat was 
surgically implanted with chronic, bilateral, 14mm microinjection guide cannulae (23ga) 
positioned 2mm above the target CeA sites. Cannulae were anchored to the skull with 
bone screws and acrylic cement, and steel stylets were inserted to prevent their occlusion. 
All rats were given chloramphenicol sodium succinate (60mg/kg) to prevent infection as 
well as carprofen (5mg/kg) to provide pain relief. Carprofen was administered again 24 
hours post-surgery. 
Microinjections 
 Prior to tests, steel stylets were removed and cleaned, and 16mm microinjectors 
were inserted into the guide cannulae, pre-measured so that microinjector tips extended 2 
mm below guides. Microinjections of DAMGO (Sigma-Aldrich) or vehicle were 
controlled by a syringe pump which delivered 0.2 µL over 90 seconds. DAMGO 
injections were 0.1µg of DAMGO dissolved in 0.2µL of aCSF vehicle; control vehicle 
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inject ions were of aCSF alone in the same rats, in counterbalanced order. Tips were left 
in the cannulae for 1 extra minute to allow for drug diffusion. Before any test rats were 
given one “sham” injection of 0.2µL vehicle to habituate them to the microinjection 
process. 
Behavioral Autoshaping 
 Autoshaping training and testing was carried out in one of eight operant 
chambers (Med Associates) controlled by Med PC software, containing two retractable 
levers on opposite sides of a food receptacle. Each rat was always assigned to the same 
chamber for training and testing. Insertion of a lever on one side was designated as the 
CS+ that predicted sucrose pellet UCS delivery with 100% correlation. This CS+ Lever 
was a 4.5X2 cm retractable metal lever with a light emitting diode on its ventral surface. 
As CS+, the lever was inserted into the chamber through the wall for 8 seconds and 
accompanied by a 2.9 KHz tone. The CS+ was followed immediately by UCS 
presentation (delivery of sucrose pellet). Another lever was always present and 
designated as CS- because it bore no relation to UCS. Presses on the CS- lever were 
taken as measures of generalization or nonspecific motor activity. Sucrose UCS pellets 
(45mg) were presented in a metal dish 3cm2 at the bottom center of the same wall with 
the levers. The dish in which sucrose was delivered will be referred to from now on as 
CSdish because the sight of the dish upon head insertion was the stimulus and action most 
contiguously paired in time and space with oral receipt of the UCS.  
Training 
 Prior to Pavlovian CS-UCS pairings rats received one day of magazine training 
when 20 sucrose pellets were dropped into the CSdish, approximately one pellet every 90 
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seconds. Autoshaping (CS+ paired with UCS) training sessions started the next day. Each 
Pavlovian session began with the illumination of the red house light and insertion of the 
control CS- lever at the beginning of the trial. Subsequent 8-sec CS+ Lever presentations 
were always paired associatively with a UCS reward presentation under a Pavlovian 
contingency. Then the CS+ Lever was retracted and a UCS sucrose pellet was 
immediately presented in the CSdish. Each autoshaping session lasted about 40 minutes 
and consisted of 25 CS+ and UCS pairings with a variable intertrial interval of ~90 
seconds.  
 Rats received 5 training days. By the 3rd day, every rat began to respond to the 
CS+ onset with an approach-consummatory CR predominantly focused toward either the 
CS+ Lever itself (in which case the rat was classified as a sign-tracker) or toward the 
CSdish (in which case the rat was classified as a goal-tracker). The criterion for 
classification as sign-tracker was to approach, nibble, sniff, and bite the CS+ Lever at 
least three times more frequently than they did the sucrose dish during CS+ presentations 
on day 5. The criterion for classification as goal-tracker was to approach, nibble, sniff, 
and bite the dish at least three times more frequently than the lever during CS+ 
presentations, and additionally to approach the CSdish three times more frequently when 
the CS+ Lever was present than in intervening baseline periods when the CS+ was absent 
(to ensure that CS+ Lever presentation was the trigger for a phasic elevation in goal-






Test for effects of opioid activation of CeA 
Effects of DAMGO stimulation in CeA were tested by a within-subject 
comparison to the same rat’s behavior on vehicle (control) on days 6 and 8 (in 
counterbalanced order across rats with 48hrs in between). That is, on day 6 a rat received 
either vehicle or DAMGO (0.1µg/0.2µL) microinjection before the autoshaping session. 
On day 8 the other microinjection was administered (drug or vehicle) and the test was 
repeated.  
Behavioral Video Scoring 
Rats were always videotaped from two angles. One camera was positioned under 
the transparent floor of the autoshaping chamber to provide a clear view of the rat’s entire 
head and body wherever it was in the chamber. A second camera was directed from the 
side toward the inner surface of the CSdish to provide a close up view of the rat’s face and 
mouth movements when inside the dish. Both videos were analyzed off line in slow 
motion (1/10th to ½ actual speeds) by an observer blind to experimental conditions. For 
each trial, the 8 seconds before and 8 seconds during the 5th, 10th, 15th, 20th, and 25th 
presentation of CS+ were selected for comparison (Mahler and Berridge 2009). Scored 
behaviors were look at the cue (orienting towards the cue by moving the head or 
forequarters toward it, without bodily approaching it), approach the cue, nibble and sniff 
the cue (contact of the nose or mouth on lever or dish, combined with rapid short (<0.5 
sec) rhythmic 1-2 Hz bobbing movements of the head and nose (sniff), and of jaw, 
tongue, and/or teeth (nibble), similar to movements of normal eating of UCS) , and bite 
the cue (of jaw closing and contact by maxillary and mandibular incisors, often while 
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grasping the object with one or both paws, similar to movements that bite the actual UCS 
sucrose pellet).  
Statistical Analysis 
Within-subject ANOVAS comparing drug and vehicle days were performed for 
each anatomical area for the cue and pre-cue periods. Significant differences for 
individual dependent variables in autoshaping were determined by Bonferroni corrected 
t-tests. To avoid distortions in percentage change calculations arising from any zero 
baselines, a constant value of 1 was added to each rat’s behavioral score for both CSdish 
and CS+ Lever. 
Histology 
Rats were sacrificed immediately after the final day of testing by administration 
of a sodium pentobarbital overdose. Rats were decapitated and the brains were extracted 
and fixed in 10% paraformaldehyde solution for 1-2 days followed by a 25% sucrose 
solution in 0.1M NaPB for 2-3 days before slicing. 60 micron slices through the CeA 
were taken from each rat, mounted, dried, and stained with cresyl violet. Microinjection 
center was determined for each bilateral injection site and slides were compared with the 
stereotaxic atlas (Paxinos and Watson 2007) to determine placement in the CeA. Those 
rats with placements outside the CeA were excluded from analysis 
Results 
Overview: Mu opioid stimulation of central amygdala potently enhanced approach 
and appetitive-consummatory actions of goal-trackers toward dish but of sign-trackers 
toward lever.  
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In goal-trackers, DAMGO microinjections in CeA potently increased the number 
of appetitive-consummatory sequences directed toward their CSdish. The increase was 
selective to moments when the CS+ Lever was physically present. The increased 
sequences were always initiated by CS+-triggered approaches to the dish, followed by 
nibbles and sniffs of the dish rim and internal surface. In sign-trackers, these CeA 
DAMGO enhancements were matched by increased numbers of approaches and 
appetitive-consummatory sequences directed to the CS+ Lever. That is, CeA DAMGO 
similarly intensified the motivated cue-triggered behaviors that each phenotype directed 
at their own prepotent Pavlovian target.  
In more detail, for goal-trackers, DAMGO in CeA selectively increased the 
number of CS+-triggered approaches, nibbles and sniffs to the goal CSdish by 150%, 
compared to vehicle microinjection effects in the same rats. Simultaneously, CeA 
DAMGO conversely decreased goal-trackers’ already low rate of approach to the CS+ 
Lever when it was present, indicating that the increase in the number of already-dominant 
goal tracking responses was at the expense of already-weaker sign-tracking responses 
( F(4,8)=7.3, p<.01; F(1,11)=8.639, p<.05). Similarly but conversely, sign-trackers increased 
their approaches, nibbles and sniffs of the prepotent CS+ Lever by 230% more under 
DAMGO compared to vehicle conditions, while oppositely decreasing their already low 
level of approaches to the goal or CSdish. (Overall F(3,4)=11.1,p<.05; F(1,6)=11.791, p<.05). 
For both sign-trackers and goal-trackers, CeA-induced effects on these appetitive-
consummatory behaviors were manifest only when the CS+ Lever was physically present, 
and never in intervening baseline intervals when the lever was absent, regardless of target 
for approach. That is, even for goal-trackers whose dish target was always present, CeA 
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selectively enhanced phasic elevations of approach and consumption-related behaviors 
toward the dish only during the CS+ presentations, and did not enhance lower baseline 
levels of approaches or consummatory actions toward the dish during longer intervals in 
the absence of CS+ (goal-trackers: F(4,8)=1.1, p>.1). Likewise, sign-trackers only 
enhanced approach/consummatory sequences during CS+ presentation, but that was 
perhaps less surprising since consummatory actions could not be directed to an absent 
lever; however, we note that DAMGO also failed to enhance sign-tracker’s baseline 
levels of approach to the location in the chamber where the CS+ appeared, which in 
principle could still have been enhanced in lever absence (F(3,4)= 1.27, p>.1)(Figure 2.1). 
Finally, a sequence was usually terminated by opening the mouth and dipping the head in 
the CSdish (for goal trackers) or grasping, biting and depressing the CS+ lever (for sign 
trackers).  
Approach to target 
 DAMGO enhanced approach to each rat’s individualized target CS, as reflected 
in a) the alacrity or speed with the target CS was reached, and b) the ability of the CS 
target as a motivational magnet to pull all cue-triggered approaches exclusively to itself. 
In terms of approach latency, microinjection in CeA made both sign-trackers and goal- 
trackers approach their prepotent cue more quickly. Overall, rats reached their target 
within 1 to 3 seconds after trigger onset of CS+ Lever under vehicle conditions. While it 
is difficult to move much faster than a 2 second latency, it is possible to speed up 
longer >2 sec latencies toward the <2 sec floor. Here we found that all rats which took 
over 2 seconds to reach their targets after vehicle microinjection (mean ±SEM = 2.5 ± 
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0.15 sec latency) speeded up  and reached their target in less than 1.5 sec after DAMGO 
in CeA (mean ± SEM = 1.4 ± 0.33 sec, t(6)=3.7, p<.05).  
Similarly, the strength of a motivational magnet can be assessed by the ability of a 
target CS to fully capture all appetitive approach behavior toward itself during whenever 
the CS+ lever or trigger is presented, and so to eliminate the defection of any approaches 
toward the alternative CS. Exclusivity of appetitive capture by a target CS can be 
dichotomized as either 100% complete capture (i.e., the rat exclusively approaches only 
its prepotent CS, and does not defect at all to the nonprepotent cue while triggers are 
present), or as incomplete capture (i.e., the rat approaches both CSs at least once during a 
trial). In principle, prepotent capture could also fail completely (so that the rat 
approached only the nonprepotent CS during a trigger), but that happened on less than 6% 
of vehicle cue presentations and was never observed after DAMGO in CeA. Instead the 
motivational magnet strength of the target CS essentially varied between 100% complete 
capture versus incomplete, and DAMGO selectively strengthened the target CS’s 
completeness of capture for goal-trackers and sign-trackers. For rats overall, the 
incidence of 100% complete capture by the prepotent target CS, or sessions in which the 
rat never defected even once to the non-prepotent CS during any recorded trigger 
presentation, rose from 9/19 rats (47%) under vehicle  to 15/19 rats (79%) under 
DAMGO (McNemar’s test, p<.05). Even for goal-trackers considered separately, 
completeness of capture rose from 5/12 rats (41%) under vehicle to 11/12 rats (92%) 
under DAMGO (McNemar’s test, p<.05). Accordingly, the probability of any visit by the 
rat to the nonprepotent cue during a trial fell from 29% under vehicle (this 29% includes 
approximately 5% contributed by 2 rats that exclusively approached their nonprepotent 
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CS on few stimulus presentation) to just 6% under DAMGO (F(1,18)=6.0, p<.05). 
Similarly, the probability of visiting both CSs during a trigger fell from 24% under 
vehicle to 6% under DAMGO for all rats (F(1,18)=6.4, p<.05).  
This DAMGO pattern of endowing the prepotent CS with ability to completely 
capture 100% of all cue-triggered appetitive behavior suggests DAMGO made the 
prepotent target CS into a stronger “motivational magnet” for both goal-trackers and sign 
trackers. In summary, when a rat’s CeA was in an opioid-stimulated state its prepotent 
target CS attracted approach more quickly to itself as soon as the trigger stimulus 
appeared, and more exclusively to itself (i.e., away from the alternative nonprepotent CS). 
These appetitive features applied to goal-trackers as well as sign-trackers. 
Focus on target.  
In terms of relative focus of incentive salience between the two CSs, for all rats, 
opioid stimulation by DAMGO in CeA increased the proportion of approaches, nibbles 
and sniffs directed by each rat to its already prepotent CS, while simultaneously 
decreasing the already low proportion of nibbles and sniffs toward its nonprepotent CS 
(F(11,8)= 5.8, p=.01). In more detail, 71% of all nibbles and sniffs by goal-trackers were 
directed at their prepotent CSdish under vehicle conditions, and that proportion rose under 
DAMGO stimulation to 77% at the CSdish (t(11)=-2.52, p<.05). Simultaneously, the 
proportion of responses directed by goal-trackers toward their non-prepotent CS+ Lever 
fell from 29% under vehicle to 23% under DAMGO (Figure 2.1). Conversely, for sign-
trackers 68% of nibbles and sniffs were directed at their prepotent CS+ Lever under 
vehicle, and that proportion increased to 78% under DAMGO stimulation (F(11,8)= 5.8, 
p=.01). Simultaneously, the proportion of responses directed by sign-trackers toward 
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their non-prepotent CSdish fell from 32% under vehicle to 22% under DAMGO in CeA. 
This narrowing of focus on the individual’s own prepotent target, occurring at the 
detriment of attraction to the alternative nonprepotent cue, is compatible with a “winner 
take all” property of incentive salience enhancement induced by CeA opioid stimulation. 
Under DAMGO, all rats more nearly ignored their nonprepotent cue, instead focusing the 
increase in approaches, nibbles and sniffs only toward their prepotent cue, whichever 
stimulus that was for an individual rat. In short, CeA DAMGO microinjections made the 
sign-trackers better sign-trackers and made goal-trackers better goal-trackers. This can be 
seen most clearly by plotting each rat individually for its number of nibbles and sniffs 
directed at the CSdish, and simultaneously the number directed at the CS+ Lever on each 
trial. DAMGO stimulation shifts each animal towards a more extreme preference. This 
demonstrates an enhancement of focus and intensity for both goal-trackers and sign-
trackers (Figure 2.2). 
 In the middle: Individuals that balance targets still enhance only the prepotent one 
The ‘winner-take-all’ feature applied even to relatively balanced individuals that 
showed substantial attraction to both CSs. One way to see this is to assess every 
individual separately, to trace the effect of CeA DAMGO on individualized response 
patterns. Every individual’s signature can be plotted as a point in a space defined by two 
orthogonal axes of goal-tracking strength versus sign-tracking strength, and the effect of 
CeA stimulation is visible as moving the individual to a second point location (Figure 
2.2). This individual-by-individual analysis revealed that DAMGO virtually always 
enhanced appetitive-consummatory response sequences only toward each individual’s 
own prepotent target. Even if the initial bias approached balance as closely as 60:40, only 
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responses toward the prepotent CS (e.g., 60) were enhanced by DAMGO. Thus, the 
prepotent CS is a stronger ‘motivational magnet’ for every individual under CeA 
DAMGO stimulation, while the weaker CS typically gets weaker.  
A more collective way to assess that ‘winner-take-all’ feature is to isolate for 
statistical analysis the intermediate one-third of the population, which typically shows 
mixed sign-tracking and goal-tracking responses in more nearly equal proportions 
(compared to the extreme one-third of goal trackers, or the opposite one-third of extreme 
sign-trackers) (Flagel, Akil et al. 2009; Saunders and Robinson 2010) (Figure 2.2). Split 
into three groups of one-third each, the middle group divided their CS+-triggered 
responses under vehicle in roughly 60:40 proportions between targets (some preferring 
the CS+ lever and others the CSdish). DAMGO microinjection into CeA selectively 
enhanced only the prepotent target even for this middle group, which increased its 
preference ratio to 75:25 (F(1,5)=7.8, P<.05). The absolute number of nibbles and sniffs 
for this middle group directed to the prepotent target also more than doubled from 1.2 
under vehicle conditions to 3.1 after DAMGO stimulation (F(1,5)=7.7, p<.05). Conversely 
the number of responses directed at the nonprepotent cue trended downward, if anything 
for this group (.3 to .2, n.s.). Taken together, these results show that the attribution of 
“wanting” becomes more narrowly focused on a single Pavlovian target for all 
individuals, as well as intensified in level, after DAMGO microinjection in CeA.  
Temporal pattern phasic enhancements of approach & consummatory behaviors.  
In terms of response timing, enhancements of nibbles and sniffs on the prepotent 
cue were always limited to phasic bouts lasting only 8 sec for both sign-trackers and 
goal-trackers, each bout triggered by the insertion of CS+ Lever, lasting for its duration, 
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and terminating almost immediately when the lever was retracted (F(5,7)=31.9, p<.001). 
For goal-trackers, DAMGO microinjection in CeA amplified the number of cue-triggered 
approaches and consummatory actions toward the CSdish by over 50% during each CS+ 
presentation, but did not alter the low baseline level in the absence of the CS+ Lever 
(Drug*Cue interaction F(1,11)=5.4, p=.04; Figure 2.3). Likewise DAMGO microinjections 
in CeA doubled the number of sign-trackers’ approach and consummatory CRs to CS+ 
Lever (5.6 per 8 sec presentation) while not altering the baseline number of approaches to 
the same location when CS+ was absent (F(3,4)=1.27, p>.1). These patterns demonstrate 
that approaches and consummatory acts were always temporally locked to the insertion of 
the CS+ Lever, and that CeA stimulation enhancement was similarly time-locked and 
triggered by presentations of CS+ Lever, even for goal-trackers, for which the prepotent 
target CSdish was always present.  
CeA DAMGO intensifies microstructure of appetitive-consummatory behavior at 
prepotent target 
A more fine-grained behavioral (frame-by-frame to 1/5 speed) video analysis of 
the detailed microstructure pattern of nibble-and-sniff movements directed toward the 
prepotent CS suggested that motivated behaviors also became more frenzied after CeA 
stimulation, and in the same way for goal-trackers and sign-trackers. To show the 
DAMGO change, the nibble-and-sniff behavior was choreographed in a randomly 
selected subset of animals under both vehicle and CeA DAMGO trials using a visual 
notation system (Mahler and Berridge 2009) (Figure 2.4). DAMGO in CeA increased the 
temporal rate of early-phase nibble and sniff movements to the prepotent CS that 
normally began an appetitive-consummatory sequence, as well as the number of those 
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actions. As a consequence, the bout of intensified nibbles and sniffs endured several 
seconds longer and so postponed the occurrence of slower bite movements that typically 
ended an 8 sec sequence (Figure 2.4; Duration of nibble-sniff bout before first bite 
vehicle vs. DAMGO F(1,12)=5.9, p<.05). Increases in rate, number, and bout duration of 
these rapid early-phase sniff-nibble movements gave a more frenzied appearance to 
consummatory CRs under DAMGO. That pattern also suggested that incentive salience 
enhancement particularly promoted appetitive behavior and consummatory initiation, 
without necessarily potentiating late-phase consummatory termination acts involving the 
bite and swallow movements of actual UCS ingestion. In other words, the DAMGO 
stimulation of CeA appeared to make the metal cue take on food-like incentive properties, 
but did not make the rats mistake the lever or dish object for food. 
Anatomical specificity of DAMGO enhancement in CeA 
Microinjection cannulae tips that produced enhancements were located bilaterally 
well within the CeA in 19 rats (out of 25; Figure 2.5). In order to assess whether 
DAMGO was likely to be contained within the borders of CeA, we applied the earlier 
observation by Mahler and Berridge that DAMGO microinjections in CeA filled a tissue 
volume of approximately 0.43mm3 surrounding the microinjection tip (based on radius of 
Fos plumes produced at the same dose used here) (Mahler and Berridge 2009). If a 
similar radius applied here, we estimated that 90% of the entire DAMGO impact volume 
would have been contained inside CeA for 15 out of the 19 rats that had tips within CeA. 
Over 75% of the DAMGO impact volume would have been contained within CeA for 
another two rats, and over 50% contained within CeA for the final two rats. By contrast, 
we observed that other rats with placements outside the CeA (e.g., in IPAC) would not 
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have entered CeA, and did not express a DAMGO enhancement of their prepotent target, 
by contrast to the 19 placements contained within CeA that did (F(2,4)=2.8, p<.1). Thus I 
am confident that DAMGO enhancement effects observed here were mediated essentially 
by receptors within CeA.  
Further, a more precise localization of function for incentive salience 
enhancement in a subregion of CeA was potentially indicated by a spatial clustering of 
the most effective sites in a mid-anterior subregion of CeA, compared to other sites in 
CeA (Figure 2.5). Sites where DAMGO enhancements exceeded >200% in the number of 
CS+-triggered approaches, nibbles and sniffs to the individual’s pre-potent target (e.g., 
more than twice the vehicle-control level for the same rat) all fell into this restricted mid-
anterior subregion (Figure 2.5). To quantitatively probe this function localization, a 
hotspot was tentatively defined anatomically by outlining the outer border of the cluster 
of contiguous placements where DAMGO enhancements exceeded >200% over vehicle, 
and comparing the magnitude of increase for sites inside the hotspot versus outside the 
hotspot but still in CeA. Hotspot sites produced a DAMGO enhancement that averaged 
236% in behavioral magnitude whereas other CeA sites that fell outside this hotspot 
averaged only 145% enhancement (T(18)=-3.9, p<.05). Although the number of sites here 
is too small to draw a firm conclusion, we note that a similar anatomical mid-anterior 
clustering of the most potent sites in CeA was also found by Mahler and Berridge 
(Mahler and Berridge 2009), suggesting that this anterior CeA hotspot may well be real 
for CS motivational magnet enhancement.  
Sign-tracker vs. goal-tracker differences in absence of CeA DAMGO stimulation 
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Do goal-trackers ordinarily attribute less incentive salience to their prepotent 
target than sign-trackers do to theirs, in absence of special mesocorticolimbic stimulation? 
Under vehicle conditions, our goal-trackers may have shown a slightly lower intensity 
cue-triggered increase in incentive salience than sign-trackers at least in one sense. That 
is, goal-trackers had a lower cue-triggered relative increase when incentive salience was 
calculated as a percentage increase in approaches, nibbles and sniffs to the prepotent 
target triggered by the CS+ presentation, over immediately prior pre CS+ levels (Goal-
trackers = 163% , sign-trackers = 339%; F(1,17)=6.873, p<.05). By contrast, administration 
of DAMGO raised both groups to higher and equal levels of relative CS+-triggered 
increase (Drug*phenotype F(11,8)=2.15, P<.05). However, while the lower relative 
increase under vehicle may reflect lower CS+-triggered levels of incentive salience in 
goal-trackers than in sign-trackers under vehicle condition (Flagel, Clark et al. 2011), it 
also reflects higher pre CS+ baseline levels in goal-trackers (ST=.1 per 8 seconds, GT=.9 
per 8 seconds; F(1,17)=5.402, P<.05), and the absolute levels of cue-evoked nibbles and 
sniffs did not statistically differ between sign- and goal- trackers here under vehicle 
conditions (ST= 2.45 per 8 seconds, GT= 2.18 per 8 seconds; F(1,17)=.106, P>.1) . Still, 
we agree with the proposition of Robinson and colleagues that goal-trackers may 
ordinarily attribute lower incentive salience than sign-trackers (Flagel, Watson et al. 2007; 
Flagel, Clark et al. 2011; Saunders and Robinson 2011) (when in an ordinary 
mesocorticolimbic state involving no physiological stimulation), and we note that even 
under vehicle condition our goal-trackers had a mild physiological state of hunger that 
could induce mesocorticolimbic reactivity because all of our rats were maintained at 
roughly 90% ad libitum body weight (fed 12-15 g chow daily to keep them at that 
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weight). By contrast, studies by Robinson and colleagues typically have tested rats in a 
completely sated state of permanent ad libitum access to chow (Flagel, Clark et al. 2011; 
Saunders and Robinson 2011). Recent pilot data from our lab suggests that such 
differences between mildly-hungry and fully-sated testing may matter for incentive 
salience, and that the phenotype difference between goal-trackers vs. sign-trackers may 
best be observed when rats are fully sated. Using similar autoshaping procedures, studies 
in our lab have found that fully sated goal-trackers show significantly slower latencies of 
CS-triggered approaches to CSdish than fully-sated sign-trackers to CS+ Lever, and that 
hunger enhances approach for both phenotypes (ST= 1.5 ±.28, GT= 3±.67; p<.05; 
personal observations, Springstead and DiFeliceantonio).  
Discussion 
Central nucleus of the amygdala focuses incentive salience. 
Goal-trackers and sign-trackers ordinarily differ in their targets of incentive 
salience, so that it has been suggested that sign-trackers may uniquely attribute incentive 
salience to discrete CSs for reward in ways relevant to addiction (Flagel, Watson et al. 
2007; Flagel, Akil et al. 2009; Saunders and Robinson 2010; Flagel, Clark et al. 2011; 
Saunders and Robinson 2011). Our results add a degree of richness to this picture by 
confirming that goal-trackers can achieve similar high intensities of incentive salience 
pulses, though focused on a different type of Pavlovian CS target, especially when their 




Our results indicate that goal-trackers in a state of mesolimbic activation attribute 
intense incentive salience to their own prepotent CSdish target. This occurs as a phasic 
pulse that makes the dish into a ‘motivational magnet’ as strong as the CS+ lever is to 
sign-trackers, during moments while the CS+ trigger is present (here about 8 sec each 
presentation). That is, mu opioid stimulation of CeA enhanced incentive salience levels 
that each phenotype attributed to its own prepotent Pavlovian target. Our results also 
suggest that both sign-trackers and goal-trackers share the same trigger stimulus, namely 
presentation of the CS+ Lever.  
After DAMGO microinjection in CeA, goal-trackers were more intensely 
attracted to the delivery CSdish where sucrose arrives (goal), specifically at moments 
when the CS+ Lever was present. DAMGO in CeA enhanced the number of goal-trackers’ 
approaches and number of appetitive-consummatory nibble and sniff sequences toward 
the CSdish target, each time the CS+ Lever appeared, without at all enhancing those 
motivated behaviors towards the same object during intervening baseline periods when 
the CS+ was absent. Sign-trackers, after DAMGO in CeA, were similarly attracted at 
those same CS+ Lever moments to their prepotent sucrose-predicting CS+ cue (sign), so 
that the CS+ lever acted as both their trigger and target. The enhancement of attraction to 
the prepotent cue was accompanied by a simultaneous reduction of attractiveness of the 
alternative cue. In short, this “winner takes all” pattern of incentive salience was always 
limited to one CS target, corresponding to the individual’s own prepotent Pavlovian 





Synergy of incentive salience generation.  
A synergy between mesocorticolimbic state and trigger presence in generating 
incentive salience is revealed by the need for two simultaneous conditions: CS+ Lever 
presence (phasic trigger; present for only 8 sec per occurrence) and CeA opioid 
stimulation (which presumably was relatively constant during the 40-min test). 
Simultaneous necessity of CS+ presence and stimulated brain state has been 
computationally modeled for incentive salience enhancement by Zhang et al. (Zhang, 
Berridge et al. 2009) as: Ṽ(St)=r(rt,K)+(γV(St+1). In that Zhang model Ṽ(St) is the 
intensity of incentive salience triggered at the moment (t) when the trigger CS+ (S) 
appears. Here the target of the pulse of “wanting” was selectively always the individual’s 
own prepotent target CSdish or CS+ Lever, but the trigger was always CS+ Lever, 
reflecting the rt carried by its Pavlovian correlation with sucrose UCS in the past. That rt 
essentially corresponds to a memory cache formed by previous reward encounters and 
prediction errors, drawing on a temporal difference model of reward learning (Sutton and 
Barto 1981). Mesocorticolimbic reactivity, which is influenced by CeA state, is 
represented by K, a multiplicative gain factor that interacts with rt at the moment of CS+ 
Lever encounter. Stimulation of CeA mu opioid receptors by DAMGO here can be 
understood as having elevated K>>1, thus dynamically elevating the multiplied product 
of Ṽ(St) to produce excessive incentive salience at those particular moments. Applying 
this model to our results, the cached memory value was not changed intrinsically by 
opioid stimulation of CeA during the test, but the reactivity was heightened of 
mesocorticolimbic circuits that phasically generate “wanting” to the rt association, and 
attributes the incentive salience directionally toward the Pavlovian prepotent target. The 
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rise in intensity of target “wanting” was triggered each time the CS+ was inserted and 
was revealed in more frenzied appetitive and consummatory behaviors directed at the 
prepotent target. 
Sign-trackers’ and goal-trackers’ phenotypes: differences and similarities. 
 Our finding of similarities for CeA enhancement of incentive salience in sign-
trackers and goal-trackers does not deny that sign-trackers ordinarily differ from goal-
trackers in many important neurobiological and psychological ways. For example, Flagel, 
Robinson and colleagues have shown that sign-trackers have higher tonic levels of 
mRNA for dopamine D1 receptors in the nucleus accumbens, whereas goal-trackers have 
higher mRNA for D2 receptors, tyrosine hydroxylase, and the dopamine transporter in 
the ventral tegmental area (VTA) (Flagel, Watson et al. 2007). Psychologically, the same 
group has reported that only sign-trackers assign incentive salience to the CS+ Lever, and 
that sign-trackers ordinarily assign high intensities of incentive salience to their target CS 
but goal-trackers do not (Flagel, Watson et al. 2007; Flagel, Clark et al. 2011). For 
example, Flagel and colleagues reported that sign-trackers show higher dopamine 
elevations than goal-trackers in nucleus accumbens to CS+ Lever presentations (Flagel, 
Clark et al. 2011). Behaviorally, only sign-trackers learn to perform a new instrumental 
response to obtain CS+ presentation (i.e., instrumental conditioned reinforcement) (Flagel, 
Akil et al. 2009; Robinson and Flagel 2009; Flagel, Clark et al. 2011). Such observations 
have led to suggestions that sign-trackers attribute high levels of incentive salience, 
whereas goal-trackers rely upon non-”wanting” psychological processes of S-R habit or 
of cognitive expectations (Robinson and Flagel 2009; Flagel, Clark et al. 2011). In 
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conformance with that situation, I agree that non-hungry and pharmacologically non-
stimulated goal-tracking rats may attribute less incentive salience than sign-trackers.  
Our findings apply especially to heightened states of mesocorticolimbic reactivity, 
induced here by CeA opioid stimulation, which generate intense levels of incentive 
motivation. I conclude that, when in a heightened mesocorticolimbic state, goal-trackers 
and sign-trackers showed intense and comparably high elevations of incentive salience, 
narrowly attributed to their own particular target. Those pulses of intense incentive 
salience attribution to the target phasically came and went with the presence of the shared 
CS+ trigger, while simultaneously reducing the attractiveness of the competing 
alternative target in the same moments. This capacity for similarity in intense incentive 
salience states may also be related to why some psychological, pharmacological, or 
neurobiological manipulations are able to shift potential goal-trackers to become sign-
trackers, or vice versa (Simon, Mendez et al. 2009; Holden and Peoples 2010; Doremus-
Fitzwater and Spear 2011). 
CeA modulation of corticolimbic circuitry with DLS.  
What features of CeA allow its opioid stimulation to both magnify incentive 
salience intensity and narrow the target focus of attribution even more than usual to a 
single Pavlovian CS? Opioid circuits in central nucleus of amygdala may particularly aid 
the translation of previously learned information, in the form of a static Pavlovian CS-
UCS reward association, into dynamic incentive salience that motivates behavior at the 
moment when CS is subsequently re-encountered (Dores, Akil et al. 1984; Hall, 
Parkinson et al. 2001; Phelps and LeDoux 2005; Swanson 2005; Mahler and Berridge 
2009). Thus CeA is in an excellent position to modulate “wanting” of Pavlovian CSs.  
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The central nucleus of amygdala receives distinct inputs that might be important 
to reward processing, including gustatory inputs from the parabrachial nucleus in pons, 
and has important outputs, including indirect modulation of mesolimbic dopamine 
neurons in the ventral tegmentum (Gauthier, Parent et al. 1999; Lundy 2001). CeA also 
has been suggested to be embedded within the larger extended amygdala macrosystem 
(Swanson and Petrovich 1998; de Olmos and Heimer 1999; Alheid 2003; Heimer, Van 
Hosen et al. 2008), the lateral (or central) division of which begins in CeA and connects 
to the bed nucleus of stria terminalis (BNST), sublenticular extended amygdala (SLEA) 
and interstitial posterior limb of the anterior commissure (IPAC) (Zahm 2006). The 
extended amygdala system shares special features with caudal portions of the medial 
shell of the nucleus accumbens (Reynolds and Zahm 2005; Heimer, Van Hosen et al. 
2008). The CeA also can be viewed in light of macrocircuit concepts described by 
Swanson (Swanson 2005; Heimer, Van Hosen et al. 2008), in which CeA is a striatal-
level component (GABAergic), receiving inputs from the basolateral nucleus of 
amygdala (BLA) as a cortical-level component (glutamatergic), and sending outputs to 
BNST, SLEA and IPAC as pallidal-level components (GABAergic). A striatal-level 
status may be especially noteworthy for CeA’s status as an incentive salience generator, 
in that other several other striatal-level structures also can generate intense enhancements 
of incentive salience when neurochemically stimulated (Wyvell and Berridge 2000; 
Pecina and Berridge 2008; Smith, Berridge et al. 2011)These include nucleus accumbens 
(ventral striatum) and even regions of neostriatum (dorsal striatum). Thus, CeA having 
striatal-level features may be important to its capacity for opioid stimulation to intensify 
CS “wanting”.  
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In analyses of emotional learning, CeA has often been considered to be an output 
relay for BLA (Pare, Quirk et al. 2004). Comparing BLA to CeA, BLA inputs have been 
indicated to be especially important for pure Pavlovian learning functions such as 
formation of specific cue-reward associations or learning of new positive cognitive 
incentive values, whereas the CeA may be more involved in the active translation of 
learned information into motivation and generating incentive salience at moments of CS 
re-encounter (Gallagher, Graham et al. 1990; Corbit and Balleine 2005; Lee, Gallagher et 
al. 2010; Wassum, Cely et al. 2011).  
Opioid neurotransmission in CeA appears to be especially important to dynamic 
amplification and focusing of incentive salience that makes a Pavlovian cue into a 
motivational magnet. Endogenously, CeA neurons receive mu opioid stimulation from 
local enkephalin neurons of amygdala and from B-endorphin axons projecting from the 
hypothalamic arcuate nucleus (Jackson and Berridge 2008; Poulin, Castonguay-Lebel et 
al. 2008; Le Merrer, Becker et al. 2009). DAMGO microinjection in CeA may mimic 
such endogenous opioid sources, increasing FOS gene transcription in CeA neurons 
(Mahler and Berridge 2009). Opioid stimulation may promote GABAergic disinhibition 
of output structures (Morris and Dolan 2001; Zhu and Pan 2004), to modulate and 
stimulate mesocorticolimbic dopamine circuits, via indirect projections such as to the 
lateral hypothalamus and peduncular pontine nucleus which in turn project to VTA 
(Gonzales and Chesselet 1990; Gauthier, Parent et al. 1999; Zahm 1999; Heimer, Van 
Hosen et al. 2008; Day, Jones et al.). Here, DAMGO microinjections into CeA may well 
have potentiated mesolimbic dopamine circuits to nucleus accumbens as a step in 
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amplifying the intense bouts of incentive salience observed in appetitive-consummatory 
behavior (Wyvell and Berridge 2000; Jackson 2009; Smith, Berridge et al. 2011). 
Clinical implications. 
 Brain mechanisms that generate intense levels of incentive motivation may be 
especially relevant to addiction. Addiction and related compulsive pursuit disorders 
involve intense motivations that often have two important features: incentive specificity 
and temptation fluctuation. The first feature is that the ‘wanted’ target is usually specific. 
At moments of peak urge, a particular incentive may be ‘wanted’ much more than 
anything else. Drug addicts mostly ‘want’ drug rewards, and some addicts may even 
‘want’ a particular drug, whereas binge eaters ‘want’ food, and perhaps a particular food. 
Other compulsive motivations have their own specific targets and triggers (sex, gambling, 
shopping, etc.). The focusing of incentive salience attributed to a prepotent target, at the 
expense of other competing targets, here made the one stimulus more ‘wanted’ above all 
else. Conceivably, related CeA circuits might similarly be involved in sharpening the 
focus of “wanting” on a single incentive target in intense compulsive disorders like drug 
addiction and binge eating.  
The second feature in drug addiction and other compulsive motivations is 
temporal fluctuation in the cue’s temptation power: a reward cue may be resisted many 
times successfully, only to elicit overpowering attraction on a subsequent encounter that 
triggers relapse. Why does the same Pavlovian CS+ trigger greater temptation on some 
occasions than on others? Our data suggest that one factor is the mesocorticolimbic 
reactivity state at the moment of cue re-encounter, which modulates the intensity of 
incentive salience that is triggered. Mesocorticolimbic reactivity can be enhanced by mu 
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opioid activation of CeA related circuitry, by mesolimbic dopamine or opioid stimulation 
of nucleus accumbens, and by drug-induced sensitization of those mesocorticolimbic 
circuits, all of which exploit the motivational plasticity of mesocorticolimbic circuits that 
evolved for natural appetite states (Wyvell and Berridge 2000, 2001; Tindell, Smith et al. 
2006; Jackson 2009; Mahler and Berridge 2009; Smith, Berridge et al. 2011). All may 
similarly amplify the intensity of phasic pulses of incentive salience triggered by a 
predictive CS+. I suggest that temporal fluctuation of mesocorticolimbic circuit states 
involving CeA opioid activation could dynamically amplify incentive salience attributed 
to a previously-resisted CS at a particularly intense moment of temptation, creating a 
more powerful “wanting” for its reward that could drive relapse in maladaptive drug 
















 Figure 2.1. CeA DAMGO enhances focus. CeA DAMGO microinjection amplifies 
and focuses appetitive-consummatory behaviors directed toward the prepotent cue for 
both sign-trackers and goal-trackers. Both the amount of approaches, nibbles and sniffs 
directed at the prepotent cue and proportion of all approaches, nibbles and sniffs directed 
at the prepotent cue is increased, while the proportion directed toward the nonprepotent 
CS is decreased. Yellow background indicates periods when the CS+ is physically 
present; white backgrounds indicate before and after CS+ presentations * indicates 
p<0.05 . Pie-graph circles show the proportion of appetitive-consummatory behaviors 










Figure 2.2 Individual Variation. DAMGO microinjection into the central nucleus of 
the amygdala makes sign-trackers into more intense sign-trackers and goal-trackers into 
more intense goal-trackers. In this scatter plot, each individual rat is represented by two 
dots: a blue dot in vehicle condition and a connected red dot in DAMGO condition. Sign-
trackers are circles and goal-trackers are diamonds. Vertical axis plots the number of 
sign-tracking behaviors toward CS+ Lever (sign). Horizontal axis plots the intensity of 
goal-tracking behaviors toward CSdish (goal). DAMGO always intensifies the pre-existing 













Figure 2.3. Cue Locked Enhancement. DAMGO microinjection increases nibbles 
and sniffs to the prepotent cue during cue presentations (CS+ Lever insertions into 
chamber; yellow backgrounds) only, but not during inter-cue intervals. This cue-locked 
increase is similar for both sign-trackers and goal-trackers, even though the CSdish is 
always present for goal-trackers.  On vehicle nibbles and sniffs increase during the cue 
periods (p<.05) and on DAMGO this cue-locked increase is greatly enhanced (DrugXCue 
p<.05). Left: temporal pattern of behaviors over successive CS+ Lever presentations and 
baseline intervals during the 40 min test session for goal-trackers (top) and sign-trackers 
(bottom). Pre-cue nibbles and sniffs were subtracted from all values depicted to 
normalize baseline levels. Right: total approaches, nibbles and sniffs to each CS during 












Figure 2.4. Topography of Behavior. DAMGO shifts the individual choreography 
of each rat’s response to more anticipatory nibbles and sniffs and less terminal slow bites. 
Consequently, latency to the first slow bite is increased after DAMGO microinjection. 
Each choreograph shows a ‘typical’ instance compiled from several actual rats. Time 
proceeds from left to right during 7 second presentation of CS+. Green downward 
triangles denote individual CS sniff actions; purple upwards triangles denote nibble 









Figure 2.5. Localization of DAMGO effects. The center of each microinjection 
cannulae placement is represented as a circular point . The enhancement effect of 
DAMGO on that rat’s CS+ lever-triggered ‘motivational magnet’ attraction toward its 
individualized target CS (lever or dish) is color coded and represented as % change from 
vehicle control level in the same rat. A DAMGO “hotspot” of maximal effect is 
highlighted in anterior CeA, defined as a contiguous cluster of anatomical placements 
that produced enhancements >200%. DAMGO placements outside of CeA did never 











 Effects of Mu Opioid and Dopamine Receptor Stimulation in Dorsolateral 
Neostriatum on Incentive Salience of a Preferred Cue 
 
Introduction 
The dorsolateral subregion of neostriatum (i.e., the lateral 50% of the most dorsal 
25% of neostriatum), and its dopamine and corticostriatal connections, has been viewed 
traditionally to mediate movement, action sequencing, stimulus-response (S-R) habits, 
simple learning processes (S-R), and the actor in actor-critic models of learning (Schultz 
and Dickinson 2000b; Packard and Knowlton 2002a; Balleine and Ostlund 2007; Wise 
2009; Bornstein and Daw 2011). The dorsolateral neostriatum’s involvement in addiction 
has been suggested to produce overly-strong S-R habit rituals of reward-seeking.  On the 
other hand, reward motivation for learned rewards is viewed to be a function provided by 
more ventral or medial levels of striatum, especially the nucleus accumbens (Wise, 
Fotuhi et al. 1989; Robinson and Berridge 1993; Wyvell and Berridge 2000). Recently, 
however, dorsal levels of neostriatum have begun to be increasingly recognized to 
participate in reward and motivation functions too (Volkow, Wang, Fowler, Logan, Jayne, 
Franceschi et al. 2002; Volkow, Wang et al. 2006; Palmiter 2008a; Stice, Spoor et al. 
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2008; Wise 2009; DiFeliceantonio, Mabrouk et al. 2012; Nummenmaa, Hirvonen et al. 
2012; Schneck and Vezina 2012) . For example, dorsal neostriatum activates to food or 
drug rewards and cues in neuroimaging and electrophysiological studies (Schultz and 
Dickinson 2000b; Volkow, Wang, Fowler, Logan, Jayne, Franceschi et al. 2002; Volkow, 
Wang et al. 2006; Stice, Spoor et al. 2008; Nummenmaa, Hirvonen et al. 2012). Opioid-
stimulating microinjections in the anteromedial region of dorsal neostriatum  generate 
intense motivation to eat (DiFeliceantonio, Mabrouk et al. 2012), and damage to 
dorsolateral neostriatum reduces cue-triggered “wanting” for reward (Corbit and Janak 
2007).  
Incentive salience is a motivation function that interacts specifically with 
Pavlovian learning to make reward-associated cues attractive and ‘wanted’ and potently 
trigger pulses of motivation to obtain and consume reward (Robinson and Berridge 1993; 
Mahler and Berridge 2009; DiFeliceantonio and Berridge 2012; Robinson and Berridge 
2013). The intensity of a cue-triggered pulse of motivation is actively generated at the 
moment of cue re-encounter  based on  reactivity states of mesocorticolimbic circuits, not 
fixed by previous learning alone, and so can vary across encounters (Wyvell and Berridge 
2000; Pecina, Schulkin et al. 2006; Mahler and Berridge 2009; Zhang, Berridge et al. 
2009; DiFeliceantonio and Berridge 2012; Saunders and Robinson 2012; Robinson and 
Berridge 2013).  Sudden increases in the attractiveness of Pavlovian cues can be detected  
using autoshaping or sign-tracking measures in animal neuroscience studies (Robbins and 
Everitt 2002; Robinson and Flagel 2009; Doremus-Fitzwater and Spear 2011; 
DiFeliceantonio and Berridge 2012). For example, neurochemical stimulation of 
amygdala circuitry that interfaces learning with motivation cam make a Pavlovian 
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conditioned stimulus (CS), such as a metal lever object that predicts sucrose reward 
unconditioned stimulus (UCS), to be attributed with more intense incentive salience, so 
that the Pavlovian metal CS is more ‘wanted’, approached and targeted with 
consummatory grasps, sniffs and ingestive licks, nibbles, and bites that normally belong 
to sucrose (Zener 1937 ; Jenkins and Moore 1973; Boakes, Poli et al. 1978; Meyer, Lovic 
et al. 2012).  
Here we examined the role of the dorsolateral region of neostriatum (DLS) 
specifically in amplifying and directing the incentive salience of learned reward-cues 
upon re-encounters, to direct motivated behavior to specific cues as intensified 
‘motivational magnets.’ Effects of mu opioid stimulation and dopamine stimulation in 
DLS were compared after DAMGO versus amphetamine microinjections. 
Our results indicate that mu opioid stimulation of dorsolateral neostriatum focuses 
enhanced “wanting” on one single CS that is individually tailored or prepotent, at the 
motivational expense of an alternative CS, in a ‘winner take all’ style reminiscent of 
addiction (CS sign lever that predicts reward for individual sign-trackers; CSdish goal that 
delivers reward for individual goal trackers). By contrast, dopamine stimulation only 
enhanced “wanting” for the most goal-proximal CS (CSdish), suggesting heightened 
attractiveness of cues that occur closest in time or space to a reward experience.  
Materials and Methods  
Subjects. 
 Sprague Dawley rats (n=26 for sign-tracking/goal-tracking; n=14 for moved cue 
sign-tracking; n=10 for satiety devaluation of moved sign tracking; n=29 for instrumental 
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conditioned reinforcement) weighing 280-350 grams at the start of the experiment were 
pair housed on a reverse light/dark cycle. Water was provided ad libitum; food was 
provided ad libitum except during weeks containing autoshaping training or test sessions, 
when rats were restricted to 90% free feeding weight and fed about 14gs of standard 
laboratory chow daily after each training session. Before surgery, all rats received 2-4 10 
minute sessions of experimenter handling to acclimate them to being held. All 
experiments were conducted in accordance with protocols approved by the University of 
Michigan Committee on Use and Care of Animals (UCUCA). 
Surgery.  
All rats were anesthetized with ketamine (80 mg/kg), xylazine (7 mg/kg), and 
atropine (0.04 mg/kg). To prevent infection, chloramphenicol sodium succinate (60 
mg/kg) was administered as well as carprofen (5 mg/kg) to provide pain relief. Carprofen 
and chloramphenicol were administered again 24 h post-surgery. All rats were allowed 5-
7 days to recover from surgery before testing.  
Chronic bilateral 14 mm (23 ga) guide cannulae aimed at dorsolateral neostriatum 
(AP 0-2.5, ML ±3-4, DV -3.5-4.5; coordinates marked from Bergman at flat skull; n=13) 
or medial control placements (AP 0-2.5, ML ±1.8, and DV -3.5-4.5; n= 13) based on 
Paxinos and Watson (Paxinos and Watson 2007). All guide cannulae tips were implanted 
2 mm above intended target injection site. Cannulae were anchored to the skull with bone 
screws and acrylic cement. Steel stylets were inserted into guide cannulae to prevent 
occlusion.  Localization of function was further determined by mapping the causal 
efficacy of neostriatal microinjection sites to enhance behaviors. Symbols in maps were 
sized to the maximum radius of "Fos plumes" surrounding DAMGO microinjections. Fos 
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plumes were measured in separate rats after a single microinjection in order to capture 
maximal spread and avoid serial plume shrinkage (Fos radius reflects the anatomical 
spread of drug impact, Fig 3).  
 
Microinjections and drugs 
 Prior to all tests, steel stylets were removed and cleaned, and 16mm microinjectors 
were inserted into the guide cannulae, pre-measured so that microinjector tips extended 2 
mm below guides. Microinjections of [D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO; 
Sigma), amphetamine, or vehicle (aCSF; Harvard Apparatus) were controlled by a 
syringe pump which delivered 0.5 µL over 120s. DAMGO was dissolved in aCSF at 973 
µM concentration (0.25µg/0.5µL), amphetamine was dissolved at 116.5 mM 
concentration (10µg/0.5µL). Microinjector tips were left in cannulae for 1 min following 
the injection to allow diffusion away from microinjector tips. Each rat received a “sham” 
injection 1 day prior to testing of vehicle to habituate them to the microinjection 
procedure.  
Statistical Analysis.  
Within subject repeated measures ANOVAs comparing drug and vehicle days 
were performed on data from autoshaping testing. Placement within neostriatum, cue 
period, and prepotent cue (sign- vs. goal-tracker) were between subjects variables. 
Between subjects multivariate and univariate ANOVAs were used to determine 
difference between drug and vehicle groups in moved cue and conditioned reinforcement 





Rats were sacrificed immediately after the final day of testing by administration 
of a sodium pentobarbital overdose. Rats were decapitated and the brains were extracted 
and fixed in 10% paraformaldehyde solution for 1-2 days followed by a 25% sucrose 
solution in 0.1M NaPB for 2-3 days before slicing. 60 micron slices through the 
neostriatum were taken from each rat, mounted, dried, and stained with cresyl violet. 
Microinjection center was determined for each bilateral injection site and slides were 
compared with the stereotaxic atlas (Paxinos and Watson 2007) to determine placement 
within the dorsal neostriatum.  
Rats used for Fos analysis were anesthetized and transcardially perfused 75 min 
after bilateral microinjection of vehicle (dorsomedial n = 8; dorsolateral n = 6), DAMGO 
(dorsomedial n = 10; dorsolateral n = 9), or normal (dorsomedial n = 2; dorsolateral n = 
2). Brains were extracted, frozen, and sliced at 40 µm. Slices were processed for c-Fos-
like immunoreactivity using NDS, goat anti-cFos (Santa Cruz Biotechnology, Santa Cruz, 
CA) and donkey anti-goat Alexa Flour 488 (Invitrogen, Carlsbad, CA) (Pecina and 
Berridge 2005; Richard and Berridge 2011). Slices were mounted, air dried, and cover 
slipped with ProLong Gold antifade reagent (Invitrogen). The radius and intensity of 
plumes of c-Fos positive cells surrounding the microinjection site were mapped as 
described previously (Pecina and Berridge 2005; Richard and Berridge 2011). 
Behavioral Autoshaping Training 
All rats received the same autoshaping training procedures as previously 
described (Mahler and Berridge 2009; DiFeliceantonio and Berridge 2012). In brief, 
autoshaping training and testing for a particular rat was always carried out in one of eight 
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operant chambers (Med Associates) controlled by Med PC software, containing two 
retractable levers on opposite sides of a food receptacle. Rats first received one session of 
magazine training consisting of 20 sucrose pellets being delivered into the food dish. 
Pavlovian autoshaping training (CS+ paired with UCS) began started the second day. 
Training sessions began with illumination of the house lights, followed by insertion 
presentations of the CS+lever with a light emitting diode on its ventral surface and 
accompanied by an auditory 2.9 KHz tone. Each CS+lever/tone presentation lasted 8s 
before the lever was retracted back through the wall, which was followed immediately by 
delivery of one sucrose pellet into the food dish (UCS; Test Diet). Twenty-five CS+ UCS 
pairs were presented on a 90s variable inter-trial interval schedule during the 40 minute 
session. A control lever was always present in the chamber.  
 Training sessions were repeated over 5 consecutive days. By the 3rd training day, 
every rat began to respond to the CS+ onset with an approach-consummatory CR 
predominantly focused toward either the CS+lever itself (in which case the rat was 
classified as a sign-tracker) or toward the CSdish (in which case the rat was classified as a 
goal-tracker). All rats’ prepotent and non-prepotent cues were discernible by day 3. 
Autoshaping Testing 
Testing began on day 7 and continued day 9, when either DAMGO or vehicle was 
microinjected immediately prior to the autoshaping session (order counter-balanced 
across rats; one microinjection per day). One camera was positioned under the 
transparent floor of the autoshaping chamber to provide a clear view of the rat’s entire 
head and body wherever it was in the chamber. This allowed scoring of both sign-
tracking approaches and goal-tracking approaches, as well as scoring of consummatory 
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behaviors in sign-trackers. A second camera was directed from the side toward the inner 
surface of the CSdish to provide a close up view of the rat’s face and mouth movements 
when inside the dish. A test trial consisted of 25 CS-UCS autoshaping trials identical to 
trainings. Recordings were scored later offline by the experimenter blind to drug 
condition. 
Behavioral Video Scoring: Autoshaping 
Behavior of rats toward CS+ lever and dish were always video recorded from two 
angles simultaneously through two strategically positioned cameras. One camera was 
positioned under the transparent floor of the autoshaping chamber to provide a clear view 
of the rat’s entire head and body movements wherever it was in the chamber. A second 
close-up camera was directed from the side toward the inner surface of the CSdish to 
provide a detailed view of the rat’s face and mouth movements when inside the metal 
dish. Both videos were analyzed off line in slow motion (1/10th to ½ actual speeds) by an 
observer blind to experimental conditions. For each trial, the 8 seconds before and 8 
seconds during the 5th, 10th, 15th, 20th, and 25th presentation of CS+ were selected for 
comparison (Mahler and Berridge 2009). Scored behaviors were look at the cue 
(orienting towards the cue by moving the head or forequarters toward it, without bodily 
approaching it), approach the cue, sniff the cue (contact of the nose and rhythmic nose 
flaring movements), and  nibble (contact of mouth or teeth on lever or dish, combined 
with rapid short (<0.5 sec) rhythmic 1-2 Hz bobbing movements of the head), and 
rhythmic opening and closing movements of  jaw, tongue, and/or teeth similar to 
movements of normal eating of UCS) , and bite the cue (of jaw closing and contact by 
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maxillary and mandibular incisors, often while grasping the object with one or both paws, 
similar to movements that bite the actual UCS sucrose pellet).  
Moved cue training 
Rats were trained in the autoshaping procedures described above. They received 5 
sessions of 25 CS+ UCS pairings. For this experiment only identified sign-trackers were 
tested in the moved cue paradigm.  
Moved cue testing 
  One classical feature of S-R habits is that they become stereotyped rituals of 
centrally-programmed movements (Carr and Watson 1908). Ritualized habits persist  
unchanged in the same movement sequence initially when objects are spatially 
rearranged, sometimes even resulting in collision with objects in new locations (Carr and 
Watson 1908). Therefore we pitted habit against motivated “wanting” of the CS+lever 
expressed by flexible pursuit.  
 After autoshaping training, rats were given microinjections of DAMGO or vehicle 
and placed in the operant chamber. For the first time, the CS+lever was inserted into the 
box from a new location, the opposite wall and opposite side from its previous location 
(Fig. 4b). Because each rat had to experience the sudden cue shift under either DAMGO 
or vehicle for the first time, a between subjects design was used.  
Moved cue behavioral video scoring 
In addition to all behaviors described above, approaches, looks, and nibbles and 
sniffs directed at the CS+lever entry slot were also scored. To determine typical and 
atypical responses to CS+lever onset, a choreograph of each response was created. When 
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a pattern of response emerged for each rat, this was designated as “typical,” patterns that 
differed were “atypical.” During moved cues testing, the first 3 cues were used for 
analysis, as these first cues best capture the sudden shift in the environment.  
Free intake paradigm testing 
On test days, rats received free access to palatable milk chocolate candies (M&Ms) 
in a 1-hr intake test (DiFeliceantonio and Berridge 2012). DAMGO or  vehicle 
counterbalanced across days with 48 h between each testing session Rats were habituated 
for 4 days to clear plastic tub cages with ~3 cm of corn cob bedding, 20 g of pre-weighed 
M&Ms, 20 g of pre-weighed chow. Water was available through a drinking spout. 
M&M’s remaining were counted and re-weighed, and videoed eating behavior was 
scored at a later date offline.  
Free intake paradigm video scoring 
 Videos were scored by experimenters blind to the experimental condition of each 
rat. Seconds spent engaging in the following behaviors were recorded: eating M&Ms 
(actual chewing and consumption), eating chow, drinking, and chewing on non-food 
items. The following behaviors were recorded as a single event: sniffing M&Ms 
(anticipatory sniffs and approaches), sniffing chow, grooming, cage crossing, and rearing 
(Richard and Berridge 2011). 
Devaluation testing 
Rats received 3 days of autoshaping training. On the fourth day rats were exposed 
to one of two conditions: 1) exposure to sucrose pellets used in training, 2) no exposure. 
For the exposure group pellets were delivered into the magazine at a VI 30s interval and 
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were continuously delivered until rats refused to consume more. Rats typically ate about 
60 pellets before refusing to eat more. After this point rats were removed from the 
operant chambers and placed briefly in their home cages. Rats in the no exposure group 
remained in the operant chambers for the average amount of time spent in the chamber by 
the exposed groups (30min) and then returned briefly to their home cages. Rats were then 
removed from their home cages and tested using the moved cue procedure described 
above.  
Conditioned reinforcement testing 
 After 5 days of autoshaping training, rats were microinjected with either 
DAMGO or vehicle and immediately placed in the operant chamber. In this test the 
operant chamber had been altered. The food magazine was removed and the front panel 
now contained two nose ports on either side of a retractable lever (Fig. 5). Each nose port 
was randomly assigned as “active” (produced the CS+lever) or “inactive” (no 
consequence). Pokes into the active nose port resulted in a 2s presentation of the 
CS+lever and tone. The session lasted 30 minutes. Number of active and inactive nose 
pokes was recorded at the end of the session. 
Results 
Overview  
In sign-trackers, DAMGO microinjection in the dorsolateral neostriatum (DLS) 
made rats approach their CS+lever more quickly, and upon reaching it more avidly sniff, 
grasp and nibble their prepotent metal lever cue. In goal-trackers, DAMGO 
microinjection in DLS instead made the rats more rapidly and intensely approach, sniff, 
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grasp and nibble their prepotent CS+ metal dish. Both enhancements occurred only at 
moments when the CS+lever trigger was physically present, and both occurred at the 
expense of approaches and nibbles of the alternative CS. By contrast, dopamine 
stimulation of DLS by amphetamine microinjections enhanced only goal-tracking 
responses in any rats. 
Further, DAMGO in DLS did not simply activate an S-R habit or motor ritual, but 
instead  enhanced several motivated features of behavior: 1) rats more flexibly followed 
their CS to a new location with greater alacrity after DLS opioid stimulation, abandoning 
their previously habitual ritual of approach to old location; 2) rats were more willing to 
learn a new response and work to earn their CS+lever after DAMGO in DLS,  in an 
instrumental conditioned reinforcement test, and 3) the original learned conditioned 
response sequence of approach-sniff-grasp-nibble appeared never to have been a habit in 
the sense of persisting independent of outcome, because  we found that satiety 
devaluation of sucrose UCS produced an immediate transfer of reduced approach to the 
CS+lever in a subsequent extinction test (no UCS).  
Mu opioid receptor activation in dorsolateral neostriatum enhanced cue-
locked “motivational magnet” properties of an incentive stimulus.  
Classification of sign- and goal- trackers. Robinson and colleagues have created 
an index to classify animals into sign- and goal- trackers. This Pavlovian conditioned 
approach (PCA) index ranges from -1 (goal-tracker) to 1 (sign-tracker). There are three 
inputs to this score: approach bias which incorporates number of responses made on each 
cue, probability bias, which is the probability a cue will be contacted, and latency score, 
which is the difference in speed of approach for each cue. To create this score, either 
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computer scored data can be entered (as used by Robinson and colleagues) or hand 
scored video data (used here). Using computer scored data we identified 8 goal-trackers 
and 5 intermediate animals with no sign-trackers, likely due to the sensitivity of our 
levers in our operant chambers. Using the exact same equations, but using hand scored 
data as the input, we identified 8 goal-trackers, 4 sign-trackers, and 1 intermediate rat.  
DAMGO microinjections into the dorsal neostriatum selectively enhanced the 
‘motivational magnet’ power of each rat’s prepotent target CS to elicit approach and 
consummatory actions regardless of their classification as sign- or goal- tracker by either 
method. All animals tested, including the intermediate, were used in analysis. Here sign- 
and goal-trackers are presented as those calculated using video scored data and video 
scored data is used unless explicitly noted. Each animal’s behavior can be broken down 
into measures of approach (probability and speed) and consummatory actions, these are 
discussed separately below. 
Approach. Here, the probability to make a single contact with the preferred 
stimulus for each cue was calculated according to Meyer et al. (2011). Using detailed 
video scoring data all rats approached their preferred cue with 100% probability and after 
DAMGO microinjection continued to approach their preferred cue with 100% probability 
(Figure 3.1). Probability to approach the non-preferred cue was 12% under vehicle 
conditions (GT=12.9%, ST= 8%). DAMGO microinjection enhanced the selectivity of 
responding by focusing behavior on the preferred cue by decreasing the probability to 
approach the nonpreferred cue to 6% (GT=8%, ST= 7.5%).  Although an enhancement in 
probability to approach the preferred cue was not observed due to a ceiling effect (vehicle 
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= 100%), the decrease in the probability to approach the nonpreferred cue demonstrates 
an enhancement of focus of behavior after DAMGO microinjection. 
Another measure of approach, speed of approach, was also enhanced by DAMGO 
microinjection. After DAMGO microinjections in dorsolateral neostriatum rats reached 
their target lever or dish nearly twice as fast upon CS+lever appearance (t(11)=5.9, p<.05; 
Figure 3.1). Under vehicle conditions, rats approach their cue rapidly with a latency of 
1.5s (ST=0.9 s, GT=1.7 s). This rapid approach was further increased after DAMGO 
microinjection, shortening latency to 0.8s (ST=0.6 s, GT=0.9 s).  
Consummatory grasps, sniff, and nibbles of metal CS. Once rats reached their 
prepotent CS, opioid stimulation of DLS additionally made rats emit more frenzied 
appetitive/consummatory actions of grasping, sniffing, licking, and nibbling the metal 
lever or dish  (DAMGO: F(4,7)=7.371, p<.05; CUE: F(4,7)= 59.130, p<.001; 
DAMGO*CUE: F(4,7)= 10.520, p<.01, Figure 3.2). Overall, DLS DAMGO microinjection 
increased the number of consummatory grasps, nibbles and sniffs to over 150% of 
vehicle levels on the prepotent target CS (ST=168%, GT=142%)(t(11)=20.09, p<.01; Fig. 
3.2), while never enhancing consummatory action on alternative CS (ST vehicle= 1.68, 
ST DAMGO= 0.69; GT Vehicle=1.4, GT DAMGO=1.3; t=.99, p>.3, Fig.3.2b). For sign-
trackers DLS DAMGO microinjections specifically increased consummatory acts toward 
CS+ Lever, rising over 60% from 5.48 to 9.24 in grasps, nibbles & sniffs directed to 
metal lever (t(4)=3.595, p=.023). For goal-trackers, DLS DAMGO microinjections 
specifically directed the intense consummatory acts toward the metal CSdish, or dish 
associated with sucrose delivery, rising 40% from 4.2 after vehicle to 6.0 after DAMGO 
per 8-sec presentation of the CS+lever (before the UCS sucrose pellet arrived; t(7)=4.006, 
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p=.005). By contrast to the individual’s prepotent CS, the alternative CS was never 
enhanced for consummatory actions in either phenotype. (ST vehicle= 1.68, ST 
DAMGO= 0.69; GT Vehicle=1.4, GT DAMGO=1.3; t=.99, p>.3, Fig.3.2b).Thus the 
prepotent dish or lever CS became more ‘edible’ in the sense of being perceived as 
eligible for ingestive-style consummatory actions after DAMGO microinjection in 
dorsolateral neostriatum (F(3,48)=35.17, p<.001; Cue Type F(1)=96.12, p<.001; 
DAMGO*Cue Type F(1)=5.49, p<.05.). 
DLS DAMGO enhancements of prepotent dish or lever attraction were always 
time-linked to triggering appearances of the CS+lever. Even for goal-trackers, the 
enhancement of  CSdish as target of grasps, sniffs and nibbles on was temporally bound 
to the presence of CS+ lever (8 sec duration), coming as bouts with the insertion of the 
CS+lever into the cage and fading within seconds after it disappeared. This temporal 
pulse pattern suggested that the reward-predictive lever was the trigger of the incentive 
salience pulse, whereas the reward-proximal CSdish was the target stimulus that became 
more ‘wanted’ for goal trackers (DiFeliceantonio and Berridge 2012). At all other 
moments, when the CS+lever was absent, no enhancement of nibbles and sniffs or of 
approaches to lever or dish was detectable after DAMGO microinjections in either sign-
trackers or goal-trackers (F(4,7)= 3.091, p>.05; beam breaks t(11)= 0.0, p>.9). This need for 
simultaneous opioid brain state and CS+lever presence for motivation enhancement 
reveals a synergy between the two inputs at the moment of cue re-encounter for the 
generation of incentive salience.  
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In the home cage, DAMGO in DLS never changed any measure of general 
locomotion general locomotion (rearing, cage crosses, treading), grooming (F(4,6)=1.63, 
p>.2), eating duration or amount of food eaten (t(9)=0.1, p>.9).  
Amphetamine in dorsolateral neostriatum shifts ‘mixed’ individuals toward 
goal-tracking  
Amphetamine microinjections in dorsolateral neostriatum more directionally 
enhanced the attractiveness of the CSdish, the CS most proximal to UCS sucrose delivery. 
This effect was most visible for ‘mixed’ individual rats that tended to equally approach 
both it and the CS+lever stimulus during lever presentations (i.e., enhancing goal-
tracking in mixed CS individuals that approached both CSs on 66% of trials). 
Amphetamine microinjection in DLS also sped up approach by about 70% to the goal CS, 
slashing the latency to reach the CSdish from 6.02 s after vehicle to 2.1 s after 
amphetamine microinjection. Latency to contact the CS+lever increased from .6s to 2s 
(p>0.05). Rats that were already goal trackers also showed a small (34%) further 
increment in in the number of nibbles and sniffs directed at the CSdish (Vehicle = 3.65, 
Amphetamine = 4.9, p>.1). Under both conditions they approach the CSdish on 100% of 
trials. All goal-tracking rats showed this increase. Similarly, exclusive sign-trackers 
nibbled and sniffed their CS+lever 32% more (Vehicle= 3.5, Amphetamine = 4.85, p>.2) 
after amphetamine microinjection while maintaining 100% probability of approach to the 
CS+lever under both conditions and showing no increase in approach or consummatory 
behaviors to the CSdish. In summary, any animal that demonstrated goal-tracking during 
training, that goal tracking was potentiated after amphetamine microinjections, but if a rat 
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did not goal-track at all, exclusive sign-tracking, that sign-tracking became more intense 
(Figure 3.3). 
In more detail for ‘mixed CR’ rats that showed the strongest effect, dopamine 
stimulation in DLS boosted the probability of mixed CR rats would approach the goal 
CSdish from 66%  after vehicle to 93% of trials after amphetamine microinjection 
(F(1,5)=10,p=.025). Sign-tracking responses to the CS+lever remained at 100% always 
after either vehicle or amphetamine. So amphetamine microinjection the appeal of the 
CSdish in a nonexclusive fashion, without pulling mixed CR rats completely away from 
the CS+lever. 
After mixed CR rats reached the CSdish, amphetamine microinjection in DLS also 
increased the number of consummatory grasps, sniffs, and nibbles on the metal dish 
during the CS+lever extinction presentation (though no sucrose UCS was present). Mixed 
CR rats more than doubled their number of nibbles and sniffs on the metal dish from 1.4 
per 8 sec presentation of CS+lever after vehicle to 3.6 after amphetamine microinjection 
in DLS. The approach-and-nibble-dish enhancement still required the simultaneous 
presence of the triggering CS+lever stimulus, and no amphetamine enhancement was 
detected when CS+lever, was absent (F(1,5)=1, p=0.363; F(1,5)=1.359, p=0.296). 
 
Localization of opioid and dopamine CS attraction enhancements in 
dorsolateral neostriatum    
Localization of function was determined by mapping behavioral enhancement 
magnitudes on to the sites that caused them, aided by Fos plume measures of spread of 
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neurobiological impact, helped confirm that the lateral half of the dorsal neostriatum was 
the principal site for CS motivational magnet enhancements. Fos plume diameters 
provide at least some information on the radius of spread of local impact on neuronal 
function surrounding a microinjection of DAMGO or amphetamine, and the diameter of 
microinjection impact is useful in mapping location of function revealed by 
neurochemical stimulation (Pecina and Berridge 2000; Richard and Berridge 2011). In 
dorsolateral neostriatum, Fos plumes produced by an initial DAMGO microinjection 
extended about 0.2 mm in total radius, containing  both a small center of >150% Fos 
elevation (above vehicle baseline; 0.13mm radius, volume=0.009mm3), and a larger 
0.2mm radius surrounding sphere of moderate 150-200%  Fos elevation above normal 
levels (0.033mm3 volume). These were, similar to DAMGO plumes previously observed 
in dorsomedial neostriatum (DiFeliceantonio, Mabrouk et al. 2012).  
DAMGO microinjections enhanced prepotent cue attraction as described above 
only in the lateral half of the dorsal neostriatum (DLS). A microinjection site was 
classified as being contained within DLS if >75% of a total plume volume was inside the 
lateral half of dorsal neostriatum (Figure 3.4). DAMGO microinjections failed to enhance 
at sites in the medial half of neostriatum (dorsomedial striatum) if the plume did not 
penetrate into the lateral half of dorsal neostriatum (Drug*Placement: F(2,23)=5.37, 
p=.012). Dorsomedial sites for DAMGO microinjections did not increase approach 
frequency or speed, nor grasps, nibbles and sniffs on any cue (F(3,10)=1.250, p=.343; all 




DLS DAMGO enhances flexible pursuit of moved motivational magnet, not S-R 
motor rituals. 
In potential support of a habit ritual interpretation, we identified here a motor 
ritual typically displayed after 3 days of training by sign-trackers using video analysis 
(Figure 3.5a). The ritual began with 1) a rat typically sitting slightly nearer its goal dish 
(3cm) than the lever location (5cm) in anticipation before the CS+lever was inserted. 
When 2) the CS+lever actually appeared, rats typically turned 30 – 90 degrees so as to 
immediately face the CS+lever. Next 3) each rat typically took a  small forelimb step 
towards CS+lever (< 2 cm step), 4) followed with a small hind step movement to move 
the rear quarters (<2 cm step),  and then 5) repeated forelimb and hind limb steps as 
needed until the head was within 1 cm of the lever, and then 6) merely leaned forward 
without moving the hindquarters to make oral contact with the lever, often accompanied 
by a forelimb grasp, and 7) initiated consummatory sequences of sniffing and nibbling 
the CS+lever (Figure 3.5a). Does DAMGO microinjection in DLS simply strengthen this 
motor ritual? 
Here we used a manipulation that could be described as ‘who moved my cheese?’ 
similar  to Carr & Watson’s (1908) to test whether opioid stimulation of DLS would 
strengthen sign-tracking as a motor ritual or make it perseverate and decouple from 
action consequences when lever location is moved. In practice, this can most readily be 
tested by suddenly moving the CS+lever of sign-trackers to a new location on the 
opposite wall of the chamber from its previous appearances.  
To test these alternative hypotheses, separate rats were trained as above, and sign-
trackers were identified. On the test day after their DAMGO or vehicle microinjection, 
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the location of the CS+ lever was moved to a new location on the opposite wall from 
where it had previously emerged.  
DAMGO or vehicle microinjections in dorsolateral neostriatum were 
administered on a test on the 4th day. On that same day, the location of where the 
CS+lever would emerge was suddenly moved to the opposite wall, approximately 20 cm 
from the original location. No lever emerged from the original location on this test day. 
At the first CS+lever emergence in new location, rats typically abandoned their 
habitual pattern described above. Even after DAMGO microinjection in DLS rats made 
few if any approaches to the old location. Instead rats that received DAMGO 
microinjection made 20% fewer habitual visits to the old location on the first switched 
appearance of the CS+lever (0.68±0.3) than rats that received vehicle microinjections 
(0.78±0.6; Figure 3.5b). 
 Instead, rats immediately switched to the new location. The approach to the new 
location required a different movement pattern from the previous ritual. In the new 
movement sequence, rats typically 1) turned 90 – 180 degrees in opposite direction away 
from their old location and head movement, towards the opposing wall where the cue 
now appeared, 2) took a long forelimb step toward new location (i.e., >5 cm), 3) followed 
with a long hind limb step (>5 cm), 4) repeated steps # 2 and #3 at least 2 times and up to 
5 times until the new location was reached (Figure 3.5b).  
DAMGO microinjection in DLS facilitated this abandonment of original motor 
ritual and flexible shift to follow the cue to its new location. DAMGO microinjections 
sped up by 30% the first arrival at the new CS+lever location (vehicle speed = 4.65s 
±0.88, DAMGO speed=5.9±0.94). Finally, once reached, DAMGO in DLS made rats 
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emit 38%more intense nibbles and sniffs, grasps and bites of the newly placed CS+lever 
than rats that received vehicle microinjection, suggesting they were more motivated to 
‘consume’ the metal lever even in its new location (Vehicle= 2.79±1.2, DAMGO= 
3.85±0.96; Figure 3.5b). Thus, opioid stimulation of DLS makes rats abandon more 
quickly any ritualized S-R habit involved in sign-tracking. Instead, DLS stimulation 
makes the rats flexibly follow the cue to its new location, despite requiring a new 
sequence of movements. This flexible shift and new motor pattern supports the idea that 
rats more strongly ‘want’ the attractive cue more after DLS opioid stimulation in a 
motivated fashion. 
Sign-tracking does not show S-R habit resistance to UCS devaluation  
 One test of whether a conditioned response has become habitual is to assess 
whether it is insensitive to its outcome, in the sense of continuing to perseverate near 
original levels after the associated UCS reward is suddenly devalued, such as by inducing 
sensory-specific satiety (Colwill and Rescorla 1990; Dickinson and Balleine 1990; 
Balleine and Dickinson 1992). An S-R habit may persist after goal devaluation, at least 
until the UCS is re-encountered again after performing the response in a devalued state 
(Dickinson and Balleine 1990; Wassum, Cely et al. 2009).  By contrast, incentive 
salience controlling a motivated Pavlovian response can decrement or increment levels of 
behavioral responding to the CS when UCS value is shifted, without further CS-UCS 
retraining, without further S-R retraining, and without re-tasting the UCS again before 
performing the response (Dickinson, Smith et al. 2000; Berridge 2012; Robinson and 
Berridge 2013). Therefore we tested whether UCS devaluation would reduce sign-
tracking responses elicited by the CS+lever in an extinction test.  
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Sign-trackers (n=9) were trained as above for 3 days. Then the UCS was devalued 
on the 4th day by inducing sensory satiety to sucrose. Satiety (n=5) was induced by 
allowing rats to consume as much sucrose as they could within 45 min in the test 
chamber (~60 sucrose pellets and water spout available ad lib). Control non-devalued rats 
(n=4) were placed in the chamber for the same duration, but no sucrose pellets were 
given (water was still available). Approximately 5 min after this consumption or control 
session, CS extinction session was begun with the moved lever as described above 
(containing 5 presentations of CS+lever) and sign-tracking was assessed.   
Sign tracking approaches to the lever were cut in half to 53% of control levels 
after satiety was induced by sucrose consumption (Figure 3.6). The speed to reach the CS 
on presentations that were approached was also slowed to one-third of the speed of non-
devalued control rats. (t(4)=2.89, p=.047; Figure 6). The number of consummatory grasps, 
sniffs, and nibble actions performed on the metal CS+lever was similarly cut to less than 
one-third of control levels after satiety devaluation of UCS (t(4)=3.107, p=0.036), and by 
71% (t(3)=6.07, p=.009; Figure 3.6) . 
Thus UCS devaluation produced an immediate reduction of conditioned 
responding elicited by CS+lever to less than ½ control levels by merely inducing a degree 
of satiety to the UCS. This pattern suggests that sign-tracking never strongly became an 
S-R habit that was insensitive to goal value, and instead that CS “wanting” was adjusted 
by physiological state in accordance with the incentive salience hypothesis (Zhang et al. 
2009; Berridge, 2012; Robinson & Berridge, 2013).  
 
DLS opioid stimulation enhances instrumental working to obtain CS+lever.  
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A final measure of increased “wanting” for a CS+ is whether individuals will 
learn a new response and work harder in order to obtain the CS. This can be measured as 
instrumental conditioned reinforcement, which requires rats that have previously learned 
the Pavlovian CS+-UCS association to learn an entirely novel instrumental response to 
earn  presentations of the CS+lever alone (Pryor, Haag et al. 1969; Taylor and Robbins 
1984; Meyer, Lovic et al. 2012). Does DAMGO microinjection in DLS enhance the 
acquisition and performance of instrumental conditioned reinforcement?  
Rats (n=21)were trained in Pavlovian autoshaping for 5 days, and sign-trackers 
were identified as above if they directed  approaches, nibbles and sniffs more than 3 
times more frequently to the CS+lever as target than to the  CSdish. On the 6th day, sign-
trackers were tested for instrumental conditioned reinforcement after receiving bilateral 
microinjections of either DAMGO or vehicle (between subjects) in the DLS. In this 
instrumental task, rats could perform a new nose poke response, by breaking a photo 
beam inside a designated hole in the wall that had not been present on previous days, in 
order to earn presentations of the CS+lever on an FR1 schedule. A second nose poke hole 
10cm away earned nothing and served as a control for general motor activity.  
 DAMGO microinjections in DLS enhanced the number of the new instrumental 
nose poke response performed to earn the Pavlovian CS+lever presentation. Rats that 
received DAMGO worked harder to obtain the CS+lever, making 150% more nose pokes 
into the porthole, and earning 150% more 2-sec presentations of the Pavlovian CS+lever 
than control rats that received vehicle microinjections (38.00±7.5 to 57.10±5.54),  DLS 
DAMGO microinjections selectively enhanced responding on the nose poke hole that 
earned the CS+lever, and did not enhance responding into the other control hole that 
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earned nothing (inactive nose vehicle= 17.27±2.1, DAMGO = 17.30±1.6; nose poke 
type*drug interaction F(1,19)=5.17, p=.035, Figure 3.7).  
By contrast to dorsolateral sites in neostriatum that produced enhancement of 
conditioned reinforcement, more medially placed sites in dorsomedial neostriatum 
produced no change in conditioned reinforcement after DAMGO microinjection 
(F(2,6)=0.675, p=.544). Neither responding for the CS+lever (vehicle 52.8(±1.7); DAMGO 
56.37(±9.39; F(1,7)=0.071, p=0.789), or for the control hole was altered by opioid 
stimulation of dorsomedial sites (vehicle 33.12 (±6.45) ; DAMGO 25.37(±5.36; 
F(1,7)=0.905, p=0.375). This fits the conclusion from our first experiment that dorsolateral 
sites in neostriatum, but not dorsomedial sites, support opioid enhancement of “wanting” 
for a prepotent CS. 
Discussion. 
Opioid stimulation of the dorsolateral of neostriatum, via microinjection of the mu 
agonist DAMGO, amplified the motivational magnet properties of CSs for sucrose 
reward in a directional and individualized fashion, focusing higher incentive salience on 
each individual’s prepotent Pavlovian cue (pre-existing favorite) to make that CS even 
more attractive and ‘wanted’, at the expense of an alternative cue. That is, of DLS by 
DAMGO microinjections made sign trackers emit even more intense and focused sign 
tracking under the influence of mu opioid stimulation approaches and consummatory 
nibbles and sniffs of the predictive metal lever CS (while decreasing their residual goal-
tracking responses). Likewise, DLS DAMGO microinjections made goal trackers emit 
more intense and focused approach, nibbles and sniffs toward the metal dish or goal that 
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delivered sucrose pellets. Although the dish was always available as a target, the 
enhancement occurred only when the CS+lever was physically presents, and not in the 
absence of a triggering stimulus. For all individuals, the motivation enhancement was 
triggered as temporal pulses by appearance of the CS+lever. This pattern of motivation 
enhancement for a previously learned reward cue was essentially identical to the pattern 
previously reported for opioid stimulation of the central nucleus of amygdala. The 
equivalence of the two sites suggest that both may use learned Pavlovian information as 
an input, and local opioid-stimulation state as a separate input, to determine the intensity 
and exclusivity of CS “wanting” at the moment of re-encounter. 
Neostriatal opioid receptors are localized mainly in “patch” or “striosome” 
compartments (Pert, Kuhar et al. 1976; Herkenham and Pert 1980; Gerfen 1984; 
Crittenden and Graybiel 2011). In DLS, patches receive inputs from cortex limbic, 
prelimbic and anterior cingulate cortices (Ragsdale and Graybiel 1990; Eblen and 
Graybiel 1995; Kincaid and Wilson 1996; Levesque and Parent 1998; Haber, Kim et al. 
2006; Crittenden and Graybiel 2011). 
Mu opioid receptors on neurons in “patches/striosomes” in dorsolateral 
neostriatum may be in a unique position to control dopamine function, as such patch 
neurons possibly project directly to the substantia nigra pars compacta, to most directly 
influence striatal dopamine tone (Sato, Sumi-Ichinose et al. 2008; Fujiyama, Sohn et al. 
2011). It is possible that opioid stimulation of CeA and the dorsolateral neostriatum 
produce similar enhancements of prepotent CS “wanting” because both interact through 
the substantia nigra to produce a focusing of intense motivation on learned cues 
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(Gonzales and Chesselet 1990; Rouillard and Freeman 1995; Fudge and Emiliano 2003; 
Lingawi and Balleine 2012).  
Anatomical localization of CS “wanting” amplification 
Neuroanatomically, the prepotent enhancement was generated only by sites in the 
lateral half of the dorsal half of neostriatum (dorsolateral quarter of neostriatum).  Most 
effective sites were contained in the upper 25% level of dorsal neostriatum (e.g., within 
1.5mm of the dorsal edge of neostriatum measured directly above each effective site). 
Both anterior and posterior sites in the lateral half of dorsal neostriatum appeared 
effective.  At sites placed in the medial half of the dorsal neostriatum, DAMGO 
microinjections failed to alter autoshaped behavior toward CS+lever or CSdish in any 
individuals, even in the anterior region of dorsomedial neostriatum. This failure of 
dorsomedial neostriatum to control behavior directed toward learned Pavlovian CSs 
contrasts to our previous report that DAMGO in anterior portion of dorsomedial 
neostriatum produced robust enhancement of UCS consumption, and that consuming 
sweet foods triggered an endogenous enkephalin surge. That double dissociation suggests 
two conclusions. First, mu opioid stimulation in the lateral half of dorsal neostriatum 
promotes the incentive motivation attractiveness of learned Pavlovian CSs for food 
reward (but not necessarily for UCSs themselves). Second, by contrast, mu opioid 
stimulation in anteromedial portion of dorsal neostriatum promotes the attractiveness of 
the natural UCS of palatable food, but does not interact with previously learned 
Pavlovian associations to focus “wanting” on a particular CS+. This localization of 
motivation functions (UCS vs. CS targets) adds to other functions previously described 
for these regions (Vanderschuren and Everitt 2005).  
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DLS neurochemical differences between opioid and dopamine amplification 
Neurochemically, a very different pattern of CS enhancement was produced by 
dopamine stimulation via amphetamine microinjection. The effect of dopamine 
stimulation was to directionally promote goal-tracking at the expense of sign-tracking. 
This dopamine effect was more tenuous or individually selective than the opioid effect, in 
that the goal-tracking enhancement was  only observed in ‘mixed’ individuals that 
spontaneously showed both sign-tracking and goal-tracking CRs to comparable degrees 
when the CS+lever was present. Pure sign-trackers and pure goal-trackers failed to be 
modulated in their CS-directed behavior. Regarding potential mechanisms for differences 
between opioid and dopamine stimulation in DLS, mu opioid receptors are expressed 
especially on neurons located in patch or striosome compartments, and patch neurons  
may project most directly to pars compacta of substantia nigra, including to dopamine 
neurons (Crittenden and Graybiel 2011; Fujiyama, Sohn et al. 2011).  Mu opioid receptor 
stimulation in DLS might thus be expected to preferentially alter patch-striosome 
neuronal function. By contrast, amphetamine promotes dopamine release that would 
stimulate dopamine D1-type and D2-type receptors on neurons in both patch and matrix 
compartments of neostriatum, as well as on presynaptic terminals of corticolimbic 
glutamate neurons (Gerfen 1984; Packard and Knowlton 2002b; Crittenden and Graybiel 
2011).  
Dopamine stimulation in DLS specifically enhanced the attractiveness of the 
UCS-contiguous CSdish, to enhance goal-tracking particularly in mixed individuals. For 
both sign-trackers and goal trackers the CS+ Lever, which has the highest predictive 
correlation with UCS delivery, was the trigger that controlled the timing of incentive 
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salience surges after DAMGO stimulation. For sign-trackers the Pavlovian target of 
focused “wanting” was the same physical CS+ Lever, whereas for goal-trackers the 
‘wanted’ target was the CSdish, which has the closest spatial and temporal contiguity with 
the UCS (because the rat’s head was always inserted into that dish whenever the sucrose 
UCS was experienced). Contiguity has long been recognized as important to facilitate a 
Pavlovian association between a UCS and a CS, and contiguity may remain important 
even when contingency correlation dominates associative prediction (Zener 1937; 
Mackintosh 1974; Rescorla and Cunningham 1979; Delamater and Holland 2008). 
Contiguity also has been reported previously to be important for pharmacological 
dopamine-related enhancements of incentive salience (Tindell, Berridge et al. 2005; 
Simon, Mendez et al. 2009; Holden and Peoples 2010; Smith, Berridge et al. 2011), but 
see also (Doremus-Fitzwater and Spear 2011).  
 
DLS and sensorimotor S-R habit functions  
The dorsolateral or sensorimotor region of neostriatum is known to play roles in 
serial movement patterns and S-R habits. One line of evidence for DLS in habits has been 
that DLS apparently becomes increasingly recruited over time as learned actions become 
more over trained or habitual. For example, DLS lesions are reported not to disrupt 
cocaine self-administration early in training, but to produce disruptions of self-
administration if made later after additional training (Murray, Belin et al. 2012). A related 
line of evidence is that learned reward-seeking actions become increasingly independent 
of outcome as overtraining proceeds, so that over trained learned behaviors perseverate 
even if the reward has been devalued by satiety or if the act-outcome contingency is 
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diluted by free rewards (Dickinson and Balleine 1990; Balleine and O'Doherty 2010). 
Lesions of the DLS reduce such perseveration, so that learned responses decline again 
after reward devaluation or contingency dilution (Yin, Knowlton et al. 2004, 2006). A 
third line of evidence for DLS involvement in habits is serial ritualization into 
stereotyped patterns that characterize habits (Graybiel 2008). Habitual actions can be 
computationally generated by a prediction error mechanism that once trained operates 
inflexibly (Daw, Niv et al. 2005). Rigid serial patterns of action are disrupted by lesions 
of the dorsolateral neostriatum, both for learned serial rituals (Yin 2010) and for 
instinctive rituals of serial actions (Cromwell and Berridge 1996).  Further, neurons 
within the dorsolateral neostriatum track the chunking of serial actions into ritualized 
patterns, both for learned rituals (Barnes, Kubota et al. 2005) and instinctive serial rituals 
(Aldridge and Berridge 1998). In short, “habits are sequential, repetitive, motor, or 
cognitive behaviors elicited by external or internal triggers that, once released, can go to 
completion without constant conscious oversight” (Graybiel 2008), in which DLS plays 
an important role. 
DLS opioid enhancement of CS attraction: “wanting” motivation or S-R habit? 
With the above points in mind, it is crucial to ask whether DLS microinjections of 
DAMGO strengthened an S-R habit ritual to enhance approach and consummatory 
responses to a prepotent CS.  We believe the evidence clearly shows the answer to be 
‘no’.  First, there was no ‘who moved my cheese?’ perseveration of sign-trackers’ well-
established approach ritual to familiar-location when their CS+lever was suddenly moved 
to a new location. Instead, rats almost immediately abandoned their old ritual within a 
second or two, and switched to the new location using a new movement sequence of 
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opposite-direction turn and longer strides. Rats switched even faster after DAMGO and 
reached the new location with even greater alacrity, suggesting they more intensely 
‘wanted’ the moved cue and were willing to flexibly follow it. Second, DLS 
microinjections of DAMGO also made rats ‘want’ the CS+lever cue more in the sense of 
being willing to learn an entirely new movement response to earn it. Rats learned a new 
nose-poke response, and performed at higher levels to earn CS+lever insertions as an 
instrumental conditioned reinforcer after DAMGO microinjection in DLS than after 
vehicle microinjections. Although conditioned reinforcement can be explained in several 
ways, the enhancement is certainly consistent with the notion that DLS opioid stimulation 
made rats ‘want’ the Pavlovian cue more intensely. Finally, sign-tracking itself as a 
behavioral response never quite became habitual in the accepted sense of persisting after 
UCS devaluation. Instead, sign-tracking immediately reduced after UCS devaluation by 
satiety induction. Devaluation sensitivity suggests that sign-tracking always remained a 
motivated response, integrating current biological state with learned Pavlovian 
information as incentive salience computation typically does (Zhang, Berridge et al. 2009; 
Berridge 2012; Robinson and Berridge 2013).  
Dopamine stimulation in DLS by amphetamine microinjections also may have 
produced a motivational enhancement but of a different type. Amphetamine 
microinjection more selectively enhanced goal-tracking alone, and only in ‘mixed’ 
individuals that originally both sign-tracked and goal-tracked to comparable degrees.  It 
is difficult to view this as S-R habit enhancement, since there was no enhancement in 
individuals that showed the strongest patterns to begin with, i.e., sign-trackers   
 In sort, these lines of evidence demonstrate the dorsolateral neostriatum participates 
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in generation of intense motivation as incentive salience assigned to a particular 
Pavlovian cue for reward. Although motivation generation by DLS may come as a 
surprise to traditions that view it more purely as sensorimotor or habit-based, there is 
increasing supporting evidence for a motivation role. In animals, DLS participates in 
restoring motivated food-related behaviors (Palmiter 2008a), and DLS neurons code 
flexible responses as well as stable responses when reward cues are suddenly changed 
(Graybiel 2008; Kubota, Liu et al. 2009). A neural signal in DLS for learned motivational 
value could possibly be reflected by the rise in extracellular dopamine observed when a 
cocaine cue is encountered as a conditioned reinforcer (Ito, Dalley et al. 2002). In line 
with an interpretation as a focuser of motivation, dopamine signaling within the 
dorsolateral neostriatum seems to correlate most closely with the focus or selectivity of a 
response, i.e. choosing the drug nose port over the inactive nose port, rather than 
compulsive drug taking (Willuhn, Burgeno et al. 2012). In human neuroimaging 
experiments, DLS activates to food stimuli correlated with motivation ratings of desire 
(Hollmann, Hellrung et al. 2012).  
Conclusion 
 Enhancement of incentive salience attributed one particular reward CS, converting 
that CS into a more powerful motivational magnet that controls both the direction and 
intensity of behavior expands the role of the dorsolateral neostriatum in motivation. DLS 
can make a Pavlovian CS more ‘wanted’, in a winner take all fashion. This may have 
implications for disorders of intense compulsion and addiction. In particular, our findings 
suggest that DLS recruitment may magnify the amplitude and persistence of cue-
triggered pulses of behavior focused on an incentive target, through a Pavlovian 
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motivation mechanism that can operate independently of simple S-R habits or 


























Approach and consummatory behaviors are enhanced by DAMGO. Here both 
approach and consummatory behaviors are mapped as % vehicle. Raw values are shown 
next to end points. Speed of approach as well as consummatory behaviors to the preferred 
cue were enhanced by DAMGO. DAMGO decreased approaches and consummatory 





Figure 3.2. Dorsolateral DAMGO enhances focus. Dorsolateral DAMGO 
microinjection amplifies and focuses appetitive-consummatory behaviors directed toward 
the prepotent cue for both sign-trackers and goal-trackers. Both the amount of approaches, 
nibbles and sniffs directed at the prepotent cue and proportion of all approaches, nibbles 
and sniffs directed at the prepotent cue is increased, while the proportion directed toward 
the nonprepotent CS is decreased. Yellow background indicates periods when the CS+ is 
physically present; white backgrounds indicate before and after CS+ presentations * 
indicates p<0.05 . Pie-graph circles show the proportion of appetitive-consummatory 








Figure 3.3 Individual variation for DAMGO microinjection. DAMGO 
microinjection into the dorsolateral neostriatum made sign-trackers into more intense 
sign-trackers and goal-trackers into more intense goal-trackers. In this scatter plot, each 
individual rat is represented by two dots: a blue dot in vehicle condition and a connected 
red dot in DAMGO condition. Sign-trackers are circles and goal-trackers are diamonds. 
Vertical axis plots the number of sign-tracking behaviors toward CS+ Lever (sign). 
Horizontal axis plots the intensity of goal-tracking behaviors toward CSdish (goal). 
DAMGO always intensifies the pre-existing preference of an individual that was already 









Figure 3.4 Individual variation for amphetamine microinjection. Amphetamine 
microinjection into the dorsolateral neostriatum had the most noticeable effect on animals 
that showed a mixed phenotype (yellow group), showing sign- and goal-tracking during 









Figure 3.5. Dorsolateral not dorsomedial neostriatum enhances motivational 
magnets. Each microinjection in represented in 3 anatomical planes. The size of the 
symbol represents the area of maximal drug spread (inset). For clarity in mapping, the 
distance from the dorsal most portion of the striatum for each placement in its appropriate 
slice was measured and maintained here in the representative slice. There is a clear 






Figure 3.6. Environmental shift. The ritualized behavior exhibited by most rats during 
training is represented in Panel A. In Panel B the effect of the shift in the lever location is 
represented. The inset shows DAMGO facilitated the shift to the new location by 
reducing nibbles and sniffs and the old location and enhancing speed and nibbles and 












Figure 3.7. Reinforcer value shift.  In this experiment the value of the sucrose pellet 
was devalued by sensory specific satiety in separate rats. Those rats that spent only time 
in the chamber are represented at 100% by the black line. The detriment in approaches 
and nibbles and sniffs of the lever seen in those rats that were pre-fed on sucrose pellets 










Figure 3.8. Conditioned reinforcement. After autoshaping training, rats were 
microinjected with either DAMGO or vehicle and were placed in the operant chambers. 
The chambers were now equipped with nose pokes around a center lever. Those rats 
microinjected with DAMGO made more pokes in the active port, earning more CS+ 










Enkephalin in Dorsomedial Neostriatum Says “Eat More Now!” 
Introduction 
Dorsal neostriatum has been traditionally viewed to mediate movement and habits 
(Parkinson, Cardinal et al. 2000; Balleine and Ostlund 2007; Graybiel 2008; Suto, Wise 
et al. 2011), and to respond to learned cues (Schultz and Dickinson 2000a), whereas 
ventral striatum is well known to generate reward and motivation to consume incentives 
(in large part mediated by opioid circuitry) (Pecina and Berridge 2005; Baldo and Kelley 
2007). Dorsal striatum recently has also become implicated in reward-related functions 
(Volkow, Wang, Fowler, Logan, Jayne, Franceschi et al. 2002; Volkow, Wang et al. 2006; 
Palmiter 2008a, b; Stice, Spoor et al. 2008; Wise 2009; Nummenmaa, Hirvonen et al. 
2012) and here we report that opioid signaling in an extremely dorsal region of 
neostriatum contributes to generating intense motivation to over-consume palatable food 
rewards. In dorsal neostriatum, mu opioid receptors are localized mainly in “patch” or 
“striosome” compartments (Pert, Kuhar et al. 1976; Gerfen 1984; Crittenden and 
Graybiel 2011). Patches or striosomes in neostriatum receive converging inputs from 
limbic regions of prefrontal cortex, including from orbitofrontal, prelimbic, and anterior 
cingulate regions (Ragsdale and Graybiel 1988, 1990; Eblen and Graybiel 1995; Kincaid 
and Wilson 1996; Levesque and Parent 1998; Graybiel 2008; Crittenden and Graybiel 
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2011). We focused here on the medial region of dorsal neostriatum, which has been 
implicated by previous studies in processing value of rewards (Yin, Knowlton et al. 
2005). 
Materials and Methods 
Subjects 
 Sprague Dawley female rats (n = 42 for microinjection studies, n = 12 for sucrose 
taste reactivity, n=8 for M&M fragment taste reactivity, n = 9 for enkephalin 
microdialysis, and n = 5 for dynorphin microdialysis) weighing 280-370g at the start of 
the experiment were pair housed on a reverse light/dark cycle. Water and food (Purina 
Rat Chow) were provided ad libitum at all times for rats in microinjection experiments 
and food was restricted to 10g for one light/dark cycle prior to dialysate collection. All 
experiments were conducted in accordance with protocols approved by the University of 
Michigan Committee on Use and Care of Animals (UCUCA). 
Surgery 
All rats were anesthetized with ketamine (80 mg/kg), xylazine (7 mg/kg), and 
atropine (0.04 mg/kg). To prevent infection, chloramphenicol sodium succinate (60 
mg/kg) was administered as well as carprofen (5 mg/kg) to provide pain relief. Carprofen 
was administered again 24 h post-surgery for all rats and chloramphenicol was 
administered 24 h post-surgery and as needed for taste-reactivity rats. All rats were 
allowed 5-7 days to recover from surgery before testing.  
Intracranial microinjections. Chronic bilateral 14 mm (23 ga) cannulae aimed at 
anterior dorsomedial neostriatum (AP 1-2.5, ML ±1.8, and DV -3.5-4.5), posterior 
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dorsomedial neostriatum (AP 0-1, ML ±1.8, and DV-3.5-4.5), anterior dorsolateral 
neostriatum (AP 1-2.5, ML ±3-4, DV -3.5-4.5) and posterior dorsolateral neostriatum 
(AP 0-1, ML ±3-4, and DV-3.5-4.5) were implanted 2 mm above target injection site. 
Dorsoventral coordinate was marked from bregma at flat skull. Placement coordinates for 
cranial cannulae were calculated based on Paxinos and Watson (Paxinos and Watson 
2007) and lowered into place with a stereotaxic apparatus. Cannulae were anchored to the 
skull with bone screws and acrylic cement. Steel stylets were inserted to prevent their 
occlusion. Rats used for c-Fos analysis received the same cannulae implantation except 
for those designated as “normal.” These animals received all procedures except cannulae 
implantation.  
 
Taste Reactivity. As above, chronic bilateral 14 mm (23 ga) cannulae aimed at 
anterior dorsomedial neostriatum (AP 1-2.5, ML ±1.8, and DV -4.5) were implanted. 
Additional oral cannulae were inserted to allow infusion of taste solutions directly into 
the mouth. Oral cannulae were constructed in house of ethyl vinyl microbore tubing (0.04 
inch inner diameter; Cole-Parmer) and stainless steel (19 ga). Each was inserted just 
lateral to the first maxillary molar and run subcutaneously along the zygomatic arch to 
the top of the skull where the cannulae exited through the incision made for the cranial 
cannulae. There, they were secured using wire and acrylic cement. After 3 days of 
recovery, oral cannulae were cleaned and flushed with water daily to prevent buildup of 
food materials and blockage of the cannulae. Rats used for solid M&M taste reactivity 




Microdialysis. Chronic unilateral cannula (CMA-12, Harvard Apparatus) aimed at 
anterior dorsomedial striatum (AP 1-2.5, ML ±1.8, and DV -4) was implanted. 
Lateralization of the unilateral cannula was varied across rats (Left=5, Right=4). Cannula 
was secured in place with bone screws and acrylic cement. A stainless steel wound clip 
was fixed to the acrylic cement to allow the rat to be attached to a tethering system that 
provided free movement around the apparatus. A dummy probe (CMA-12, Harvard 
Apparatus) was inserted into the cannula to prevent occlusion.  
 
Drugs and intracranial microinjections 
 Prior to free food intake and taste reactivity tests, steel stylets were removed and 
cleaned. Microinjectors (16 mm) were inserted into the guide cannulae, pre-measured so 
that microinjector tips extended 2 mm below guides. Microinjections of [D-Ala2, N-
MePhe4, Gly-ol]-enkephalin (DAMGO; Sigma), [D-Pen2,5] Enkephalin, (DPDPE; Sigma) 
or vehicle (aCSF; Harvard Apparatus) were controlled by a syringe pump which 
delivered 0.5 µL over 120 s. DAMGO and DPDPE were dissolved in aCSF at 973 µM 
concentration (0.25µg/0.5 µL). Microinjector tips were left in cannulae for 1 min 
following the injection to allow diffusion away from microinjector tips. Each rat received 
a “sham” injection 1 day prior to testing of vehicle to habituate them to the 
microinjection procedure.  
Behavioral Testing Procedures 
Food Intake. Rats were habituated for 4 days to clear plastic tub cages with ~3 cm 
of corn cob bedding, 20 g of pre-weighed M&Ms, 20 g of pre-weighed chow, and a 
subset received chow shaped wood blocks. Water was available through a drinking spout. 
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On the fourth day, rats received a “sham” microinjection. Cages were set up identically 
for habituation and testing. On test days, 29 rats received DAMGO and vehicle 
counterbalanced across days with 48 h between each testing session. 13 rats received 
DPDPE, DAMGO, and vehicle, counterbalanced across days with 48 h between testing 
sessions. Rats were microinjected and then immediately placed into plastic tub cages, 
they were videotaped for 60 min, removed, and all food left in the cage was weighed. 
Behavioral video tapes were scored at a later date offline.  
Taste Reactivity. Rats were habituated for 4 days to the taste reactivity testing 
apparatus and the food intake cages described above. On the fourth day rats received a 
“sham” intracranial injection of vehicle and a “sham” oral infusion of water (1ml/1min) 
to habituate them to the procedure. On test days rats received DAMGO or vehicle, 
counterbalanced across days. After a delay of 20 min (Pecina and Berridge 2005), 1% 
sucrose was delivered (1 mL/1 min) for 1 min into the mouth. Hedonic reactions were 
recorded from an angled mirror aimed up through the clear plastic floor of the testing 
apparatus. Videos were coded at a later date offline in slow-motion (ranging from frame-
by-frame to 1/10th normal speed) by an observer who was blind to the rat’s DAMGO vs. 
vehicle condition. After completion of the oral infusion, 6 rats were transferred for 60 
min to the food intake paradigm described above to measure food intake.  
For solid M&M taste reactivity rats were habituated to the apparatus described 
above. On test days rats received either DAMGO or vehicle microinjections counter 
balanced across days. 20 minutes after the injection, rats were presented with a sequence 
of 0.2g fragments of M&M candy, which they were allowed to eat as the close-up camera 
recorded their orofacial reactions through the transparent floor. Each rat was only 
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allowed to consume a maximum of 8 M&M fragments to avoid influence of satiety. 
Immediately after consuming each fragment, rats typically persisted in emitting post-
prandial hedonic reactions for about 6 sec. Hedonic reactions during the post-prandial 6-
sec period  were recorded and analyzed offline (Feurte, Nicolaidis et al. 2000).      
 Microdialysis. Rats were habituated for 3 days to a 15X15X12 inch Plexiglas 
enclosure containing ~3 cm of corn cob bedding, M&M candies, a drinking spout, and 
various “toys” (wood pellets, paper, and plastic weigh boats). On the third day, rats were 
connected to the tether line, but no probe was lowered, to allow them to habituate to the 
counter weight. Prior to testing, rats were restricted to 10 g of chow for the preceding 
light/dark cycle and M&M candies were removed from the testing apparatus. Testing 
occurred during the beginning of the dark cycle for the rats and the room was kept dim 
throughout collection as enkephalin levels are diurnally modulated and are highest at the 
start of the night period (Bayon and Anton 1986; Will, Vanderheyden et al. 2007) . At the 
start of each collection day the rat was handled, gently restrained, and a dummy probe 
inserted into the guide cannula. This probe was left in place for 5 min. A new probe 
(CMA-12 PAES, 2 mm) was flushed and inserted after the removal of the dummy. The 
rat was then attached to the tethering system and allowed to move freely about the 
apparatus. Perfusate was pumped at a rate of 1.5 µL/min for 1 h, at 1 µL/min and 0.6 
µL/min for 30 min each during a 2 h washout period. Baseline collection then began. 
Sample bins of 20 min (equal to the dead volume) were collected at 0.6 µL/min while the 
animal moved freely and interacted with the “toys.” After baseline, M&M candies were 
introduced to the chamber and animals were allowed to feed to satiety. M&M candies 
remained in the chamber until the end of the experiment. The entire experiment (baseline 
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and feeding) was videotaped and scored offline. 
Behavioral Video Scoring 
 Microdialysis. Videos were scored by experimenters, offline.  The following 
behaviors were recorded during baseline collections: rearing, locomotion, chewing on 
non-food objects, and drinking. During feeding collections all of the following were 
recorded as well as latency to first M&M consumption, time spent feeding, and number 
of M&Ms consumed.  
 Food Intake. Videos were scored by experimenters blind to the experimental 
condition of each rat. Seconds spent engaging in the following behaviors were recorded: 
eating M&Ms (actual chewing and consumption), eating chow, drinking, and chewing on 
non-food items. The following behaviors were recorded as a single event: sniffing 
M&Ms (anticipatory sniffs and approaches), sniffing chow, grooming, cage crossing, and 
rearing.   
 Taste Reactivity.  Videos were scored at 1/25th to 1/10th speed using Observer 
software (Noldus, Netherlands). Total reactions were tallied using a previously described 
binning method (Berridge, Flynn et al. 1984; Berridge 2000). Hedonic reactions were 
rhythmic tongue protrusions, lateral tongue protrusions, and paw licking. Neutral 
reactions were neutral mouth movements and grooming behavior. Aversive reactions 
were rare and of those reactions only forelimb flails were observed, with only 4 rats total 
demonstrating forelimb flails in both conditions.  
 For solid chocolate M&M scoring of taste reactivity, the scoring procedure 
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subtracted any periods when a clear view of the rat’s face and mouth was obscured by 
either paws or chocolate.  The goal was to produce a hedonic reaction score per a total of 
40 seconds of clear visibility. Hedonic reactions occurring during a 6 second post-
prandial period when the mouth was unobstructed were scored. Rhythmic tongue 
protrusions, lateral tongue protrusions, and paw licking were observed and recorded 
(Feurte, Nicolaidis et al. 2000). Aversive reactions were not observed during chocolate 
eating at any point. 
Dialysate Analysis 
 Met-ENK and leu-ENK were measured using a slight modification of a previously 
described capillary liquid chromatography-mass spectrometry (LC-MS) method (Li, 
Zubieta et al. 2009; Mabrouk, Li et al. 2011). Chromatography columns (50 µm i.d.) and 
electrospray ionization emitter tips (25 µm i.d.) were prepared in-house using 28 and 10 
cm lengths of fused silica capillary, respectively. Columns were packed to 3 cm bed 
length with 5 µm Alltima C18 reversed-phase particles (Alltech, Deerfield, IL, USA). 
The column and emitter tip were coupled to a PV-550 nanospray ESI source (New 
Objective, Woburn, MA, USA) interfaced to a LTQ XL linear ion trap mass spectrometer 
(Thermo Fisher Scientific, Waltham, MA, USA). A +3.0 kV potential was applied to a 
liquid junction prior to the column for electrospray. 
  7.5 µL samples were injected using a WPS-3000TPL autosampler (Dionex, 
Sunnyvale, CA, USA), in partial loop injection mode (10 µL loop). Samples were loaded 
onto the column at 2 µL/min by an air-driven fluid pump (DHSF-151, Haskel Inc., 
Burbank, CA, USA). The column was rinsed and desalted with 0.15% formic acid in H2O 
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for 2 min using the same pump and flow rate. Following loading and desalting, an 
injector valve was switched to put the micro HPLC pump (MicroPro, Eldex Laboratories, 
Napa, CA, USA) online for gradient elution at 200 nL/min. Mobile phase A was LC-MS 
grade H2O with 0.15% formic acid and mobile phase B was LC-MS grade acetonitrile. 
The gradient program began with an isocratic step of 20% B for 1 min, then a linear 
increase to 95% over 2.5 min, followed by an isocratic step at 95% B for 0.5 min. All 
valve switching and runs were controlled with Xcalibur software (Thermo Fisher 
Scientific). The MS3 m/z pathways for met-ENK and leu-ENK were: 574  397  278, 
323, 380 and, 556  397  278, 323, and 380, respectively. The dynorphinA 1-8 
fragment was measured and the MS2 pathway for dynorphin was 491 435. 
 Baseline met- and leu- enkephalin levels were 2.61±0.56 pM and 2.32±0.30 pM, 
respectively. Baseline dynorphin levels were 4.6±0.96 pM. According to our previous 
works, limits of detection for met-enkephalin were 1 pM and 0.5 pM for leu-enkephalin 
(Li, Zubieta et al. 2009). Therefore the baseline levels reported here are well above 
detection limits for the current LC-MS method.  
Histology 
Rats were sacrificed immediately after the final day of testing by administration 
of a sodium pentobarbital overdose. Rats were decapitated and the brains were extracted 
and fixed in 10% paraformaldehyde solution for 1-2 days followed by a 25% sucrose 
solution in 0.1 M sodium phosphate buffer for 2-3 days before slicing. 60 micron slices 
through the neostriatum were taken from each rat, mounted, dried, and stained with cresyl 
violet. Microinjection center was determined for each bilateral injection site for 
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microinjection experiments and probe center was determined for microdialysis studies. 
Slides were compared with the stereotaxic atlas (Paxinos and Watson 2007) to determine 
placement in the neostriatum.  
Fos analysis for functional drug spread. Microinjection spread was assessed by 
“Fos plumes” surrounding drug microinjections. We have previously found that drug 
induction of Fos plumes is reduced after several microinjections (Berridge, Ho et al. 
2011), and therefore we used a dedicated Fos group measured after a single 
microinjection to measure Fos radius under similar conditions in order to detect 
maximum spread of impact, as described previously (Pecina and Berridge 2005; 
Reynolds and Berridge 2008). Rats used for Fos analysis were anesthetized and 
transcardially perfused 75 min after bilateral microinjection of vehicle (n = 6), DAMGO 
(n = 10), or normal (n = 2). Brains were extracted, frozen and sliced at 40 µm. Slices 
were processed for c-Fos-like immunoreactivity using NDS, goat anti-cFos (Santa Cruz 
Biotechnology, Santa Cruz, CA) and donkey anti-goat Alexa Flour 488 (Invitrogen, 
Carlsbad, CA) (Reynolds and Berridge 2008; Berridge, Ho et al. 2011). Slices were 
mounted, air dried, and cover slipped with ProLong Gold antifade reagent (Invitrogen). 
Areas of c-Fos positive cells were mapped in “plumes” around microinjection sites, as 
described previously (Pecina and Berridge 2005; Reynolds and Berridge 2008; Berridge, 
Ho et al. 2011). 
Statistical Analysis 
 All drug effects were compared using within subjects ANOVAs with Bonferroni 
corrected t-tests to examine group differences. Effects of placement were determined by 
designating placements as a between subjects factor. Met- and Leu- enkephalin levels 
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followed similar patterns and were combined for analysis as “Enkephalin.” All 
enkephalin and dynorphin levels were normalized as percent baseline by computing the 
average peak area baseline levels and calculating a percentage of that score for each rat. 
Due to small sample size and nonparametric, normalized data, Freidman’s test and 
Wilcoxon’s signed rank test were used to assess within subjects differences across 
collection bin. Spearman’s rho was calculated to test associations between latency to feed 
and enkephalin levels. To avoid the influence of outliers, we used Wilcox’s skipped 
correlation to calculate spearman’s rho without bivariate outliers using the R environment 
(Rousselet and Pernet 2012).Correlations calculated with and without the outlier are 
reported. All significant non-parametric tests were also significant using their parametric 
counterpart. Effect sizes were calculated using the equation for Cohen’s d with the 
adjustment for repeated measures used where appropriate.  
Results 
Summary 
In short, our microinjection results revealed that exogenous mu opioid stimulation 
by DAMGO microinjection into the anteromedial dorsal neostriatum potently enhanced 
eating of palatable M&M™ chocolates, more than doubling the total M&M™ intake. 
This hyperphagic effect was specifically localized within the anterior medial quadrant of 
the dorsal neostriatum (DAMGO = 251% average increase over vehicle levels). 
Accordingly, our microdialysis study of that same anteromedial quadrant of dorsal 
neostriatum found that endogenous enkephalin levels rose to 150% of baseline when rats 
99 
 
were suddenly allowed to eat chocolates. These endogenous and exogenous results are 
described in detail below. 
Endogenous enkephalin release 
Microdialysis probes implanted in anteromedial dorsal  neostriatum measured 
extracellular levels of endogenous striatal opioid peptides: enkephalin (likely released 
from ‘indirect path’ neurons that also express dopamine D2 receptors), and dynorphin 
(likely released from ‘direct path’ neurons that express dopamine D1 receptors). 
Enkephalin and dynorphin were measured first during a normal quiet behavioral state in 
mildly hungry rats before any meal to establish a baseline, and next when a large quantity 
of palatable chocolate candies (M&Ms™) was suddenly presented. Opportunity to eat 
chocolate M&Ms™ evoked avid consumption, averaging 10 M&Ms™ in 20 min (≈10 g), 
and elicited an immediate rise in endogenous levels of met-enkephalin and leu-
enkephalin, reaching an elevation of >150% over pre-meal baseline (Baseline: met-
enkephalin = 2.61 ± SEM 0.56 pM, leu-enkephalin = 2.32 ± SEM 0.30 pM; Friedman’s 
test, p<0.01; baseline = 100%; Figure 4.1 and Figure 4.2A). Enkephalin levels remained 
elevated throughout the roughly 20-40 min period that each rat continued to eat, and then 
began to decline as rats slowed and gradually ceased eating, typically returning fully back 
to baseline within the next 40 minutes (1st baseline vs. last sample Wilcoxon’s test, n.s.). 
 In contrast to enkephalin, dynorphin levels failed to rise during eating, and 
instead remained unchanged throughout the meal (Friedman’s test, p>0.1; Figure 4.2B). 
Therefore, only enkephalin in the anteromedial quadrant of dorsal neostriatum became 
dynamically elevated during consumption of palatable food.  
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Enkephalin surges did not seem to be a consequence of mere motor activity. 
Enkephalin changes were measured during “motor” periods when the rat performed non-
ingestive active movements, such as oromotor gnawing of plastic or wood objects, 
spontaneous body grooming, or locomotion (walking and/or rearing) in the absence of 
food (Figure 4.2C). During these non-ingestive activities, enkephalin levels never rose 
(Friedman’s test, p=1, n.s.), suggesting that the rise described above in the same rats to 
eating chocolates was not due simply to the motoric production of active movements 
involved in eating. By contrast, enkephalin levels did rise when M&Ms™ were presented 
and eaten, compared to the previous periods when rats engaged in locomotor and other 
movements (Friedman’s test, p=0.023), again suggesting that enkephalin reflected more 
than simply the occurrence of ongoing motor activities (Figure 4.2C). Therefore it 
appears that enkephalin rose specifically with onset of the reward experience of eating 
palatable chocolates, remained elevated during eating, and declined soon after.   
Finally, we found that the magnitude of enkephalin surge in each rat correlated 
with that individual’s speed or latency to begin consuming its first M&M (spearman’s 
rho=-0.90, p=0.002, CI [-1,-.392]; Figure 4.1 inset): the faster a rat started eating, the 
higher its relative increase in enkephalin levels. This correlation raises the possibility that 
anteromedial dorsal neostriatum opioid levels might contribute a motivational “eat now” 
command. That causal hypothesis was tested further in the microinjection study below. 
Exogenous mu stimulation of intense eating. 
We found that DAMGO microinjection in dorsal neostriatum stimulated more 
intense eating of chocolates in non-deprived rats, but depending on precise site or 
quadrant. Sites within the anteromedial quadrant of dorsal neostriatum produced by far 
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the most intense increases of >250% in intake of M&Ms™ (t(18)=5.1, p<.001, 95% CI 
[9.96, 4.15], Cohen’s d= 1.217; compared to vehicle control intake levels by the same 
rats; Figure 3A). Anteromedial quadrant sites produced higher elevations of eating than 
all other quadrants of dorsal neostriatum (Anteromedial vs. other quadrants F(1,36)=8.44, 
p=.006, 95%CI [136,235], Cohen’s d=1.09). Localization of function was further 
determined by mapping the causal efficacy of neostriatal microinjection sites to stimulate 
eating, using symbols sized to the measured radius of Fos plumes surrounding DAMGO 
microinjections in dorsal neostriatum (Fos radius reflects the anatomical spread of drug 
impact, Fig 3). For sites that elevated eating >250%, at least 90% of the volume of 
DAMGO-induced local Fos plumes would have been contained entirely within the 
anteromedial quadrant of dorsal neostriatum. That is, DAMGO Fos plumes were 
measured to have a 0.18 mm total radius (0.02 mm3 volume), containing an inhibited 
small center (0.15mm radius, volume=0.016mm3 zone of halved Fos expression 
compared to vehicle baselines) surrounded by a larger excitatory Fos sphere (0.18mm 
radius, 0.02mm3 volume; zone of doubled Fos expression over normal baseline; 
center/surround Fos opposition possibly reflects reciprocal local inhibitory connections 
between the two zones; Figure 4.2A inset). These plume measurements allow confidence 
that the intense over-consumption was generated by DAMGO stimulation of 
anteromedial dorsal neostriatum, rather than by diffusion to other regions of neostriatum, 
ventral striatum or nucleus accumbens. 
 For sites in the highly effective anteromedial quadrant of dorsal neostriatum, 
most rats ate over 17g of M&Ms™, equal to about 5% of their 300g body weight (Figure 
4.3A). That level of elevated consumption (5% of body weight) is roughly proportional to 
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a 150lb human consuming about 8 lbs. of M&Ms™ in a single hour, thus clearly 
overriding normal satiety signals (Kelley, Baldo and Pratt 2005; Woolley, Lee et al. 
2007).  
DAMGO microinjection in this anteromedial quadrant also made rats faster to 
begin to eat (in addition to making them eat more): decreasing the latency to begin eating 
their first M&M of the day (Vehicle=55.4 ± SEM 10.4. DAMGO = 28.7 ± SEM 4.2; 
t(25)=2.49, p=.019, 95% CI [4.69, 48.85], Cohen’s d= 2.781). Faster speed to eat supports 
the hypothesis that mu opioid receptor stimulation in this neostriatum region provides a 
command to “eat now” as well as to “eat more.”  
In contrast to the anteromedial quadrant, as microinjection sites moved posteriorly 
in medial dorsal neostriatum the level of stimulated eating gradually declined. Strong 
elevation of eating was still produced at intermediate medial sites where the diameter of 
Fos plumes straddled the border between anteromedial and posteromedial quadrants of 
dorsal neostriatum (190% increase). No significant elevation was produced by more 
posterior sites fully contained within the posteromedial quadrant (i.e., where no part of a 
posterior site’s Fos plume would contact the anteromedial border; average 118%, 
n.s.).Thus, overall for the entire posteromedial quadrant, intermediate 150% elevations of 
eating were found, due mostly to the medial sites that straddled the anterior/posterior 
border (t(8)=2.52, p=.036, 95% CI [7.28, 0.33, Cohen’s d= 0.939). Comparing anterior 
versus posterior directly as entire quadrants, DAMGO in the anteromedial quadrant 
produced a greater increase in intense eating than DAMGO in the posteromedial quadrant 
(t(23)=2.21, p=.037, 95% CI [201.6, 6.96], Cohen’s d= 0.85).  
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Eating elevations fell off to zero abruptly as microinjection sites moved laterally 
from the anteromedial quadrant. Anterolateral quadrant sites produced no increase at all 
over vehicle levels (i.e., outside and lateral to effective sites in dorsomedial neostriatum; 
only 103%; t(9)=0.1, p=0.917; Fig 4.3A).  
By contrast to mu stimulation of eating, delta opioid receptor stimulation by 
DPDPE microinjections failed to increase eating behavior or intake over vehicle control 
levels at all sites in dorsomedial neostriatum, even in the anteromedial quadrant (F(1,12)=.4, 
p>0.1; Figure 4.4). Accordingly, M&M™ intake was much higher after mu agonist 
DAMGO microinjection than after delta agonist DPDPE microinjection at the same 
anteromedial dorsal neostriatum sites (DAMGO= 6.31 ± SEM 1.13, DPDPE= -0.46 ± 
SEM 0.68; t(36) = 5.10, p < 0.001, 95% CI [9.47, 4.09], Cohen’s d = 1.65). That difference 
suggests that enkephalin may act primarily at mu receptors in anterior dorsomedial 
neostriatum to stimulate increases in consumption, rather than at delta receptors.  
Further, DAMGO microinjections in all areas of neostriatum, including the 
anterior dorsomedial quadrant, failed to produce any general increases in locomotor or 
oromotor activity, measured by cage crosses, rearing, grooming or treading behaviors, 
chow consumption, or wooden block gnawing (behaviors F(5,28)=0.151, n.s.; chow 
F(15,90)=0.68, n.s.; gnawing t(4)=2.1, n.s.).  
Exogenous mu stimulation fails to alter hedonic ‘liking’ for sweetness. Finally, we 
used the affective taste reactivity test of orofacial ‘liking’ reactions to ask whether mu 
opioid enhancement of motivation to eat sweet food reflected purely generation of 
motivation to eat (similar to opioid effects in most of ventral striatum outside a cubic-
millimeter hotspot and in central amygdala) or additionally involved any enhancement of 
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hedonic impact or ‘liking’ for the taste of sweet reward (typical only of restricted 
hotspots in ventral striatum, ventral pallidum, etc.)(Pecina and Berridge 2005; Smith and 
Berridge 2005; Mahler and Berridge 2011). This measure draws on rodent affective 
orofacial reactions (e.g. positive tongue protrusion and lip licking to sweetness versus 
aversive gapes to bitterness) that are homologous to human infant affective facial 
expressions elicited by tastes (Grill and Norgren 1978; Pecina and Berridge 2005; Smith 
and Berridge 2005).  We tested for hedonic enhancement in a standard taste reactivity test 
using a sucrose solution infused directly in the mouth to control stimulus quality and 
duration, and separately for  the taste of sweet/fatty chocolate as rats voluntarily ate 0.2 g 
fragments of M&Ms™, replicating the chocolate stimulus and conditions of eating 
enhancement (Feurte, Nicolaidis et al. 2000). Taste reactivity results of both tests showed 
that DAMGO microinjections in anterior dorsomedial neostriatum failed to enhance 
positive hedonic taste reactions at all, either to oral infusions of 1% sucrose solution 
(F(3,9)=1.875, p=.204; Figure 4.3B) or to the chocolate taste of solid M&Ms™ fragments 
(F(3,5)=0.175, p=0.91; Fig 4.3B).  Although no increase in hedonic impact was observed, 
the DAMGO microinjections again increased motivation to eat in the voluntary intake 
test so that the rats doubled their consumption of chocolate over vehicle control levels 
(t(5)=15.58, 95% CI [9.90, 7.09], Cohen’s d= 2.3). Thus DAMGO in dorsomedial 
neostriatum appeared to make rats selectively ‘want’ to eat M&Ms™ more intensely, in 
the sense of enhanced eating behavior and intake, without making them ‘like’ sweetness 
any more, in the sense of hedonic reactions to sucrose or chocolate tastes. We note that 
similar dissociations involving selective increases in “wanting” without ‘liking’ are 
typical of opioid stimulation at many other brain sites, including ventral striatum (except 
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in the hotspot of nucleus accumbens shell) and striatal-related structures (Pecina and 
Berridge 2005; Smith and Berridge 2005; Mahler and Berridge 2011). This dissociation 
between “wanting” versus ‘liking’ suggests that mu opioid stimulation in anterior 
dorsomedial neostriatum may generate increases of motivation as a specific 
psychological mechanism to drive intense eating and consumption of food rewards.  
Discussion 
We acknowledge that our finding of intense over-consumption produced by mu 
opioid stimulation in the anteromedial dorsal neostriatum contrasts at first sight with 
previous reports of relative failure to observe any increase in eating after DAMGO 
microinjection in dorsal neostriatum (Bakshi and Kelley 1993a, b; Zhang and Kelley 
2000). However, earlier studies never distinguished anatomically among the four 
quadrants of dorsal neostriatum as defined here, and typically used placements that as a 
whole were more centrally located in the dorsal half of neostriatum (i.e., more ventral and 
posterior to our eating hotspot). Our finding of eating localization in the anteromedial 
quadrant of the dorsal level may explain why studies that mixed together different 
subregions failed to find eating stimulation in dorsal neostriatum.   
Other hints of dorsal neostriatum involvement in motivation to consume rewards 
have emerged in the past decade (Volkow, Wang, Fowler, Logan, Jayne, Franceschi et al. 
2002; Volkow, Wang et al. 2006; Palmiter 2008a; Stice, Spoor et al. 2008; Wise 2009; 
Nummenmaa, Hirvonen et al. 2012). In humans, dorsal striatum activation has been 
reported to be elicited by palatable food and its cues in obese binge eaters, and by cocaine 
and its cues in drug addicts (Volkow, Wang, Fowler, Logan, Jayne, Wong et al. 2002; 
Volkow, Wang et al. 2006; Stice, Spoor et al. 2008; Nummenmaa, Hirvonen et al. 2012). 
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Such dorsal striatal activations have remained slightly ambiguous, as they could be 
viewed either as reward motivation or as hedonic impact, incipient movements, habits, 
cognitive processing, or learned predictions. Similarly, dorsal neostriatal neuronal 
activations elicited by rewards or cues are reported in monkeys and rodents, and often 
have been interpreted as reflecting learned predictions or teaching signals (e.g., prediction 
error model) (Apicella, Ljungberg et al. 1991; Haracz, Tschanz et al. 1993; Schultz and 
Dickinson 2000a; Suto, Wise et al. 2011). Our results more specifically indicate that 
dorsal striatal activation can participate in generating intense motivation to over-consume 
a reward. Thus the generative role shown here might link some functions of dorsal 
neostriatum more closely to the reward motivation functions of ventral striatum (nucleus 
accumbens) (Berridge and Robinson 1998; Carelli and Ijames 2001; Pecina and Berridge 
2005; Will, Vanderheyden et al. 2007). This also seems consistent with reports that 
restoring synaptic function to a region of dorsal neostriatum can rescue eating in an 
aphagic mutant mouse model, and supports the interpretation that such neostriatum 
mediated rescues may involve a motivational component(Palmiter 2008b). 
The hypothesis that opioid circuitry in dorsomedial neostriatum participates in 
generating motivation to over-consume a palatable food reward also seems concordant 
with its anatomical wiring from limbic prefrontal cortical inputs (Ragsdale and Graybiel 
1988; Gerfen 1989; Ragsdale and Graybiel 1990; Eblen and Graybiel 1995; Kincaid and 
Wilson 1996; Levesque and Parent 1998) (Figure 4). For example, corticostriatal 
projections to the anteromedial region of dorsal neostriatum (“rostromedial sector of 
caudate-putamen”), similar to that studied here, originate from the prelimbic region of 
medial prefrontal cortex in rats (Levesque and Parent 1998). Corticostriatal projections 
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from “posterior [lateral] orbitofrontal/anterior insular cortex and the mediofrontal 
prelimbic/anterior cingulate cortex” similarly terminate in striosomes in the medial 
caudate in macaque primates, which probably overlaps with our eating site (Eblen and 
Graybiel 1995). It is also noteworthy that direct mu opioid stimulation of prefrontal 
cortex regions, via DAMGO microinjections in orbitofrontal and prelimbic/infralimbic 
(ventral anterior cingulate) cortex, can stimulate eating in rats, raising the possibility of a 
larger opioid-related corticostriatal circuit involved in eating and motivation (Mena, 
Sadeghian et al. 2011).  
We speculate that opioid surges particularly within anteromedial patches of dorsal 
striatum might modulate presynaptic corticostriatal glutamate release or modulate 
postsynaptic activity of eating-related neurons in striosomes that contain mu opioid 
receptors (Jiang and North 1992; Wang and Pickel 1998). In addition, some D1 receptor-
expressing neurons in striosomes may uniquely project directly to dopamine neurons in 
substantia nigra (Fujiyama, Sohn et al. 2011), which might facilitate modulation of 
dopamine systems to additionally help generate intense motivation.  Beyond the 
neostriatum, the anterior dorsomedial neostriatal region described here likely interacts 
with other parts of the distributed mesocorticolimbic network involved in eating and 
intake, including hypothalamus, ventral striatum, limbic cortex, amygdala, and 
mesolimbic dopamine nuclei (Gosnell 1988; Kelley, Baldo and Pratt 2005; Will, 
Vanderheyden et al. 2007; Mena, Sadeghian et al. 2011) 
In conclusion, our results provide novel evidence that enkephalin surges and mu 
opioid stimulation in the same anteromedial dorsal neostriatum region contribute to 
signaling the opportunity to eat a sensory reward and to causally generating increased 
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consumption of that reward. The neostriatum-generated increase in motivation can be 
powerful enough to more than double the amount of food a rat “wants” to eat, yet be 
functionally specific enough to the motivational component of reward, rather than the 
hedonic component, to not enhance “liking” for the same sweet chocolate treat. Opioid 
circuitry in anterior dorsomedial neostriatum could in this way participate in normal 
motivations, and perhaps even in generating intense pathological levels of motivation to 


















Figure 4.1. Endogenous extracellular opioid peptides in response to palatable 
food consumption. Extracellular enkephalin levels surged when rats began to eat milk 
chocolate M&Ms™. Onset of eating coincided with a robust increase in extracellular 
enkephalin (met and leu), which remained sustained during eating, and gradually tapered 
off as eating declined. The magnitude of the enkephalin rise in individuals correlated with 
their latency to eat their first M&M™: higher enkephalin rise for the fastest eaters. The 
correlation between faster speed to start eating and higher enkephalin also remains 
significant if the highest outlier individual (upper right of inset) is removed (spearman’s 
rho=-0.85, p=0.013, 95% CI [-1,-0.4]). * indicates p<0.05. Error bars represent standard 







Figure 4.2. Details of endogenous enkephalin surge. Absolute concentrations of 
met- enkephalin and leu- enkephalin are displayed in panel A. In contrast, dynorphin 
remained relatively stable throughout resting, eating and other behaviors (panel B). 
Enkephalin levels did not rise during non-ingestive activities involving forelimbs, body, 
or orofacial movements (walking, rearing, gnawing, grooming), here the “motor” period. 
Enkephalin levels as percent “quiet” are represented. Average percent of time the rats 
engage in each behavior is represented in the pie charts (panel C). * indicates p<0.05. 






Figure 4.3. Map of microinjection causation of intense eating. DAMGO 
microinjection into anterior dorsomedial neostriatum potently enhanced intake of 
M&M™ chocolate candies (high-fat & high-sugar). All DAMGO-evoked eating behavior 
and intake changes are expressed as percent increases over vehicle-evoked control levels 
measured in the same rat (panel A). A two layer “Fos plume” shows the maximal spread 
of Fos locally surrounding DAMGO microinjections. This measured radius was used to 
assign the size of symbol to the microinjection site for each behaviorally-tested rat. The 
color of each symbol depicts the magnitude of eating behavior stimulated by DAMGO 
microinjection at that site (relative to vehicle control level of the same rat). The largest 
increases in eating were localized to the anteromedial quadrant of dorsal neostriatum. 
Taste reactivity results show that DAMGO injected into the same dorsomedial area did 
not increase hedonic impact of sucrose (during oral infusions) or M&M™ chocolates 
(during voluntary eating) (panel B). * indicates p<0.05. Error bars represent standard 












Figure 4.4.Mu but not delta. Mu- but not delta- opioid receptor activation enhances 
food intake. Microinjection of DAMGO potently enhanced the amount of M&M’s 
consumed while DPDPE microinjection had no effect. Data is presented as percent of 
amount eaten on vehicle microinjection day, raw average amount eaten is written in bar. 












Disruption of Sign-tracking and Enhancement of Goal-tracking after Mu Opioid 
Receptor Activation in Ventrolateral Neostriatum 
 
Introduction 
The ventrolateral (VLS) portion of striatum receives projections from forelimb 
and oromotor areas of sensory motor cortex and dopaminergic manipulation of this area 
often results in oromotor stereotypy (Kelley, Lang et al. 1988; Kelley, Gauthier et al. 
1989b; Delfs and Kelley 1990; Dickson, Lang et al. 1994). However, opioid and some 
dopaminergic manipulations of VLS has been demonstrated to produce intense eating of 
palatable foods (Kelley, Gauthier et al. 1989a; Bakshi and Kelley 1993b, a; Zhang and 
Kelley 2000). One interpretation of this increase in consumption is that it is due to an 
increase in oromotor and forelimb movement that manifests as an increase in 
consumption (Salamone, Mahan et al. 1993; Cousins, Trevitt et al. 1999; Mayorga, 
Gianutsos et al. 1999). Another interpretation is that VLS is participating in a wider 
motivation generating circuitry (Kelley, Baldo and Pratt 2005). Here, I aim to use opioid 
manipulation of the VLS to test the role of the ventrolateral neostriatum in motivation for 
food and learned cues. 
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Often, manipulations that generate consumption of primary rewards also increase 
motivation for learned cues, but this is not always the case (Bakshi and Kelley 1993b, a; 
Pecina and Berridge 2000; Zhang and Kelley 2000; Jackson 2009). In previous chapters I 
have demonstrated that mu opioid receptor activation in dorsomedial neostriatum 
produces robust increases in eating with no change in motivation for learned cues. In 
contrast, mu opioid receptor activation in dorsolateral neostriatum produces an intense 
amplification and focusing of incentive salience on learned cues while producing no 
increase in motivation for primary rewards. Here we will test if mu opioid receptor 
activation in ventrolateral neostriatum produces intense motivation for learned cues using 
an autoshaping paradigm. I will also replicate previous findings that mu opioid receptor 
activation in this area increases consumption of palatable primary rewards.   
 
Materials and Methods 
Subjects. 
 Sprague Dawley rats (n=15 for autoshaping, n=6 for food intake) weighing 280-
350 grams at the start of the experiment were pair housed on a reverse light/dark cycle. 
Water was provided ad libitum; food was provided ad libitum except during weeks 
containing autoshaping training or test sessions, when rats were restricted to 90% free 
feeding weight and fed about 14gs of standard laboratory chow daily after each training 
session. Before surgery, all rats received 2-4 10 minute sessions of experimenter handling 
to acclimate them to being held. All experiments were conducted in accordance with 
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protocols approved by the University of Michigan Committee on Use and Care of 
Animals (UCUCA). 
Surgery.  
All rats were anesthetized with ketamine (80 mg/kg), xylazine (7 mg/kg), and 
atropine (0.04 mg/kg). To prevent infection, chloramphenicol sodium succinate (60 
mg/kg) was administered as well as carprofen (5 mg/kg) to provide pain relief. Carprofen 
and chloramphenicol were administered again 24 h post-surgery. All rats were allowed 5-
7 days to recover from surgery before testing.  
Chronic bilateral 14 mm (23 ga) guide cannulae aimed at ventrolateral 
neostriatum AP≈.6, ML≈3.6, DV≈7.5 based on Paxinos and Watson (Paxinos and 
Watson 2007). All guide cannula tips were implanted 2 mm above intended target 
injection site. Cannulae were anchored to the skull with bone screws and acrylic cement. 
Steel stylets were inserted into guide cannula to prevent occlusion.   
 
Microinjections and drugs 
 Prior to all tests, steel stylets were removed and cleaned, and 16mm 
microinjectors were inserted into the guide cannula, pre-measured so that microinjector 
tips extended 2 mm below guides. Microinjections of [D-Ala2, N-MePhe4, Gly-ol]-
enkephalin (DAMGO; Sigma) or vehicle (aCSF; Harvard Apparatus) were controlled by 
a syringe pump which delivered 0.5 µL over 120s. DAMGO was dissolved in aCSF at 
973 µM concentration (0.25µg/0.5µL). Microinjector tips were left in cannulae for 1 min 
following the injection to allow diffusion away from microinjector tips. Each rat received 
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a “sham” injection 1 day prior to testing of vehicle to habituate them to the 
microinjection procedure.  
Statistical Analysis.  
Within subject repeated measures ANOVAs comparing drug and vehicle days 
were performed on data from autoshaping testing and food intake.  All t-test presented 
were corrected for multiple comparisons using the Bonferroni correction.  
Histology. 
Rats were sacrificed immediately after the final day of testing by administration 
of a sodium pentobarbital overdose. Rats were decapitated and the brains were extracted 
and fixed in 10% paraformaldehyde solution for 1-2 days followed by a 25% sucrose 
solution in 0.1M NaPB for 2-3 days before slicing. 60 micron slices through the 
neostriatum were taken from each rat, mounted, dried, and stained with cresyl violet. 
Microinjection center was determined for each bilateral injection site and slides were 
compared with the stereotaxic atlas (Paxinos and Watson 2007) to determine placement 
within neostriatum.  
Behavioral Autoshaping Training 
All rats received the same autoshaping training procedures as previously 
described(Mahler and Berridge 2009; DiFeliceantonio and Berridge 2012). In brief, 
autoshaping training and testing for a particular rat was always carried out in one of eight 
operant chambers (Med Associates) controlled by Med PC software, containing two 
retractable levers on opposite sides of a food receptacle. Rats first received one session of 
magazine training consisting of 20 sucrose pellets being delivered into the food dish. 
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Pavlovian autoshaping training (CS+ paired with UCS) began started the second day. 
Training sessions began with illumination of the house lights, followed by insertion 
presentations of the CS+lever with a light emitting diode on its ventral surface and 
accompanied by an auditory 2.9KHz tone. Each CS+lever/tone presentation lasted 8s 
before the lever was retracted back through the wall, which was followed immediately by 
delivery of one sucrose pellet into the food dish (UCS; Test Diet). Twenty-five CS+ UCS 
pairs were presented on a 90s variable inter-trial interval schedule during the 40 minute 
session. A control lever was always present in the chamber.  
 Training sessions were repeated over 5 consecutive days. By the 3rd training day, 
every rat began to respond to the CS+ onset with an approach-consummatory CR 
predominantly focused toward either the CS+lever itself (in which case the rat was 
classified as a sign-tracker) or toward the CSdish (in which case the rat was classified as a 
goal-tracker). All rats’ prepotent and non-prepotent cues were discernible by day 3. Rats 
were formally defined as sign-trackers if they approached, nibbled, sniffed, grasped and 
bit the CS+ Lever at least 2.5 times more frequently than to the goal dish on day 5. Goal-
trackers were classed if they made the same responses to the metal dish 2.5 times more 
frequently than to the lever. Therefore the CS+lever was the prepotent cue for sign-
trackers (trigger and target of motivated CR) and temporal trigger for the goal-trackers, 
whereas the  CSdish was the prepotent target cue for goal-trackers (Boakes, Poli et al. 
1978; Flagel, Watson et al. 2008; Mahler and Berridge 2009) . 
Autoshaping Testing 
Testing began on day 7 and continued day 9, when either DAMGO or vehicle was 
microinjected immediately prior to the autoshaping session (order counter-balanced 
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across rats; one microinjection per day). One camera was positioned under the 
transparent floor of the autoshaping chamber to provide a clear view of the rat’s entire 
head and body wherever it was in the chamber. This allowed scoring of both sign-
tracking approaches and goal-tracking approaches, as well as scoring of consummatory 
behaviors in sign-trackers. A second camera was directed from the side toward the inner 
surface of the CSdish to provide a close up view of the rat’s face and mouth movements 
when inside the dish. A test trial consisted of 25 CS-UCS autoshaping trials identical to 
trainings. Recordings were scored later offline by the experimenter blind to drug 
condition. 
Behavioral Video Scoring: Autoshaping 
Behavior of rats toward CS+ lever and dish were always video recorded from two 
angles simultaneously through two strategically positioned cameras. One camera was 
positioned under the transparent floor of the autoshaping chamber to provide a clear view 
of the rat’s entire head and body movements wherever it was in the chamber. A second 
close-up camera was directed from the side toward the inner surface of the CSdish to 
provide a detailed view of the rat’s face and mouth movements when inside the metal 
dish. Both videos were analyzed off line in slow motion (1/10th to ½ actual speeds) by an 
observer blind to experimental conditions. For each trial, the 8 seconds before and 8 
seconds during the 5th, 10th, 15th, 20th, and 25th presentation of CS+ were selected for 
comparison (Mahler and Berridge 2009). Scored behaviors were look at the cue 
(orienting towards the cue by moving the head or forequarters toward it, without bodily 
approaching it), approach the cue, sniff the cue (contact of the nose and rhythmic nose 
flaring movements), and  nibble (contact of mouth or teeth on lever or dish, combined 
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with rapid short (<0.5 sec) rhythmic 1-2 Hz bobbing movements of the head), and 
rhythmic opening and closing movements of  jaw, tongue, and/or teeth similar to 
movements of normal eating of UCS) , and bite the cue (of jaw closing and contact by 
maxillary and mandibular incisors, often while grasping the object with one or both paws, 
similar to movements that bite the actual UCS sucrose pellet).  
Behavioral testing: Food intake  
Rats were habituated for 4 days to clear plastic tub cages with ~3 cm of corn cob 
bedding, 20 g of pre-weighed M&Ms, and 20 g of pre-weighed chow. Water was 
available through a drinking spout. On the fourth day, rats received a “sham” 
microinjection. Cages were set up identically for habituation and testing. On test days, 
rats received DAMGO and vehicle counterbalanced across days with 48 h between each 
testing session. Rats were microinjected and then immediately placed into plastic tub 
cages, they were videotaped for 60 min, removed, and all food left in the cage was 
weighed. Behavioral video tapes were scored at a later date offline.  
Behavioral video scoring: Food intake.  
 Videos were scored by experimenters blind to the experimental condition of each 
rat. Seconds spent engaging in the following behaviors were recorded: eating M&Ms 
(actual chewing and consumption), eating chow, drinking, and chewing on non-food 
items. The following behaviors were recorded as a single event: sniffing M&Ms 





Food intake: DAMGO microinjection potently consumption M&Ms  
 Consumption of highly palatable M&Ms was greatly increased after DAMGO 
microinjection. Under vehicle conditions, rats ate 6.5gs of M&Ms per hour session. After 
DAMGO injection, these same animals consumed around 10.6 grams of M&Ms 
(F(1,5)=11.23, p=0.02; Figure 5.1A). Rats also spent 50% more time eating after 
DAMGO injection (F(1,5)=6.9, p=0.04). Consumption of chow did not change across 
drug conditions, the increase in eating was specific to the highly palatable M&M, a 
replication of previous findings (Zhang and Kelley 2000).  
 It is important to note that no oral stereotypy was observed during the detailed 
analysis of the behavioral testing video. Cage crosses, a measure of general locomotor 
activation where the rat moves from one side of the tub to the other, did not increase 
(Vehicle = 37, DAMGO = 23; F(1,5)=2.08, p=0.21). Further, grooming chains, which 
involve forelimb and oromotor activity did not increase (Vehicle = 6, DDAMGO = 4; 
F(1,5) = 2.27, p=0.16) 
Food intake: Anatomical specificity 
 Each placement was mapped onto a coronal slice and is shown on a representative 
slice here (Figure 5.1B). Placements contained within the ventrolateral striatum but above 
the accumbens shell were included in analysis. Based on previous fos plume sizes 
(0.2mm radius maximum) reported in this dissertation and previous reports, it is unlikely 
that the increase in consumption observed was due to drug diffusion to the accumbens 
(Zhang and Kelley 2000; DiFeliceantonio, Mabrouk et al. 2012).  
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Autoshaping: Summary of results 
Sign- and goal-tracking responses can be broken down into two categories, 
approach to the cue (probability and latency) and the appetitive-consummatory actions 
directed at the cue when the animal arrives (grasps, nibbles and sniffs). After DAMGO 
microinjection, goal-trackers did not display any changes in either approach or appetitive 
actions. Sign-trackers on the other hand demonstrated increased goal-tracking approach 
and appetitive actions towards the CSdish and a decrease in their approach and appetitive 
actions directed at their preferred cue, the CS+lever. 
Goal-tracker’s Autoshaping: DAMGO microinjection in VLS does not enhance goal-
tracking. 
 Those animals classified as goal-trackers on the fifth and final day of training 
demonstrated a strong cue-locked increase in nibbles and sniffs directed at the CSdish 
(F(1,5) = 61.23, p=.001). On average goal-trackers nibbled and sniffed their Csdish 1.9 
times per 8 seconds in the absence of the CS+lever and 7.8 times in its presence. 
DAMGO microinjection, however, did not cause a significant increase in goal-tracking. 
Each rat’s probability to approach the CSdish remained stable at about 96% under both 
vehicle and drug conditions (p>0.05) and the probability to approach the CS+lever also 
remained stable across drug conditions at around 55% (p>0.05). In addition, the 
proportion of total responses directed at the CSdish and CS+lever did not change after 
DAMGO microinjection. Under both DAMGO and vehicle conditions, rats directed 78.5% 
of appetitive consummatory behaviors at CSdish, and 21.5% of appetitive consummatory 
behaviors at the CS+lever. There was a slight decrease in the latency to contact the CSdish 
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after CS+lever presentation. Under vehicle conditions, rats were very fast, taking just 
1.49 seconds to reach their dish, under DAMGO conditions, they were even faster, taking 
just 1.24 seconds to reach the dish (p>0.05).  
Sign-tracker’s Autoshaping: Sign-trackers shift to goal-tracking  
 The most dramatic effect of DAMGO microinjection was observed in sign-tracking 
animals.  Sign-trackers showed a shift towards goal-tracing after DAMGO microinjection. 
Under vehicle conditions sign-trackers approached the CSdish on 40% of trials, after 
DAMGO the percent of trials they approached the CSdish doubled to 80% (F(1,8)=12, 
p=0.009). To confirm this enhancement in approach we used a method of calculation 
devised by Robinson and colleagues (Meyer, Lovic et al. 2012).  This confirmed the 
approach enhancement as a doubling in probability to approach to the CSdish after 
DAMGO microinjection (Vehicle = 0.40, DAMGO = 0.80; F(1,8)= 12, p=0.009). The 
CS+lever on the other hand, appeared to lose some of its attractive value. Sign-trackers 
decreased the proportion of approaches to the CS+lever from 100% to 95% (p>0.05) and 
approached the CS+lever slower (vehicle = 0.58s, DAMGO = 1.87s, F(1,8)=5.95, p=.041) 
after DAMGO microinjection.  
 Appetitive-consummatory behaviors directed at the CSdish also increased 
dramatically after DAMGO microinjection. Under vehicle conditions the CSdish was 
nearly ignored by sign-trackers during the lever presentation, with just 0.4 average 
nibbles and sniffs directed at it per 8s cue period. After DAMGO microinjection sign-
trackers nearly quadrupled the number of nibbles and sniffs on the CSdish to an average 
1.5 per 8s cue period (F(1,8)=7.85, p=0.02). This increase in food dish nibbles and sniffs 
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was locked to the presentation of the CS+lever. Food dish nibbles and sniffs did not 
increase after DAMGO in the inter-trial interval (Vehicle = 0.92, DAMGO = 1.0, 
DRUG*CUE interaction F(1,8)=7.85, p=0.02). So, DAMGO microinjection was not in 
general making the food dish more attractive in a continuous fashion in the absence of the 
lever cue, but instead selectively enhancing goal-tracking behavior triggered by the cue 
during the CS period. To further analyze this shift to goal-tracking calculated what 
percent of total behaviors were made to each cue during the 8s period. After DAMGO 
microinjection the percent of total nibbles, sniffs, and bites on the dish increased from 4% 
for sign-trackers under vehicle conditions to 18%, an over fourfold increase (F(1,8)=2.66, 
p=0.028). DAMGO microinjection shifted the proportion of appetitive behaviors towards 
the CSdish. However, the same numbers show that sign-trackers still remained 
predominantly sign-tracking, showing a quantitative but not a qualitative shift to goal 
tracking. After DAMGO microinjection, sign-trackers still directed 82% of all appetitive-
consummatory behaviors to their preferred CS+lever. Overall the effect was a biasing of 
behavior rather than transforming the phenotype of the sign-trackers to goal-trackers.  
 It was not the case that the decrease in sign-tracking reported was a result of an 
overall decreased all appetitive behaviors. Under vehicle conditions rats made about 8 
appetitive consummatory responses per 8s CS period, after DAMGO rats made about 9 
responses (p>0.05). So, although a decrease in sign-tracking may be interpreted by some 
as a decrease in overall incentive salience, this did not appear to be the case. Rats were 
still energized by the CS+lever, but they directed a portion of their responding to a new 




Autoshaping: Anatomical specificity 
 Each rat’s microinjection placements were mapped on coronal slices and are 
shown here on a representative coronal slice (Figure 5.4). Placements for both sign- and 
goal-trackers were contained within the ventrolateral neostriatum. Each injection was 
within the ventral 30% of the neostriatum as a whole. This means the difference in the 
effects of DAMGO observed are not likely to be due to variation in microinjection site. 
Based on maximum Fos plume size for this same microinjection volume and 
concentration, it is unlikely that the results observed are due to diffusion to the 
accumbens shell (DiFeliceantonio, Mabrouk et al. 2012).  
Discussion 
 Here, I have demonstrated that mu opioid activation in ventrolateral neostriatum 
potently enhances consumption of highly palatable foods, as previously reported (Zhang 
and Kelley 2000).  The novel result of this study was that mu opioid receptor activation 
via DAMGO microinjection into the ventrolateral neostriatum shifted sign-tracking rat’s 
behavior to display more goal-tracking behavior. Rats that already predominately goal-
tracked did show significant changes in their behavior after microinjection. Therefore, 
mu opioid receptor activation in ventrolateral neostriatum seemed to impact the behavior 
of the sign-trackers exclusively.  
 Sign-trackers may be unique in attributing incentive salience primarily to the 
CS+lever.  One possibility is that DAMGO reduces “wanting” and helps them revert to a 
more rational conditioned response (CR) elicited by a food pellet (Flagel, Watson et al. 
2007; Flagel, Clark et al. 2011). However, mu opioid receptor activation enhanced food 
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consumption, suggesting at least a UCS enhancement of “wanting” if not a CS 
enhancement (Jackson 2009). An alternate explanation is that DAMGO microinjection 
has shifted the target of some of the incentive salience for sign trackers from the 
CS+lever to the CSdish. As discussed in chapter 2, both sign- and goal-trackers can be 
interpreted as attributing incentive salience, just to different targets (DiFeliceantonio and 
Berridge 2012). For goal-trackers the target is the CSdish and for sign-trackers the target is 
the CS+lever. Although the food cup is present at all times, it is not attributed with 
incentive salience until the trigger is present, the CS+lever. Both sign- and goal-trackers 
show phasic increases in incentive salience time locked to the presentation of the trigger. 
According to this hypothesis, mu opioid receptor activation in ventrolateral neostriatum 
enhanced the incentive salience of the CSdish for sign-trackers, leading it to compete with 
the CS+lever.  
Some evidence for this hypothesis is that overall levels of responding did not 
decrease for sign- or goal-trackers. If incentive salience was generally decreased, you 
may expect an overall decrease in approach and appetitive consummatory behaviors after 
DAMGO microinjection. These total numbers remained stable, but where they were 
directed was shifted towards the CSdish for the sign-trackers. This shift was not absolute, 
as can be seen in figure 5.3, sign-trackers did not become solely goal-trackers. The 
amount of shift seems consistent with the idea that each cue has an amount of incentive 
salience attributed to it that is computed on line at each cue presentation (Zhang, Berridge 
et al. 2009). Here, DAMGO microinjection increased the amount of incentive salience 
attributed to the CSdish allowing it to compete with the CS+lever and drawing appetitive 
consummatory behaviors away from the lever and to the CSdish.  
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Other studies have reported a similar shift to goal-tracking after sensitization with 
drugs such as amphetamine and cocaine (Simon, Mendez et al. 2009; Holden and Peoples 
2010) (but see also (Doremus-Fitzwater and Spear 2011)). Conceptually, sensitization 
should enhance incentive salience and accordingly the authors of these studies predicted 
sign-tracking would be increased. Instead, approach to the contiguous, proximal CS was 
enhanced, leading to the interpretation that contiguity could be important for incentive 
salience attributing.  
Contiguity of CS with UCS may become even more important for incentive 
salience attribution when mesocorticolimbic circuits are pharmacologically stimulated 
(Tindell, Berridge et al. 2005; Smith, Berridge et al. 2011). For example, previous studies 
reported that opioid or dopamine stimulation of the nucleus accumbens selectively 
enhanced incentive salience of a UCS-contiguous CS2 stimulus, but not of a UCS-
predictive CS1. Contiguity dominance applied to all rats when tested in a Pavlovian CS-
CS-UCS series, in which a UCS-predictive CS1 was followed by a UCS-contiguous CS2, 
(Tindell, Berridge et al. 2005; Smith, Berridge et al. 2011).  
Overall, these findings are not consistent with the view that enhancements in 
consumption after VLS manipulation are due to impairment of oromotor function 
(Salamone, Mahan et al. 1993; Cousins, Trevitt et al. 1999). A motor impairment 
hypothesis would predict overall deficits in responding in both sign-trackers and goal-
trackers. Here, no overall changes in total amount of behavior were observed. In addition, 
no gross motor impairments were noted in a detailed analysis of video recordings for all 
tests. It appears instead that mu opioid receptor activation in VLS plays a specific role in 
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enhancing motivation for primary rewards and reward cues paired closest in time and 
space with those primary rewards.  
 This interpretation has interesting implications, because it means that mu opioid 
receptor activation in ventrolateral neostriatum selectively enhances the incentive 
salience of a proximal, contiguous cue over a distal, more predictive cue. CS-UCS 
contiguity has long been recognized as important to facilitating Pavlovian associations 
(Zener 1937; Mackintosh 1974; Rescorla and Cunningham 1979). Further, a proximal 
action is closely regulated by satiety state, but a more distal action is only changed after 
an experience with the sucrose reinforcer in a sated state, requiring a cognitive memory 
(Corbit and Balleine 2003). This means proximal, contiguous cues may gain incentive 
salience through a separable system that is closely tied to physiological state and may 












Figure 5.1. DAMGO potently enhances M&M consumption in ventrolateral 
neostriatum. DAMGO microinjection to ventrolateral neostriatum potently enhanced 
grams of M&Ms consumed (Panel A). Panel B displays the anatomical location of all rats. 








Figure 5.2. DAMGO enhances appetitive behaviors directed at the food cup in a 
time-locked manner. In the absence of the CS+lever, sign-tracking animals nibble, sniff, 
and bite the food cup at similar levels under both DAMGO and vehicle conditions. Under 
vehicle conditions and during the CS+ period, sign-trackers rarely interact with the food 
cup (line graph) and allocate a small percentage of their responding to the food cup (pie 
chart). After DAMGO injection and during the cue period, sign-trackers greatly increase 
the number of appetitive consummatory behaviors they direct at the food cup (line graph) 








Figure 5.3. Individual Variation. DAMGO microinjection into the ventrolateral 
neostriatum shifts sign-trackers to engage in more goal-tracking. Sign-trackers (diamonds) 
show more approaches, nibbles, and sniffs to the CSdish, shown here as a rightward shift. 
Goal-trackers do not significantly shift behavior. Inset: DAMGO microinjection doubles 










Figure 5.4. Microinjection sites within ventrolateral neostriatum. All 
microinjections included in the analysis were contained within the ventrolateral 
neostriatum Sign-trackers are represented as diamonds and goal-trackers as circles. 
Enhancement of goal-tracking by DAMGO microinjection is represented as percent 









 The experiments described in this dissertation demonstrate that central nucleus of 
the amygdala and dorsal neostriatum can amplify incentive motivation for natural 
rewards and learned cues.  
General summary of findings 
 In chapter 2, I assessed whether central amygdala mu opioid receptor stimulation 
enhances the phasic incentive salience of the goal-cue for goal-trackers during moments 
of predictive cue presence (expressed in both approach and consummatory behaviors to 
goal cue), just as it enhances the attractiveness of the predictive cue target for sign-
trackers. Using detailed video analysis I measured the approaches, nibbles, sniffs, and 
bites directed at their preferred target for both sign-trackers and goal-trackers. I reported 
here that DAMGO microinjections in central amygdala made goal-trackers, like sign-
trackers, show phasic increases in appetitive nibbles and sniffs directed at the goal-cue 
expressed selectively whenever the predictive cue was present. This indicates 
enhancement of incentive salience attributed by both goal trackers and sign-trackers, but 
attributed in different directions: each to their own target cue. For both phenotypes, 
amygdala opioid stimulation makes the individual’s prepotent cue into a stronger 
motivational magnet at phasic moments triggered by a CS that predicts the reward UCS.  
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 Building on these findings in Chapter 3, I explored the function of the dorsolateral 
neostriatum (DLS), a neostriatal area functionally connected with the CeA (Gonzales and 
Chesselet 1990; Faure, Haberland et al. 2005; Lingawi and Balleine 2012). I 
microinjected the mu opioid receptor agonist DAMGO into DLS and reported an increase 
in intensity and focus of sign- and goal-tracking behavior. After DAMGO microinjection 
both sign- and goal-trackers approached their target cue more exclusively and expressed 
more intense appetitive behaviors.  
To explore whether this enhancement was mediated by activation of habitual S-R 
response patterns, or whether it was due to the enhanced incentive motivation of the 
target cues, we altered 2 aspects of our paradigm known to reveal S-R responding, the 
environment and the value of the reinforcer (Carr and Watson 1908; Dickinson and 
Balleine 1990). When the CS+lever suddenly appeared out of the back wall of the 
operant chamber, a place it had never appeared before, rats abandoned their trained motor 
ritual and using a new motor pattern, followed the CS+lever to its new location. DAMGO 
microinjection did not inhibit this switch by enhancing the motor habit; in contrast 
DAMGO microinjection slightly facilitated this shift. To determine if following the lever 
to a location was in fact the S-R association (S = lever presentation, R = approach and 
follow), rather than the motor ritual, we devalued the sucrose pellet and presented the 
CS+lever in a new location. Rats that were fed to satiety on sucrose pellets before testing 
(in extinction) did not follow the CS+lever to its new location and rats that only received 
time in the operant chamber, but no food, followed the CS+lever (as was observed 
previously). So, the CS+lever’s value and the value of the following response were 
dependent on the value of the UCS sucrose pellet, indicating the following response was 
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not habitual in nature. Thus, it can be concluded that the enhancement of sign- and goal-
tracking by DAMGO was not due to activation of previous motor action patters or 
learned S-R associations, but rather to the dynamic enhancement of the incentive salience 
properties of the target cue.  
Finally, we sought to test if DAMGO microinjection also enhanced the 
conditioned reinforcing properties of the CS+lever for sign-trackers. In this paradigm 
animals learned an entirely novel nose poke response. Responding in the active port was 
rewarded with a 2 second CS+lever presentation while responding in the inactive nose 
port produced nothing and was used as a motor control measure. After DAMGO 
microinjection, rats responded significantly more in the active port (responding on the 
inactive port did not change), this demonstrates that DAMGO activation of DLS 
increased the conditioned reinforcing properties of the CS+lever.  
The enhancement of incentive salience attributed to reward cues after DAMGO 
microinjection in dorsolateral neostriatum was neuroanatomically unique within the 
neostriatum. Microinjections of DAMGO to the dorsomedial neostriatum did not enhance 
the incentive salience of learned cues, nor did it enhance the conditioned reinforcing 
properties of the CS+lever. This demonstrates a functional dichotomy between the two 
nearby regions where dorsomedial neostriatum is important for amplifying incentive 
salience for natural UCS rewards and dorsolateral neostriatum participates in amplifying 
incentive salience attributed to preferred learned CSs.  
To explore the neurochemical specificity of this enhancement of incentive 
salience attributed to the preferred target cue, I injected a low dose of amphetamine into 
the DLS before autoshaping testing. The effects of this treatment were not similar to 
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those of DAMGO. After amphetamine microinjection, purely sign- and goal-tracking rats 
did not demonstrate an increase in responding. Those rats that were mainly sign-trackers, 
but showed some goal-tracking greatly increased the amount of goal-tracking they 
performed following amphetamine microinjection. These results are novel and indicate 
enhanced dopamine transmission in DLS may bias behavior towards more proximal, 
contiguous cues rather than more distal, predictive cues.  
In chapter 3, I demonstrated that activation of mu opioid receptors within the 
dorsomedial neostriatum did not increase incentive motivation for learned cues. In 
chapter 4, I explored the role of this region in generation of motivation for primary 
rewards, namely palatable M&M candies.  First, I investigated endogenous opioid release 
in dorsal neostriatum during spontaneous eating of a palatable sweet food using 
microdialysis. Samples were analyzed using liquid chromatography coupled with mass 
spectrometry (MS3). I observed a robust increase in extracellular enkephalin, but not 
dynorphin, at the onset of the palatable meal, which decreased as rats stopped eating. 
This surge was unique to the period of time rats were consuming M&Ms. Periods of 
intense oromotor and forelimb movement did not produce the same enkephalin surge.  
To determine if this enkephalin surge caused intense motivation to consume 
palatable foods, I stimulated mu opioid receptors via DAMGO microinjection in 
dorsomedial neostriatum and observed that rats doubled their intake of a sweet palatable 
food. This effect was confined anatomically to the anteromedial quadrant of dorsal 
neostriatum. Delta opioid receptor stimulation did not cause a similar effect. Using the 
taste reactivity test, I demonstrated that mu opioid receptor activation did not enhance the 
‘liking’ or hedonic impact of the sweetness or the M&Ms themselves. Together these 
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results indicate a role for enkephalin and mu opioid receptors in dorsomedial neostriatum, 
in the generation of motivation to consume sensory rewards.  
In chapter 5, I tested the ventrolateral neostriatum, an area that had previously been 
demonstrated to generate increases in consumption of palatable food, but is also 
implicated in forelimb motor function, making it difficult to separate motor function from 
motivation. In this chapter I replicated the findings that DAMGO microinjection to VLS 
enhances consumption of palatable foods. After DAMGO microinjection, rats ate about 
180% vehicle levels of M&Ms. When DAMGO was injected in the autoshaping 
paradigm, it increased goal-tracking in sign-trackers. Sign-trackers doubled their 
approaches to the CSdish and greatly increased the appetitive behaviors directed at the 
CSdish. In contrast, goal-trackers did not shift to sign-trackers or goal-track more. It 
appears the DAMGO microinjection shifted the target of incentive salience from the 
distal, predictive lever, to the contiguous, proximal goal. This shift was not total, they did 
not become goal-trackers, but the CSdish was now attributed with enough incentive 
salience to compete with the CS+lever.  
 
General discussion of CS trigger versus CS target roles. 
A continuing puzzle is why target and trigger are separate objects for goal-
trackers, but not for sign-trackers. For sign-trackers, the situation is most intuitive. The 
CS+ Lever presentation is always the most predictive event for reward delivery, being 
correlated in event probability with the UCS. Each CS+ (lever insertion and sound) was 
followed 8 sec later by a UCS, and the UCS never occurred without being preceded by 
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the CS+. This predictive relationship makes the CS+lever the trigger (and at least for 
sign-trackers, also the target). 
 By comparison, the CSdish was less informatively predictive, being always 
present and therefore associated both with UCS and with its absence. However, the CSdish 
was the Pavlovian CS with closest spatial and temporal contiguity to the UCS. That is, 
the dish was always the last thing the rat saw or felt before tasting sucrose reward, 
because the rat’s head was always inserted into that dish at the moment of pellet ingestion. 
This dish-in-the-face as stimulus complex was paired almost simultaneously with the 
hedonic taste of sucrose. CS-UCS contiguity has long been recognized as important to 
facilitating Pavlovian associations, and contiguity may remain important in controlling 
the target for goal-trackers even when contingency dominates the associative correlation 
that generates rt as a phasic prediction from the trigger (Zener 1937; Mackintosh 1974; 
Rescorla and Cunningham 1979; Wassum, Cely et al. 2009).  
Contiguity of CS with UCS may become even more important for incentive 
salience attribution when mesocorticolimbic circuits are pharmacologically stimulated 
(Tindell, Berridge et al. 2005; Smith, Berridge et al. 2011). For example, previous studies 
reported that opioid or dopamine stimulation of the nucleus accumbens selectively 
enhanced incentive salience of a UCS-contiguous CS2 stimulus, but not of a UCS-
predictive CS1. Contiguity dominance applied to all rats when tested in a Pavlovian CS-
CS-UCS series, in which a UCS-predictive CS1 was followed by a UCS-contiguous CS2, 
(Tindell, Berridge et al. 2005; Smith, Berridge et al. 2011). Here, DAMGO in CeA and 
DLS of goal-tracking individuals selectively enhanced attribution of incentive salience to 
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that contiguous CSdish, target alone, just as it enhanced the attributions by sign-trackers to 
their own prepotent cue, the predictive CS+ Lever.  
In contrast, activation of dopamine receptors indirectly through microinjection of 
amphetamine only enhanced the incentive salience to the contiguous CSdish. Previous 
studies using amphetamine or cocaine systemically have demonstrated a shift from sign- 
to goal-tracking after injection (Simon, Mendez et al. 2009; Holden and Peoples 2010). 
This is not exactly what was observed in the present study, however. Those rats that did 
not goal-track at all during training were not transformed into goal-trackers. Only those 
rats that had attributed some incentive salience to the CSdish during training demonstrated 
an enhancement in goal-tracking after amphetamine injection. So, it appears that 
amphetamine microinjection to DLS is not enough to entirely shift the target of incentive 
salience to the CSdish, but instead is able to enhance the attractive power of the contiguous 
CSdish only if it had any to begin with.  
Anatomical connectivity of extended amygdala with neostriatum 
How can manipulations of activity in the central nucleus of the amygdala and the 
dorsolateral striatum produce similar enhancements in focus and selectivity? More 
generally how does the extended amygdala interact anatomically with the striatum?  
CeA has been suggested to be embedded within the larger extended amygdala 
macrosystem (Swanson and Petrovich 1998; de Olmos and Heimer 1999; Alheid 2003; 
Heimer, Van Hosen et al. 2008), the lateral (or central) division of which begins in CeA 
and connects to the bed nucleus of stria terminalis (BNST), sublenticular extended 
amygdala (SLEA) and interstitial posterior limb of the anterior commissure (IPAC) 
(Zahm 2006). The extended amygdala system shares special features with caudal portions 
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of the medial shell of the nucleus accumbens (Reynolds and Zahm 2005; Heimer, Van 
Hosen et al. 2008). The CeA also can be viewed in light of macrocircuit concepts 
described by Swanson (Swanson 2005; Heimer, Van Hosen et al. 2008), in which CeA is 
a striatal-level component (GABAergic), receiving inputs from the basolateral nucleus of 
amygdala (BLA) as a cortical-level component (glutamatergic), and sending outputs to 
BNST, SLEA and IPAC as pallidal-level components (GABAergic). This striatal-level 
status may be especially noteworthy for CeA’s status as an incentive salience generator, 
in that several other striatal-level structures also can generate intense enhancements of 
incentive salience when neurochemically stimulated, including the ventral striatum and 
portions of the neostriatum as described here (Wyvell and Berridge 2000; Pecina and 
Berridge 2008; DiFeliceantonio, Mabrouk et al. 2012). This allows us to group these 
structures anatomically and psychologically as striatal incentive salience generators.   
Interestingly, the CeA can also interact with the DLS through the substantia nigra. 
The CeA is functionally and anatomically connected to the substantia nigra pars 
compacta (Gonzales and Chesselet 1990; Rouillard and Freeman 1995). Specifically, the 
CeA projects to the same region of the compacta that then projects to the dorsolateral 
neostriatum (Gonzales and Chesselet 1990; Faure, Haberland et al. 2005; Lingawi and 
Balleine 2012). So, change in activity at either end (CeA or DLS) could be tuning part of 
the same circuit that directs and amplifies incentive salience.  
The major input structure to the CeA within the extended amygdala construct is 
the BLA (Alheid 2003). The BLA itself receives cortical input from prelimbic, 
infralimbic, and orbitofrontal cortices (Grace and Rosenkranz 2002; Rosenkranz and 
Grace 2002; Wassum, Tolosa et al. 2012). So, through the BLA, the CeA receives similar 
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cortical information as does the striosome/patch compartment within the dorsal 
neostriatum (Figure 6.1).  
Opioid neurotransmission in CeA and dorsal neostriatum appears to be especially 
important to dynamic amplification and focusing of incentive salience that makes a 
Pavlovian cue into a motivational magnet. Endogenously, CeA neurons receive mu 
opioid stimulation from local enkephalin neurons of amygdala and from β-endorphin 
axons projecting from the hypothalamic arcuate nucleus (Jackson and Berridge 2008; 
Poulin, Castonguay-Lebel et al. 2008; Le Merrer, Becker et al. 2009). DAMGO 
microinjection in CeA may mimic such endogenous opioid sources, increasing FOS gene 
transcription in CeA neurons (Mahler and Berridge 2009). Opioid stimulation may 
promote GABAergic disinhibition of output structures (Morris and Dolan 2001; Zhu and 
Pan 2004), to modulate and stimulate mesocorticolimbic dopamine circuits, via indirect 
projections such as to the lateral hypothalamus and peduncular pontine nucleus which in 
turn project to VTA (Gonzales and Chesselet 1990; Gauthier, Parent et al. 1999; Zahm 
1999; Heimer, Van Hosen et al. 2008; Day, Jones et al.). Here, DAMGO microinjections 
into CeA may well have potentiated mesolimbic dopamine circuits to nucleus accumbens 
as a step in amplifying the intense bouts of incentive salience observed in appetitive-
consummatory behavior (Wyvell and Berridge 2000; Jackson 2009; Smith, Berridge et al. 
2011). 
Within the dorsal neostriatum, enkephalin in released from dopamine D2 receptor 
expressing neurons in the matrix. In dorsal neostriatum, mu opioid receptors are localized 
mainly in “patch” or “striosome” compartments (Pert, Kuhar et al. 1976; Herkenham and 
Pert 1980; Gerfen 1984; Crittenden and Graybiel 2011). Patches or striosomes in 
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neostriatum receive converging inputs from limbic regions of prefrontal cortex, including 
from orbitofrontal, prelimbic, and anterior cingulate regions (Ragsdale and Graybiel 1988, 
1990; Eblen and Graybiel 1995; Kincaid and Wilson 1996; Levesque and Parent 1998; 
Graybiel 2008; Crittenden and Graybiel 2011), again similar to those that converge on the 
BLA and in turn the CeA (Figure 6.1).  
Cortical inputs are also compartmentalized according to layer, with “deep” layers 
projecting preferentially to patch and superficial layers projecting preferentially to matrix 
(Wilson 1987; Gerfen 1989). Further, although these distinctions hold true for dorsal 
neostriatum, they start to break down along the dorsoventral axis where areas that did 
project solely to patch begin to project also to the matrix (Gerfen 1984; Eblen and 
Graybiel 1995; Kincaid and Wilson 1996; Levesque and Parent 1998).  
So, cortical afferents seem to project preferentially to one compartment over the 
other, at least most clearly in dorsal neostriatum. Cortical projecting neurons can also be 
categorized into one of two projection types: 1) intra-telencephalic-projecting (IT-type) 
and 2) pyramidal tract-projecting (PT-type) (Reiner, Jiao et al. 2003). IT-type neurons 
project to both hemispheres and synapse preferentially on D1 receptor containing neurons 
(direct pathway). PT-type neurons on the other hand synapse preferentially on D2 
receptor containing indirect pathway neurons. IT-type neurons are enriched in upper 
layers while PT-type neurons are enriched in deep layers. There is some debate as to 
whether these projection types show compartment specificity and what the functional role 
of this specificity would be (Reiner, Hart et al. 2010; Crittenden and Graybiel 2011). 
Reiner et al (2010), suggest that both IT-type and PT-type neurons synapse on direct and 
indirect pathway neurons respectively in the matrix, but only PT-type projections are 
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found in the patch. The authors do not posit a functional role for this compartmental 
specificity, but rather for the general direct or indirect pathway systems, irrespective of 
compartment. Based on their model, however, this would mean activity in patch is related 
to suppression of movements and disruption of this inhibition through mu opioid receptor 
activation by enkephalin should lead to an increase in a selected behavior (Graybiel 2005; 
Reiner, Hart et al. 2010).  
Other roles for the patch and matrix  
Another division of function for patch and matrix comes from a model of learning 
known as the actor-critic model. In this model there is an adaptive critic that computes 
the likelihood and magnitude of reward for different actions and an actor that carries out 
these actions by referring to saved action values (Joel, Niv et al. 2002). Houk and 
colleagues (1995) proposed that within the striatum, the patch compartment acts as the 
critic, while the matrix acts as the actor. In this model the patch critic signals the value of 
an action or a stimulus by chronically inhibiting DA neuron firing and allowing bursts of 
phasic excitation (Houk, Adams et al. 1995). Altering activity of the critic through 
pharmacology could lead to a specific action gaining exaggerated value. Specifically 
activation of mu opioid receptors could lead to the critic assigning more value to 
approach and consumption of the CS+lever or CSdish. This model would either require 
incremental increases in approach and appetitive-consummatory behaviors to the 
preferred cue reflecting incremental increases in the feedback from the critic to the actor 
or a single feedback event that brings the action value of approach to the preferred cue to 
asymptote. Therefore, the results reported here are congruent with an actor/critic model 
of patch/matrix function. Some evidence for this hypothesis is that rats will more readily 
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administer intracranial self-stimulation if the electrodes are placed in the patch, rather 
than the matrix. This could be due to stimulation of the critic which then provides 
exaggerated feedback to the actor, greatly increasing the action value of lever pressing 
(White and Hiroi 1998).  
This raises the further question of the division of function between dorsomedial and 
dorsolateral neostriatum. Presumably, DAMGO microinjection is affecting the 
patch/critic similarly regardless of area within the neostriatum. This begs the question of 
where the regional specificity arises. One option is which action value that is enhanced 
by the critic would logically differ according to which actions are encoded by nearby 
ensembles in the matrix actor. If values of approach and appetitive behaviors directed at 
cues were encoded in dorsolateral neostriatum and values of more proximal primary 
consumption actions were held in the dorsomedial neostriatum, the results observed here 
would be expected.  
Other roles for the dorsolateral neostriatum 
The dorsolateral or sensorimotor region of neostriatum is known to play roles in 
serial movement patterns and S-R habits. One line of evidence for DLS in habits has been 
that DLS apparently becomes increasingly recruited over time as learned actions become 
more over trained or habitual. For example, DLS lesions are reported not to disrupt 
cocaine self-administration early in training, but do produce disruptions of self-
administration if made later after additional training (Murray, Belin et al. 2012). This and 
similar evidence has led to the hypothesis that dorsolateral neostriatum mediates habitual 
action and is especially important for pathologies such as addiction (Everitt and Robbins 
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2005; Everitt, Belin et al. 2008). Interestingly, many of these studies use a conditioned 
reinforcer during the test phase (Vanderschuren, Di Ciano et al. 2005; Belin and Everitt 
2008b; Murray, Belin et al. 2012). Here, I have demonstrated that opioid receptor 
activation in dorsolateral neostriatum enhances the conditioned reinforcing properties of 
cues. It is possible that, rather than controlling an established action pattern solely; 
dorsolateral neostriatum can also maintain and amplify cue values. This interpretation 
does not detract from the work of Everitt and colleagues but generates new questions that 
can be answered through experimental techniques that explicitly test action versus cue 
value such as the ones used here in Chapter 3.  
A related line of evidence is that learned reward-seeking actions become 
increasingly independent of outcome as overtraining proceeds, so that over trained 
learned behaviors perseverate even if the reward has been devalued by satiety or if the 
act-outcome contingency is diluted by free rewards (Dickinson and Balleine 1990; 
Balleine and O'Doherty 2010). Lesions of the DLS reduce such perseveration, so that 
learned responses decline again after reward devaluation or contingency dilution (Yin, 
Knowlton et al. 2004, 2006). A third line of evidence for DLS involvement in habits is 
serial ritualization into stereotyped patterns that characterize habits (Graybiel 2008). 
Habitual actions can be computationally generated by a prediction error mechanism that 
once trained operates inflexibly (Daw, Niv et al. 2005). Rigid serial patterns of action are 
disrupted by lesions of the dorsolateral neostriatum, both for learned serial rituals (Yin 
2010) and for instinctive rituals of serial actions (Cromwell and Berridge 1996).  Further, 
neurons within the dorsolateral neostriatum track the chunking of serial actions into 
ritualized patterns, both for learned rituals (Barnes, Kubota et al. 2005) and instinctive 
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serial rituals (Aldridge and Berridge 1998). In short, “habits are sequential, repetitive, 
motor, or cognitive behaviors elicited by external or internal triggers that, once released, 
can go to completion without constant conscious oversight” (Graybiel 2008), in which 
DLS plays an important role. 
DLS opioid enhancement of CS attraction: “wanting” motivation or S-R habit? 
With the above points in mind, it is crucial to ask whether DLS microinjections of 
DAMGO strengthened an S-R habit ritual to enhance approach and consummatory 
responses to a prepotent CS.  I believe the evidence clearly shows the answer to be ‘no’.  
First, there was no ‘who moved my cheese?’ perseveration of sign-trackers’ well-
established approach ritual to familiar-location when their CS+lever was suddenly moved 
to a new location. Instead, rats almost immediately abandoned their old ritual within a 
second or two, and switched to the new location using a new movement sequence of 
opposite-direction turn and longer strides. Rats switched even faster after DAMGO and 
reached the new location with even greater alacrity, suggesting the rats more intensely 
‘wanted’ the moved cue and were willing to flexibly follow it. Second, DLS 
microinjections of DAMGO also made rats ‘want’ the CS+lever cue more in the sense of 
being willing to learn an entirely new movement response to earn it. Rats learned a new 
nose-poke response, and performed at higher levels to earn CS+lever insertions as an 
instrumental conditioned reinforcer after DAMGO microinjection in DLS than after 
vehicle microinjections. Although conditioned reinforcement can be explained in several 
ways, the enhancement is certainly consistent with the notion that DLS opioid stimulation 
made rats ‘want’ the Pavlovian cue more intensely. Finally, sign-tracking itself as a 
behavioral response never quite became habitual in the accepted sense of persisting after 
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UCS devaluation. Instead, sign-tracking immediately reduced after UCS devaluation by 
satiety induction. Devaluation sensitivity suggests that sign-tracking always remained a 
motivated response, integrating current biological state with learned Pavlovian 
information as incentive salience computation typically does (Zhang, Berridge et al. 2009; 
Berridge 2012; Robinson and Berridge 2013).  
Dopamine stimulation in DLS by amphetamine microinjections also may have 
produced a motivational enhancement but of a different type. Amphetamine 
microinjection more selectively enhanced goal-tracking alone, and only in ‘mixed’ 
individuals that originally both sign-tracked and goal-tracked to comparable degrees.  It 
is difficult to view this as S-R habit enhancement, since there was no enhancement in 
individuals that showed the strongest patterns to begin with, i.e., sign-trackers   
Other roles for the dorsomedial neostriatum 
In contrast to the dorsolateral neostriatum, the dorsomedial neostriatum has been 
implicated flexible act-outcome associations rather than rigid S-R associations. 
Inactivation of this area prevents animals from updating behavior after changes in reward 
value (Yin, Knowlton et al. 2005; Yin, Ostlund et al. 2005). If dorsomedial neostriatum is 
important for encoding current reward value, the increase in food consumption reported 
here after DAMGO microinjection could be due to an increase in primary reward value.  
Dorsomedial neostriatum is also involved in reversal learning and task switching 
(Pisa and Cyr 1990; Ragozzino 2003; Kehagia, Murray et al. 2010). Therefore, 
dorsomedial neostriatum along with its cortical affects from the prefrontal cortex and the 
orbitofrontal cortex has been hypothesized to be critical for “cognitive” flexible 
behaviors (Arana, Parkinson et al. 2003; Coutureau and Killcross 2003; Pickens, Saddoris 
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et al. 2003; Grahn, Parkinson et al. 2008). Here, activation of mu opioid receptors 
potently enhanced consumption of palatable rewards, but did not enhance approach to 
reward paired cues or the conditioned reinforcing value of those cues. We also 
demonstrated that there is an endogenous enkephalin code of consumption of palatable 
foods in dorsomedial neostriatum, so the eating observed was not due to an artificial 
disruption of the system. How do we reconcile the role of the dorsomedial neostriatum in 
simple eating with its established role in “cognitive” processes? Grahn and colleagues 
(2008) suggest the “cognitive” function of medial neostriatum is that it works to promote 
an appropriate behavioral strategy. In the presence of a calorically dense resource, the 
most appropriate behavioral strategy is to engage in intense eating. This hypothesis 
requires further testing, however, perhaps by measuring enkephalin levels in task 
switching and reinforcer devaluation paradigms.  
Previous work on the function of dorsolateral and dorsomedial neostriatum has relied 
mainly on lesion and inactivation studies (Yin, Knowlton et al. 2004; Vanderschuren, Di 
Ciano et al. 2005; Yin, Knowlton et al. 2006; Belin and Everitt 2008a). Lesions or 
mixtures of GABA and glutamate acting drugs would affect both patch and matrix 
similarly. This could be why the studies described here reveal motivational processes of 
the dorsal neostriatum while others do not. Here, I’ve preferentially engaged the patch 
with a mu opioid receptor agonist, without engaging the surrounding matrix. It is possible 
that the patch acts as a distributed motivational network throughout dorsal neostriatum, 
allowing integration of motivational and motor information. Lesions and inactivations 
would not reveal these effects, but would rather show the effect of disrupting the network 




Other roles for the ventrolateral neostriatum 
Some researchers have suggested that the increase in eating observed after 
manipulation of ventrolateral neostriatum is due to activation of oromotor and forelimb 
motor responses or motor impairment (Salamone, Mahan et al. 1993; Cousins, Trevitt et 
al. 1999). Here, I sought to better understand the role of ventrolateral neostriatum in 
generating motivation by also testing a manipulation that produces eating in an 
autoshaping paradigm. A motor impairment hypothesis would predict overall deficits in 
responding in both sign-trackers and goal-trackers. Here, no overall changes in total 
amount of behavior were observed. In addition, no gross motor impairments were noted 
in a detailed analysis of video recordings for all tests. It appears instead that mu opioid 
receptor activation in VLS plays a specific role in enhancing motivation for primary 
rewards and reward cues paired closest in time and space with those primary rewards.  
Other roles for central amygdala 
CeA has traditionally been thought of as part of circuitry responsible for 
conditioned fear (LeDoux 2000), but more recently the CeA has been shown to be 
involved in translating learned information into motivation regardless of affective valence 
(Hollerman and Schultz 1998; Everitt, Parkinson et al. 1999; Hall, Parkinson et al. 2001; 
Holland and Gallagher 2003; Corbit and Balleine 2005). Lesions of CeA impair 
conditioned orienting to a discreet appetitive CS, establishing a role for CeA in appetitive 
conditioning (Gallagher, Graham et al. 1990). Further, CeA is needed for the general 
activating effects of Pavlovian to Instrumental transfer, as is the DLS (Corbit and 
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Balleine 2005; Corbit and Janak 2007), demonstrating that CeA is needed to translate 
appetitive cues into motivated action. The results presented here do not conflict with 
previous findings on CeA. Rather, they extend these findings to demonstrate that mu 
opioid receptor activation of this area enhances approach and consummatory behaviors 
directed at a preferred appetitive CS.  
Future directions 
Optogenetics is a promising tool to begin to answer some of the lingering 
questions this dissertation leaves. In CeA, CAG-ArchT or CAG-ChR2 can be used to 
generally inhibit or excite the neuronal population (Huff, Miller et al. 2013). If DAMGO 
microinjection is causing a general increase in neuronal activity in CeA, I expect those 
animals with CAG-ChR2 viral infusions will show behaviors similar to DAMGO 
microinjection.  
In addition, a promising avenue to understand how enkephalin release is 
controlled in the striatum is to combine optogenetics and microdialysis. We could take 
advantage of mice that express that uniquely express Cre recombinase in D2 containing 
striatal neurons (Kravitz, Freeze et al. 2010). Using Cre dependent channelrhodopsin, we 
could preferentially drive D2 neuron firing with laser stimulation and measure extra-
cellular enkephalin concurrently. For example, in dorsomedial neostriatum, we would 
expect optogenetic excitation of the D2 pathway would drive enkephalin release and 




 In this dissertation I sought to expand our understanding of motivational circuitry 
to areas outside the traditional “reward pathway.” Through the course of this work I have 
confirmed that central amygdala plays a role in generating intense motivation. I have 
demonstrated that dorsomedial neostriatum and dorsolateral neostriatum generate 
motivation for unconditioned and conditioned rewards, respectively. Finally, I have 
expanded our understanding of the role of the ventrolateral neostriatum in generating 
motivation. As a whole, this work begins to identify a distributed motivational network 
throughout the brain, not just in traditional “reward structures.” It underscores the 
importance of continued testing and questioning of multiple brain areas through multiple 






Figure 6.1. Anatomical connectivity of the extended amygdala, midbrain dopamine 
nuclei, striatum, and cortex. Structures are color coded according to where they project to 
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